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Aim of the thesis 
Hypertensive disorders are serious complications of pregnancy, with high perinatal 
morbidity and mortality. The etiology of these diseases is still largely unknown 
Circulating 'toxic substances', lipid peroxides or oxygen free radicals generated by the 
feto-maternal interface may lead to maternal endothelial damage and dysfunction The 
resulting maternal clinical syndrome may include a variety of pathophysiological 
features such as vasocontriction, decreased plasma volume, haemolysis and multi-
organ failure Recent studies have focussed their attention on a possible deficient 
maternal detoxicating system, unable to deal with the increased load of 'toxic 
substances'. 
The glutathione / glutathione-related enzyme system in a quantitative sense is one 
of the most important detoxicating systems in humans Glutathione and glutathione-
related enzymes (glutathione S-transferases and glutathione peroxidases) are involved 
in the detoxification of endogenous and exogenous toxic substances, carcinogens, and 
oxygen radicals. Deficiencies in parts of this system may be related to the etiology of 
hypertensive disorders of pregnancy. Serum or plasma concentrations of glutathione S-
transferases may be reliable markers for disease. For instance, plasma glutathione S-
transferase Alpha 1-1 is a sensitive and specific marker for hepatocellular impairment, 
and glutathione S-transferase Pi 1-1 may be a marker for haemolysis. 
In this thesis several studies are presented on the glutathione / glutathione-related 














The glutathione / glutathione-related enzyme system in a quantitative sense, 
is one of the most important protective systems in humans. Glutathione and 
glutathione-related enzymes are involved in the metabolism and 
detoxif icat ion of cytotoxic and carcinogenic compounds as well as reactive 
oxygen species. The role of reactive oxygen species in reproduction has 
been the subject of many investigations and there is compelling evidence for 
the involvement of these species in the physiology and pathology of both 
male and female reproductive systems. The glutathione / glutathione-related 
enzyme system is extensively studied in gynaecological oncology, but to a 
lesser extent in other fields related to reproduction. In this paper a review is 
provided on the glutathione / glutathione-related enzyme system in 
reproduction. Attention is given to its role as a detoxicating system and as 
an early marker for disease. 
1. INTRODUCTION. 
The glutathione / glutathione-related enzyme system (GSH / GSH-related enzyme 
system), in a quantitative sense, is one of the most important protective systems in 
humans. GSH and GSH-related enzymes are involved in the metabolism and 
detoxif ication of cytotoxic and carcinogenic compounds as well as reactive oxygen 
species (ROS) [1]. The role of ROS in reproduction has been the subject of many 
investigations, and there is compelling evidence for the involvement of ROS in the 
physiology and pathology of both male and female reproductive systems [2, 3]. The 
GSH-related enzymes, glutathione peroxidase (GPX) [4] and glutathione S-transferase 
(GST) are also involved in the metabolism of leukotnenes and prostaglandins [5]. Serum 
or plasma GST levels are measured as markers of disease [6]. The GSH / GSH-related 
enzyme system has been studied extensively in oncological disease [7] [for reviews see: 
Hayes 18, 9] , Beckett [6], Tsuchida [10]] So far relatively little attention has been given 
to the study of this important detoxicating and scavenging system in the etiology and 
pathophysiology of reproduction-related non-oncological disease, such as hypertensive 
disorders of pregnancy [11]. Until now this research has been focused mainly on GPX 
in relation to scavenging and lipid peroxide inactivating functions [1 1] 
In this chapter a review is provided of the GSH / GSH-related enzyme system in 
reproduction. Attention is given to its role as a detoxicating system, and as an early 
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marker for disease. 
2. DETOXIFICATION MECHANISMS. 
Reactive oxygen species (ROS) or oxygen radicals are involved in human disease [12, 
13]. Most, if not all, organisms are equipped with enzymatic and non-enzymatic 
defence mechanisms against oxidants and other toxic compounds Many toxic 
compounds are ingested through nutrition, air pollution etc , or formed within the body 
[ 1 4 ] . Enzymatic protection against ROS and the breakdown products of peroxidized 
lipids and oxidized DNA is provided by superoxide dismutases [15], catalase [ 1 5 ] , GPX 
[ 1 6 ] , GST [17], aldo ketoreductases [18] and DNA repair enzymes [19] Non-enzymatic 
detoxification is provided by many different agents such as transferrin, ceruloplasmin, 
lactofernn, vitamin E (α-tocopherol), vitamin С (ascorbic acid), uric acid and taurine, as 
well as thiols, such as GSH, cysteamine and cysteine. The GSH / GSH-related enzyme 
system, in a quantitative sense, is one of the most important protective systems in 
humans. 
2 . 1 . GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES. 
2 . 1 . 1 . Glutathione. 
The tripeptide glutathione (GSH, L-Y-glutamyl-L-cysteinyl-glycine, Fig. 1) plays a central 
role in the protection of cells against oxidative [20, 21] and electrophilic [22, 23, 24] 
stress and radiation [25] Oxidative stress refers to the unusually high presence of 
molecules wi th a high potency to abstract electrons from biomolecules Free radicals 
are the most important class of biological Oxidators Electrophilic stress is defined as 
the effect of compounds with a high reactivity towards nucleophilic centres present in 
biomolecules They are with increasing reactivity oxygen, nitrogen and sulphur This 
leads to the formation of new chemical bonds between the t w o (adduci formation) 
GSH can act either as a substrate in the cytosolic GSH-redox cycle, or is able to directly 
inactivate ROS, such as 0 2 and OH Erythrocytes and hepatocellular tissue are thought 
to contain the highest GSH redox activity [26] GSH is the most abundant non protein 
sulfhydryl present in cells, with cellular concentrations ranging from 0 5 - 1 0 m M , most 
of which exists in the reduced form [27]. The synthesis of GSH by aerobic cells can be 
considered as a way to hold high levels of usable cysteine in a non-toxic form Cysteine 
















Glutamate Cysteine Glycine 
Fig 1 The structure of the tripeptide glutathione IGSH, L-y-g/utamyl-L-cysteinyl-g/ycine) 
As a result of the hydrogen peroxides liberated during this auto-oxidation simple thiols 
such as cysteamine [29, 30] and cysteine [30] can be toxic to cells Blocking of the 
cysteine amino group by forming γ-glutamyl-cysteine considerably slows this auto-
oxidation [31] Coupling of glycine to the γ-glutamylcysteine dipeptide by GSH 
synthetase leading to GSH synthesis, makes it even more resistant to auto-oxidation 
[31] Furthermore, this reaction provides a more extended carboxylsite that is used for 
substrate recognition and active site handling by many GSH dependent enzymes [32, 
33] The abundance of GSH in biological systems has led to an enormous amount of 
research to find 'the role of GSH' [32] Currently a myriad of functions is known, and 
many of them are vital Some of these important functions are (a) the detoxification of 
xenobiotics [34], (b) removal of hydrogen peroxide and other peroxides as well as free 
radicals [ 2 1 ] , (c) maintenance of free protein sulfhydryl groups [35] and (d) the 
synthesis of leukotnene C4 and derivatives [36]. These functions may lead to variations 
in the cellular availability of GSH [37] Under conditions of marked toxicity or oxidative 
stress, a variety of processes can occur which may lead to the oxidation of GSH into 
the oxidized form GSSG [38, 39] Regeneration of GSH from oxidized GSH in the cell is 
affected by the enzyme GSH reductase Due to the high nucleophilic potency of the 
GSH sulfhydryl moiety, GSH can function as an excellent nucleophilic scavenger for 
many reactive electrophiles [22, 33] In many cases this reactivity is further increased 
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Fig 2 Glutathione conjugation by glutathione S-transferase IGST) and subsequent steps of the 
mercaptunc acid pathway The ^-glutamyl moiety is removed by γ glutamyl transferase 
(yGT) the remaining dipeptide can subsequently be cleaved by cystemyl glycine 
dipeptidase or ammopeptidase M to yield a cysteine conjugate This cysteine conjugate 
can be N-acetylated by N-acetyl transferase (NAT), which leads to mercaptunc acid 
formation 
such as DNA, thereby presenting a genotoxic risk [401, this conjugation with GSH 
furnishes an important protection mechanism In some instances however, the GSH 
conjugates may in turn be toxic to cells [ 4 1 , 4 2 , 43] GSH S-conjugates can be further 
metabolized to the corresponding cysteine conjugates by yGT, cysteinylglycine 
dipeptidase and ammopeptidase M [42], which can subsequently be N-acetylated to 
yield mercaptunc acids (Fig 2) [44, 45] The thio-ethers formed are often excreted in 
urine and can be used for biological monitoring of exposure to electrophilic compounds 
[45, 4 6 ] . Formation of GSH conjugates will lead to loss of available GSH. For an overall 
summary of GSH metabolism see Fig. 3. 
2.1.2. Glutathione S-transferases. 
The metabolism of foreign compounds usually involves two distinct stages, commonly 
referred to as phases I and II Phase I metabolism involves an initial oxidation, reduction 
or dealkylation of the xenobiotic by cytochrome P450 (CYP) monooxygenases [47] 
This step is often needed to provide a molecule with hydroxyl- or ammo-groups, which 
are essential for phase II reactions. Phase II metabolism generally adds hydrophilic 
moieties, thereby making a toxin more water soluble and less biologically active Most 
involved phase II conjugation reactions are catalyzed by GST [34], UDP glucuronyl 
transferases [48], and sulfotransferases [49] The GSTs catalyze the addition of GSH to 
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Fig 3 Overall summary of glutathione metabolism reaction 1 y-GLU CYSH synthetase 
Reaction 2 GSH synthetase. Reaction 3 and 3a glutamyl transpeptidase, Reaction 4 γ-
g/utamyl cyclotransi'erase, Reaction 5 5-oxoprolinase, Reaction 6 and 6a dipeptidase, 
Reaction 7 GSH transferases, Reaction 8 N-acetylase, Reaction 9 GSH peroxidase, 
Reaction 10 transhydrogenases. Reaction 11 GSSG reductase. Reaction 12 oxidation 
of GSH by 02 Conversion of GSH to GSSG is also mediated by oxygen free radicals 
r e s u l t i n g in the f o r m a t i o n o f m e r c a p t u n c acids 11] 
T h e c y t o s o l i c g l u t a t h i o n e S-transferases (EC 2 5.1 18) are a f a m i l y o f e n z y m e s 
c o n s i s t i n g of f o u r m a i n c lasses, A l p h a , M u , Pi and T h e t a , e a c h d i v i d e d into one or m o r e 
i s o f o r m s 1 1 , 6 ] T h e y p r o v i d e p r o t e c t i o n against e l e c t r o p h i l e s a n d p r o d u c t s of o x i d a t i v e 
s t r e s s and can also serve as i s o m e r a s e s [ 3 4 ] The i n s e n s i t i v i t y of cells t o c h e m i c a l 
s t r e s s is d e p e n d e n t o n t h e levels of e x p r e s s i o n of t h e c h e m i c a l d e f e n c e m e c h a n i s m s 
m e n t i o n e d in t h e f i r s t l ines o f th is p a r a g r a p h P r o t e c t i o n against o x i d a t i v e stress is 
p a r t l y p r o v i d e d by the p e r o x i d a s e f u n c t i o n of cer ta in GST i s o e n z y m e s by c a t a l y z i n g the 
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reduction of organic hydroperoxides to their corresponding alcohols [50] Several GST 
isoenzymes possess selenium-independent GSH peroxidase activity wi th organic 
hydroperoxides such as hnoleic and arachidonic hydroperoxide, but not with hydrogen 
peroxide [51] The class Alpha GSTs exhibit the highest peroxidase activities [9] It 
should be noted that endogenous compounds such as leukotnene C, [52) and 
prostaglandin H2 [5, 53] are also metabolized by GSTs as part of their normal 
biosynthetic pathways All GSTs possess the ability to sequester substrate or non-
substrate drugs, hormones [54], including steroid and thyroid hormones, bile acids, 
bilirubin, fatty acids, haemoglobin, penicillin, and many other compounds [9], serving as 
mam intracellular transport proteins 
GSTs are widely distributed in nature and all eukaryotes appear to possess multiple 
isoenzymes [9] Many molecular forms of GSTs have been identified from various 
organs in a variety of species [6, 9, 34, 55, 56] Humans possess multiple cytosolic 
GST-isoenzymes, each of which displays distinct catalytic as well as non-catalytic 
binding properties The cytosolic enzymes are encoded by at least four related gene 
families (designated class Alpha, Mu, Pi and Theta GST [57, 58, 59]), whereas the 
membrane-bound enzymes, microsomal GST and leukotnene C4 synthetase are encoded 
by single genes and both have arisen separately from the soluble GSTs Generally, 
GSTs that share more than 40% identity belong to the same class and those that 
possess less than 30% identity are assigned to separate classes In humans, class 
Alpha, Mu, Pi and Theta GST genes are located on chromosomes 6, 1, 11 and 22 
respectively [9] The cytosolic GSTs are dimeric proteins, homodimers or heterodimers 
consisting of two subunits of approximately 25 kD molecular mass (range 23 - 28 kD) 
[60] The distribution of GST isoenzymes is tissue specific The reasons for this specific 
expression of GST isoenzymes most likely reflects the need to deal wi th specific 
substrates, which considerably vary between organs GST class Alpha is mainly 
expressed in the liver but is also present in the kidney, testis, adrenal gland and small 
intestine [ 1 , 7, 60, 6 1 , 62, 63] Two class Alpha subunits have been identified and two 
homodimeric (GSTA1-1 and GSTA2 2) and a heterodimeric enzyme (GSTA1-2) have 
been purified from human liver [64] For GST Pi, so far one isoform is described 
GSTP1-1, which is expressed as a major form in many organs such as lung, breast, 
placenta, erythrocytes, large intestine or urinary bladder [7, 65, 66, 67, 68] The 
molecular evidence of allelopolymorphism of the human GST Pi gene locus, resulting in 
active, functionally different GST Pi proteins was reported recently [69] The human Mu 
and Theta classes of GST appear to be expressed at relatively low levels in many 
organs, Mu has been found in the liver, while other subtypes that are not expressed in 
17 
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the liver are found in muscle, liver, testis and brain [9] . A GSTM1-1 null genotype was 
found to be present in approximately 5 0 % of Caucasians tested [67, 70, 71]. Two 
class Theta GSTs have been purified: GSTT1-1 and GSTT2-2, of which class Theta1-1 
is polymorphic [72]; a GSTT1-1 null genotype was shown to be present in 15% of 
Caucasians [73]. Both percentages greatly vary between the different human races [6, 
73]. Other polymorphisms in the Mu and Theta genes have been reported [74, 75] The 
biological consequences of failure to express GSTM1-1 or GSTT1-1 enzymes can 
include increased susceptibility to bladder [76], colon |77], skin [78] or lung cancer 
[79]. 
The biological control of the cytosolic families is complex as they exhibit sex, age-, 
tissue-, species- and tumour-specific patterns of expression [9]. In addition, GSTs are 
regulated by a structurally diverse range of xenobiotics of which a significant number is 
consumed as naturally occurring non-nutrient components of vegetables and citrus 
fruits Many of the compounds that induce GST themselves are substrates for these 
enzymes or are metabolized to compounds that can serve as GST substrates, 
suggesting that induction of GST represents part of an adaptive response mechanism to 
chemical stress caused by electrophiles in the diet. In addition, ROS such as superoxide 
radical, hydrogen peroxide, and the hydroxyl radical may arise as a consequence of 
aerobic respiration, ionizing irradiation, inflammation or cellular response towards 
invaders (ι e respiratory burst) These potentially harmful compounds may interact with 
membrane lipids and DNA [80]. 
A high expression of GSTP1-1 has been found in many human tumours, including 
carcinomas of the colon, lung, kidney, ovary, pancreas, oesophagus, and stomach [7, 
68, 8 1 , 82] Several human tumour cell lines over express GSTP1-1, although incidently 
high levels of class Alpha and Mu isoenzymes are also observed [10, 83]. On the other 
hand, in ovarian tumours, amongst others, low GSTP1-1 levels have been reported, 
associated wi th responsiveness to chemotherapy [84, 85]. Measurements of plasma 
GSTP1-1 levels have shown that this protein may be dramatically increased in cancer 
patients, but the extent of over expression of this protein in many tumours is frequently 
insuff icient to allow the enzyme to serve as a tumour marker [86] Additionally, 
methodological problems may give falsely high serum or plasma GSTP1-1 levels [86]. 
Measurement of GSTP1-1 has been advocated as a marker for haemolysis, because of 
its abundant presence in erythrocytes [87]. Plasma GST Alpha has been postulated as a 
superior marker for hepatocellular impairment. In contrast with the aminotransferases 
(aspartate aminotransferase [AST] and alanine aminotransferase [ALT]), which are 
found predominantly in the periportal hepatocytes, GST Alpha is distributed uniformly 
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across the liver lobule and is present in high amounts [88]. The enzyme is rapidly 
released into the bloodstream during hepatocellular impairment [6]. In patients with 
paracetamol poisoning, halothane hepatitis or rejection following liver transplantation, 
plasma GST Alpha concentrations are known to provide a more sensitive index of acute 
hepatocellular impairment than AST or ALT activity [6, 89, 90, 9 1 , 92] . Furthermore, 
when the active phase of hepatocellular impairment is over, plasma concentrations of 
GST Alpha revert more rapidly to normal, a feature of the short half-life (under 90 
minutes [92]), whereas aminotransferase activity may be elevated much longer. 
2.1.3. Glutathione peroxidases. 
Glutathione peroxidases (GPX, EC 1.11.1.9) are enzymes that catalyze the reduction of 
organic hydroperoxides (lipid hydroperoxides, DNA hydroperoxides) or hydrogen 
peroxide [93] by GSH. GPX has been demonstrated in all mammalian tissues examined 
[94] . Two major types of GPX have been found. One type is distinguished by 
containing selenium in the form of a covalently bound selenocysteine in its active site 
(SeGPX) and is active with both organic hydroperoxides and hydrogen peroxide [95, 
96] . The second type of GPX consists of proteins that do not depend on selenium for 
catalysis and have negligible activity with hydrogen peroxide. This type comprises 
mainly of GST [97]. The peroxidase activity of the GSTs may represent a major 
biological function in protection against oxidative stress [98]. In selenium deficient 
states, the relative importance of the peroxidase activity of the GSTs may even 
increase [97]. 
Selenium-dependent GPX activity is due to the expression of multiple isozymes. At 
least four of the isozymes has been purified and characterized: (a) the classical cellular 
GPX, GPX-1 [95], (b) the phospholipid hydroperoxide GPX, PHGPX [99], (c) the plasma 
GPX, GPX-P [100, 101]. Both GPX-1 and GPX-P are tetramers and have similar 
substrate specificities. They are able to metabolize hydrogen peroxide (H202) and fatty 
acid hydroperoxides effectively, but metabohzation of the hydroperoxides of 
phospholipids and cholesterol is poor [102, 103]. PHGPX is a monomer and has 
different substrate specificities as compared to GPX-1 and GPX-P. PHGPX efficiently 
catalyzes the reduction of hydroperoxide of phospholipids or cholesterol and hnoleic 
acid much more effectively than the reduction of hydrogen peroxide or fe/t-butyl 
hydroperoxide. A fourth (d) selenium-dependent GPX, GPX-GI has recently been 
demonstrated. GPX-GI has similar substrate specificities as GPX-1. They both catalyze 
the reduction of hydrogen peroxide, ferf-butyl hydroperoxide, eumene hydroperoxide, 
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and linoleic acid hydroperoxide, but not of phosphatidylcholine hydroperoxide. GPX-GI 
is mainly located in gastrointestinal tissue (liver and colon) and occasionally in human 
breast tissue [104] . 
3. GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES AND FOLLICULAR MICRO-
ENVIRONMENT. 
Only a few studies have been published concerning the GSH / GSH-related enzyme 
system in the ovarian follicle and the follicular micro environment. Because inhibition of 
ROS leads to inhibition of ovulation, it is thought that ROS are released in connection 
with follicle rupture [105]. ROS are also thought to play a role in oocyte maturation [21. 
In a recent study, GSTP1-1 and GSTA1-1 were demonstrated in considerable amounts 
in the human ovarian follicular fluid of patients participating in an in vitro fertilization 
(IVF) programme [106, Chapter 3]. Notorious xenobiotics such as polychlonnated 
biphenyls (PCBs) [107, 108] and hexachlorobenzene (HCB) [109) were demonstrated in 
the follicular fluid of IVF patients These xenobiotics are known to induce GST in 
tissues other than ovaries [110, 111]. The presence of GSTA1-1 and GSTP1-1 in 
ovarian follicular fluid may suggest a role as detoxifying enzymes to protect the ovum 
from ROS and xenobiotics [106, Chapter 3]. Unfortunately, no data on GSH levels in 
follicles or its micro-environment are available so far. 
The presence of selenium and SeGPX has been demonstrated in follicular fluid [112]. 
Levels of selenium or SeGPX have been related to disorders of fertility Patients with 
unexplained infertility showed significantly lower follicular selenium levels as compared 
to those wi th tubal infertil ity or infertility due to male factors. The mean SeGPX activity 
in follicles yielding oocytes that were subsequently fertilized, were higher than those of 
follicles with non-fertilized oocytes. Interestingly, tobacco smoking has been shown to 
be associated with significantly diminished follicular SeGPX activity [112]. These 
results suggest that SeGPX acts as a protective enzyme for oocytes. 
In summary, detectable amounts of SeGPX, GSTA1-1 and GSTP1-1 have been 
demonstrated in human ovarian follicular fluid. The most important finding is that 
SeGPX activity is higher in follicles yielding oocytes that are subsequently fertilized as 
compared to follicles with subsequently non-fertilized oocytes. 
4. GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES IN ASSISTED REPRODUCTION. 
Numerous studies, mainly animal experiments, have described the role of GSH and 
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GSH-related enzymes in assisted reproduction Attention has been focused on male 
reproduction, reproductive performance and the influence of the exposure of 
carcinogens on semen parameters Additionally, several studies have highlighted the 
role of GSH and GSH-related enzymes in relation to in vitro fertilization and in vitro 
embryo development. 
4 . 1 . Male reproductive physiology and pathology. 
Glutathione depletion of several male reproductive tissues can be achieved by 
administration of specific glutathione depleting agents and this may affect reproductive 
outcome. Depletion of GSH in male rat reproductive tissues, such as cauda and caput 
epididymis by means of 1,2-dibromoethane injection is correlated with an increase of 
dominant lethal mutations in their offspring [113] Fluoride administration to rats has 
resulted in significantly lower GSH levels in testis and especially cauda epididymis 
(114] Intratesticular injection of GSH depleting agents (buthionine sulfoximide (BSO) or 
diethylmaleate) has resulted in selectively lowered testicular GSH levels However, no 
changes have been observed in testicular spermatid count or in the morphology or 
moti l i ty of cauda epididymal sperm [115] GSH depletion potentiates ethyl 
methanesulfonate-induced alterations of sperm chromatin structures, that are likely to 
be related to dominant lethal mutations [116] In the reproductive tissue of bulls, testis, 
caput epididymis and ampulla have shown the highest levels of GSH, whereas the GSH 
content of washed caput epididymal sperm is three times the GSH content of cauda 
epididymal or ejaculated sperm [117]. In spermatozoa, GSH has shown maximal 
staining in the midpiece and tail regions [117]. The highest level of γ-
glutamyltranspeptidase (YGT) has been encountered in the epididymis [117]. 
Administration of the GSH precursor N-acetylcysteine to male rats, prior to challenge 
w i t h ethyl-methanesulfonate has resulted in a significant decrease in post implantation 
loss, indicating a restoration of reproductive performance [118] 
GSTs are differentially expressed in testicular compartments and epididymal 
segments of rats, possibly resulting in a characteristic susceptibility of different 
celltypes to xenobiotic damage [119] GSTs have also been identified in different types 
of human testicular cells They may play a role in normal human spermatogenesis and 
may protect germ cells from teratogens and carcinogens [120] GSTA1-1 and GSTP1-1 
have been demonstrated in human seminal fluid [Knapen, unpublished results]. 
GSH reductase [ 1 2 1 , 122], GPX [ 1 2 1 , 122], and GSH [121] have been found in 
human spermatozoa, but they show little variation amongst samples GPX and GSH 
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reductase have also been identified in human seminal plasma [123] In the seminal 
plasma of bulls, it has been shown that GPX activity decreases with increasing paternal 
age [124] Sperm GPX and GSH reductase activities remain unchanged after 
cryopreservation, though enhanced levels of lipid peroxidation products have been 
found [125] . After liquid storage of sperm, an improvement of survival has been 
reported by adding increasing doses of GPX [126] From studies in mice it has been 
suggested that GPX in male reproductive tissue may play an important role in sperm 
maturation from the the very start up to the end of maturation [127] Male rat 
reproductive tissue expresses at least three different types of GPX [128]. GSH and 
GSH-related enzymes may play a role in sperm quality. Antioxidants such as GSH and 
N-acetylcysteine can protect against the damaging effect of leucocyte-derived ROS on 
sperm movement and may be of clinical value in assisted conception procedures [129]. 
Systemic supplementation of reduced GSH to patients with dyspermia due to varicocele 
or germ-free genital tract infection results in improved sperm parameters and its cell 
membrane characteristics [130] GPX added to semen samples of rams has positive 
effects on sperm motility and acrosome integrity [126] Selenium and vitamin E 
supplementation improves sperm motility and the percentage of normal spermatozoa in 
infertile men [131] 
In summary, GSH and GSH-related enzymes play a significant role in the protection 
of (developing) sperm from carcinogens, and administration of N-acetylcysteine, GSH 
and GPX seems to improve sperm quality 
4.2. In vitro fertilization and in vitro embryo development. 
Recently, Kamrin et al [132] have reviewed the role of GSH in the protection of the 
conceptus against xenobiotics It has been demonstrated that GSH synthesis, 
st imulated by cysteamme and cysteine, occurs intracellular^ during in vitro maturation 
of oocytes [133] It has been demonstrated that sperm gamma glutamyl transpeptidase 
(YGT) may be a limiting factor for male pronuclear formation in Polyspermie oocytes 
11341 yGT is present on the surface of boar spermatozoa and male pronuclear 
formation has been inhibited in yGT injected pig oocytes, which suggests that sperm 
yGT may be a limiting factor for male pronuclear formation in Polyspermie oocytes 
[134] GSH is present in the oocyte and it has been implicated in the reduction of 
disulfide bonds in the sperm nucleus during fertilization and thus in the development of 
the male pronucleus [135] 
The addition of BSO, an inhibitor of GSH synthesis, to culture media of fertilized 
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oocytes has resulted in lower numbers of blastocysts formed [136]. In accordance with 
these results, it has been demonstrated that GSH administration to medium could 
prevent embryotoxicity by 2-nitrosofluorene (NOF) through non-enzymatic formation of 
GSH-NOF adducts [137] . The percentage of bovine embryos that reach the blastocyst 
stage is significantly higher when cysteamme is added to the culture medium [138] 
Addit ion of cysteamme also increases GSH levels in oocytes, suggesting that the 
beneficial effects of cysteamme on in vitro maturation and subsequent embryo 
development after in vitro fertilization is mediated by GSH [1381 The addition of low-
molecular weight thiol compounds (beta-mercaptoethanol or, again, cysteamme) to the 
culture medium improves the in vitro development of bovine embryos, again mediated 
through enhanced intracellular GSH levels [139] 
Decreased embryonic total GSH levels have been observed in rat embryos of diabetic 
female rats The decrease is possibly a consequence of altered GSH transport across 
the yolk sac endodermal cells, which may be impaired under diabetic conditions The 
observed decreased embryonic total GSH levels may impair the protection against 
oxidative stress, as described in diabetic pathology [140]. Inhibition of yGT in rat 
embryos undergoing organogenesis can produce alterations in GSH levels and elicit 
embryotoxic effects [141] Pre-treatment with GSH provides protection against 
cadmium-induced embryotoxicity [142] 
In summary, enhancement of GSH and GSH-related enzymes in oocytes is likely to 
improve fertilization rates in IVF procedures and seems to protect the developing 
embryo from carcinogens and oxidative stress 
5. GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES AND THE RISK FOR RECURRENT 
EARLY PREGNANCY LOSS. 
Environmental toxins are likely to be a cause for recurrent early pregnancy loss [143] A 
(partly) deficient decidual or systemic detoxification system, resulting in an increased 
exposure of the conceptus to endogenous or exogenous toxins, could theoretically lead 
to recurrent early pregnancy loss Therefore, deficient GSH or GSH-related enzymes 
may contribute to the etiology of this condition Erythrocyte GPX levels in women with 
recurrent early pregnancy loss have not shown any difference from healthy controls 
[144] Recently, Hirvonen et al have reported an increased incidence of the GSTM1-1 
null genotype in a group of 29 women with recurrent early pregnancy loss as compared 
to the incidence in women with normal pregnancy outcomes [145) Unfortunately, they 
could not reproduce these results in another population group [1451. 
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In summary, alterations in erythrocyte GPX activity or a deviant incidence of the null 
genotype of GSTM1-1 do not seem to be of significant importance to the etiology of 
recurrent early pregnancy loss Recently we were able to demonstrate an enhanced 
incidence of a polymorphic GSTP1 1 gene resulting in a reduction of GSTP1-1 enzyme 
activi ty, in a group of women with recurrent early pregnancy loss (Zusterzeel et al, 
unpublished results). 
6. DEVELOPMENTAL ASPECTS OF GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES. 
Although the distribution of GST isoenzymes in human newborn or adult tissues has 
been actively studied [6, 9, 146], little is known about embryonic and fetal tissues 
Studies of these tissues, however, are of particular importance, because several drugs 
and chemicals may cross the placenta and accumulate in the fetus [147, 148] 
Xenobiotics crossing the placenta may directly reach the fetal organs (through the 
venous duct), bypassing the liver [147] In the human fetus and neonate, active drug-
metabohzing enzymes are present, except for some forms of UDP-
glucuronyltransferase, which develop after birth [149] Several components of the 
maternal diet are involved in in-utero regulation of enzymes involved in GSH metabolism 
[150] A combination of genetic, developmental and environmental factors seems to 
control fetal enzyme activities and may ultimately determine the variability in inter-
individual susceptibility to chemicals in utero [151] 
The GSH levels in human fetal liver, brain and adrenal tissue have shown a decrease 
during late gestation The decline in the brain occurrs at an earlier gestational age Fetal 
GSH levels of parents with low incomes have been found to be lower than those in 
high income groups [152). Fetal GST activities in liver, kidney, lung, muscle, heart, 
adrenal glands, pancreas, and stomach have been demonstrated to be higher than 
those of adults [1 53]. 
In fetal liver GSTs of class Alpha, Mu and Pi, but not Theta have been demonstrated 
[154] In both neonatal and adult hepatocellular tissue only GST Alpha and GST Mu are 
present, whereas GSTP1-1 is predominant in fetal hepatic tissue at 8-12 weeks' 
gestational age [155, 156] In both neonatal and adult biliary duct epithelium only 
GSTP1-1 is expressed, suggesting that during gestation the GST Pi locus is 
downregulated in hepatocytes but not in the epithelium of biliary ducts [155] The 
expression of Alpha and Mu class GST isoenzymes in liver tissue increases significantly 
at birth 1157]. In contrast to these developmental differences in GST expression, it has 
been shown that liver GPX activities do not change appreciably from 10 weeks' 
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gestational age to 3 months after birth [158] Interestingly, malathion has been shown 
to cause alterations in the levels of GSH-related enzymes and antioxidant systems in in 
vitro studies of human fetal tissue, the effects being highest in the early period of 
development [1 59]. 
Both GST Alpha and Pi are expressed along the entire developing nephron of the 
fetal kidney, until about 35 weeks' gestational age [161] After 35 weeks, the 
expression of GST Alpha is restricted to the proximal tubule The expression of GSTP1-
1 is restricted to the collecting tubules, as well as the distal part of the loop of Henle 
[160, 161] Strange et al have shown that before 20 weeks' gestational age the 
collecting tubes and primitive Bowman's capsules express GST Alpha, whereas 
primitive glomeruli and mesenchymal tissue do not [160] However, in other studies 
mainly GSTP1-1 staining has been found, whereas in meso- and metanephric tissue 
GST Alpha staining is absent [156, 162]. The expression of these enzymes in nephric 
tissue and especially in collecting tubules may point to a role in detoxification of urinary 
compounds excreted by the embryo [163] The expression of Alpha class GST enzymes 
in fetal kidney increases significantly after 40 weeks' gestational age [164] , whilst the 
expression of class Mu and Pi GST isoenzymes do not change significantly throughout 
further postnatal development [164]. 
For the fetal lung it has been demonstrated that GSTP1-1 is down regulated during 
the first half of gestation [164, 165] and appears to precede phenotypic differentiation 
of the distal airways [160] Early on in gestation, GSTP1-1 is present in epithelial cells, 
but as development proceeds, expression is maintained in proximal but not in more 
distal airway cells [160] For GST Alpha a weak immunostaming is present in the first 
half of pregnancy [165, 160], being stable throughout development [164, 165] The 
expression of GST Mu isoenzymes is also continuous throughout development [164] 
Lung GPX activities do not change appreciably from 10 weeks' gestational age until 3 
months after birth [158, 165]. The presence of GSTs in an early stage of development 
suggests an additional role of these enzymes other than the protection of the 
respiratory tract against air pollutants after birth 
A comparison of the expression of the GSTs in developing lung, kidney and liver 
shows some common patterns of expression, suggesting that these genes are under 
similar regulatory control [164]. 
GSTP1-1 in the fetal brain is localized at the site of the blood-cerebrospmal fluid 
(CSF) barrier, blood-brain, CSF brain and pia-arachnoid-bram barrier [156, 166] In a 
recent study, GST Alpha immunoreactivity has been shown to be confined to a weak 
staining of epithelial cells in the tela chonoidea [156, Chapter 4} The GST isoenzymes 
25 
Chapter 2 
are well localized to prevent neuronal exposure to potentially toxic substances delivered 
from blood or CSF This indicates that the expression of GST Alpha and Pi this early in 
gestation may be highly significant in the protection of the developing human brain In 
vitro studies of human fetal brain have demonstrated that malathion causes alterations 
in the levels of GSH-related enzymes and other antioxidant systems These alterations 
were at their highest early in development, suggesting a higher susceptibility of tissues 
in this period [159] . An impaired responsiveness to oxidative stress of the embryonic 
GSH / GSH-related enzyme system is supposed to play a crucial role in oxygen-induced 
embryopathy and may even result in neural tube defects [167] . It has been 
demonstrated that the addition of valproic acid, cytochalasin and 7-hydroxy-2-
acetylaminofluorene to rat embryo cultures causes increased incidences of neural tube 
defects, which can be diminished by the addition of the cysteine pro-drug 2-
oxothiazolidine-4-carboxylate. Increased incidences of neural tube defects are noted 
after depletion of GSH by adding BSO to the culture medium [168] Amnionic vGT 
concentrations in pregnancies bearing fetus with neural tube defects do not differ from 
those in uncomplicated pregnancies [169]. Conflicting reports have been published wi th 
respect to erythrocyte GPX activities of parents having children with neural tube 
defects Hinks et al have not found a difference in maternal whole blood GPX activities 
during pregnancy in mothers with babies with neural tube defects as compared to 
mothers w i th normal offspring [170] Graf et al., however, have found a low 
erythrocyte GPX activity in the majority of parents of a child with a neural tube defect 
[171] Children with myelomeningocele [171], and both high (thoracic) and mid 
(lumbar) [172] neural tube defects show lower erythrocyte GPX activity as compared to 
healthy control children. 
To our knowledge, only one histological study on the expression of GST Alpha and 
GSTP1-1 in several embryonic gastrointestinal tissues, other than the liver has been 
performed until now [156, Chapter 4]. Van Lieshout ef al., have demonstrated the 
expression of both isoenzymes along the embryonic gastro-mtestmal tract at eight 
weeks' gestational age. This expression is shown to be different from that in adults, 
because both GST Alpha and GST P1-1 are demonstrated in all embryonic epithelial 
cells [156, Chapter 4]. These isoenzymes are down-regulated selectively in some types 
of cells later in gestation or probably after birth. The expression of GST Alpha and Pi 
along the digestive tract of embryos, fetus and adults may stress the role of these 
proteins in the elimination of toxic and carcinogenic compounds. In embryonic 




No developmental trends in the expression of Alpha, Mu and Pi isoenzymes of GST 
are demonstrated in fetal heart and diaphragm [173]. 
GPX activities reach adult levels in fetal erythrocytes between 26 to 35 weeks' 
gestational age, and are lower before the 26th week [174]. In another study however, 
both in preterm and term neonates, erythrocyte GPX activity is shown to be less than 
the activity in adult erythrocytes [175]. 
In summary, GSH and GSH-related enzymes are well developed in embryonic and 
fetal life. GST tissue expression is often different in adults. There may be a role for this 
system in the genesis of neural tube defects and in the detoxification of noxious 
compounds that cros the placenta or are generated mtracellularly. 
7. GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES IN HYPERTENSIVE DISORDERS OF 
PREGNANCY. 
7.1 GSH and related enzymes in the etiology of hypertensive disorders of 
pregnancy. 
Hypertension complicates 6 - 20 % of all pregnancies and ranks amongst the four most 
common causes of maternal as well as perinatal mortality in the world [176, 177, 178]. 
The etiology of this gestational disorder is still largely unknown. An imbalance between 
lipid peroxides, ROS or other (endogenous) toxins on the one hand and detoxicating or 
scavenging substances on the other may contribute to its etiology [179, 180]. GSH and 
GSH-related enzymes have been investigated in numerous studies for their possible role 
in the etiology and prevention of this disease. 
In normal pregnancy, plasma thiol levels show a decrease, whereas erythrocyte thiol 
levels increase as compared to levels in the non-pregnant state, suggesting enhanced 
free radical activity in normal pregnancy [181]. In accordance to these results, 
erythrocyte GSH levels are reported to be higher in normotensive pregnant women as 
compared to GSH levels in non-pregnant women [182]. Conflicting reports have been 
published on thiols and GSH levels in hypertensive disorders of pregnancy. Wisdom ef 
al. have reported that in pregnancy-induced hypertension with or without proteinuria, 
the erythrocytic thiol levels are not different from those of non-pregnant women [181] , 
whereas plasma thiol and GSH levels are significantly lower [182, 183, 184]. Chen et 
al. have demonstrated a significantly positive correlation between levels of 
prostaglandins and antioxidant capacity [183]. The erythrocytic GSH levels in women 
wi th preeclampsia are significantly lower as compared to levels in normotensive 
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pregnant controls [184] 
Although pregnancy induces a gradual increase in lipid peroxidation products with 
increasing length of gestation, maternal erythrocyte GPX activity does not increase in 
pregnancy [185, 186] Plasma and erythrocyte GPX levels even decrease after the 20th 
and 30th week of pregnancy [187] Recently, we have found a decreased 
GSH/haemoglobin ratio in patients with preeclampsia or the HELLP syndrome as 
compared to ratios in normotensive pregnancy [188, Paragraph 5 2] 
In patients with pregnancy induced hypertension platelet and plasma GPX activities 
are significantly higher than those of normotensive pregnant women [189, 190] 
Patients with severe or superimposed preeclampsia even show significantly higher 
erythrocyte and plasma GPX activities as compared to those with mild preeclampsia 
[189 190] High maternal erythrocyte and plasma GPX activities are associated with 
fetal growth retardation and neonatal asphyxia [1901 Maternal serum selenium 
concentrations are not different in preeclampsia as compared to normotensive 
pregnancy, stressing the importance of factors other than selenium to the activity of 
GPX [191] It is interesting to note that in contrast to maternal erythrocytes, 
erythrocytic GPX activity is significantly lower in umbilical cord blood in hypertensive 
pregnancy as compared to normotensive pregnancy [192] 
An enhanced maternal GPX activity and decreased GSH levels in hypertensive 
disorders of pregnancy suggest a compensatory mechanism, implicating an enhanced 
turnover of GSH in response to high lipid peroxide or ROS levels A potential new 
therapy for hypertensive disorders of pregnancy may therefore be the supplementation 
of GSH or GSH precursors For instance, N-acetylcysteine, a precursor of glutathione, 
has been shown to enhance thiol levels in erythrocytes exposed to oxidizing agents, as 
well as unexposed erythrocytes [193] Clinical studies have reported that S-
nitrosoglutathione, a platelet-specific nitric oxide donor, and a potent vasodilator and 
inhibitor of platelet aggregation, lowers maternal arterial bloodpressure, and reduces 
platelet activation and uterine artery resistance without affecting fetal Doppler indices 
[194] In addition, a pilot study has shown that the administration of S-
nitrosoglutathione improves clinical symptoms in a patient with HELLP syndrome [195] 
Few studies on decidual tissue in hypertensive disorders of pregnancy have been 
published An enhanced lipid peroxidation may be involved in decidual foam cell 
formation, and in the pathogenesis of preeclampsia [196] Preeclampsia is associated 
wi th a change of the prostaglandin / thromboxane balance in favour of thromboxane 
formation Human decidua mainly produces thromboxane B2 (TxB2), however after 
addition of reduced glutathione, prostaglandin E2 (PGE2) becomes the main product 
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[197] Cytosols from decidua vera and placenta are most effective in stimulating 
synthesis of PGE2 Reduced GSH is able to increase the biosynthesis of PGE2 at the 
expense of other prostaglandins (PG's), both in the presence or absence of these 
cytosols [198] GSH can inhibit lipid peroxidation via membrane bound GPX [4] In the 
light of these results it is interesting that enhanced decidual GSH levels in preeclampsia 
were demonstrated in a recent study [Paragraph 5 7] Decidua of normal and 
preeclamptic pregnancies demonstrates much higher GSH levels than any other human 
tissue studied [199, 200, 201] An increase in decidual tissue GSH concentration may 
point to a preventive mechanism against excessive lipid peroxidation, and may even 
enhance prostaglandin production Significantly higher SeGPX activities, as found in 
decidual tissue of preeclamptic pregnancies as compared to decidual tissue in 
normotensive pregnancies, may also act as a compensatory mechanism [Paragraph 
5 7] By contrast, no difference in decidual GST activity has been found between 
preeclampsia and normotensive pregnancy [Paragraph 5 7] 
Placental GSH levels are reported to be higher in preeclamptic pregnancy as 
compared to placental GSH levels in normotensive pregnancy [202, Paragraph 5 7] As 
placental cytosols show to be most effective in stimulating PGE2 biosynthesis, and 
reduced GSH was found to increase the biosynthesis of PGE2 at the expense of other 
PG's [198], the high placental GSH levels in preeclampsia may also point to a 
compensatory mechanism 
With respect to GPX activities in placental tissue of preeclamptic pregnancies 
conflicting results have been reported, varying from decreased to increased activities 
GPX activity [186, 203] as well as messenger RNA levels of GPX [204] are lower in 
placentas of preeclamptic pregnancies as compared to those in normotensive 
pregnancies, whereas levels of lipid peroxides are higher [205] This may lead to an 
increased stimulation of prostaglandin Η synthetase, again resulting in an enhanced 
production of lipid peroxides and thromboxane [203] One of the functions of GPX is 
the inactivation of lipid peroxides, thereby diminishing peroxide mediated stimulation of 
prostaglandin synthetase By contrast, in other studies normal placental GPX activities 
were demonstrated in preeclampsia as compared to normotensive pregnancy [206], as 
well as significantly higher GPX activities [Paragraph 5 7] Placental GST activity is 
found not to differ between preeclampsia and normotensive pregnancy [206, Paragraph 
5 7] 
An interesting hypothesis on the etiology of preeclampsia is a possibly low or a 
unfavourably increased inherent maternal detoxification capacity A slightly higher 
incidence of the GSTT1-1 null genotype, resulting in a complete absence of this 
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detoxif icat ing enzyme, is found in patients with preeclampsia and/or the HELLP 
syndrome, whereas no difference is found for the incidence of the GSTM1-1 null 
genotype [Zusterzeel et al., unpublished results] As previously indicated, individuals 
wi th a functional GSTT1-1 allele can form mutagenic metabolites from dichloromethane 
once this compound is conjugated with GSH [74, 207] So an increased incidence of 
the GSTT1-1 null genotype may contribute to the etiology of preeclampsia or the HELLP 
syndrome. It should be stressed, however, that generally speaking reactions catalyzed 
by GST lead to detoxification. 
Generally speaking, maternal circulating GSH levels seem to be decreased, while 
GPX levels seem to be increased in hypertensive disorders of pregnancy, suggesting an 
enhanced detoxificational capacity at the expense of glutathione. Decidual 
detoxif icat ion seems to be enhanced, possibly at the expense of circulating maternal 
GSH levels, while conflicting results have been published on placental GSH and GSH-
related enzymes. Supplementation of glutathione-enhancing agents, such as N-
acetylcysteine, may be beneficial in the treatment of these gestational disorders 
7.2 GSTs as markers for haemolysis and hepatocellular impairment in hypertensive 
disorders of pregnancy. 
As reported earlier in this review, circulating GST subtypes can act as markers for 
disease. In two studies it has been demonstrated that plasma GSTA1-1 is a more 
sensitive and specific parameter for maternal hepatocellular impairment than ALT 
act iv i ty {Fig 4) [208, 209, Paragraph 5.3]. Recently, hepatocellular impairment in the 
HELLP syndrome has been demonstrated to be restricted to the mother, without any 
evidence for neonatal hepatocellular impairment. In this study neonatal hepatocellular 
impairment has been assessed by means of umbilical cord plasma GSTA1-1 
measurements [210, Paragraph 5.4]. 
In hypertensive disorders of pregnancy, haemolysis is well recognized as a major 
complication [211], and may even be a predictor for fetal and maternal outcome [212] 
Measurement of serum lactate dehydrogenase (LDH) activity may not accurately reflect 
haemolysis, because except from erythrocytes, serum LDH may also originate from the 
cardiac and skeletal muscle, kidney, pancreas or liver Haptoglobin is considered to be a 
more reliable indicator for haemolysis in hypertensive disorders of pregnancy [213] but 
concurrent hepatocellular impairment could lead to falsely low levels 1214]. Because 
GSTP1-1 is present in large quantities in erythrocytes [66, 215], measurements of 
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haematological diseases such as paroxysmal nocturnal haemoglobmuria [87] GSTP1-1 
levels are indeed found to be significantly elevated in preeclampsia and the HELLP 
syndrome as compared to normotensive pregnancy, and may be a more reliable 
indicator of haemolysis in these syndromes {Fig. 4) [Paragraph 5 5] 
In summary, GSTA1-1 seems to be a superior marker for hepatocellular impairment 
in hypertensive disorders of pregnancy, and GSTP1-1 may be a reliable marker for 
haemolysis in these multi-system disorders. 
8. THE GLUTATHIONE / GLUTATHIONE-RELATED ENZYME SYSTEM IN NEONATAL LIFE. 
GSH is an essential component of the pulmonary antioxidant defence system in 
neonates, and may be of particular importance in the early phase of oxygen exposure. 
The lungs of the prematurely born infant may be ill-adapted for the protection against 
high oxygen exposure, due to the immaturity of its antioxidant defence systems [216]. 
The deficiency of GSH in the lungs of preterm delivered animals may attribute to the 
increased susceptibility to oxygen-induced pulmonary injury [217] GSH levels in 
broncho-alveolar lavage fluid, measured in neonates requiring assisted ventilation, have 
demonstrated the lowest GSH levels in the patients with the most severe airway 
problems who had required the highest supply of oxygen [218] In newborn rats 
exposed to 100% oxygen, a rapid and sustained increase in total GSH, primarily due to 
an increase in reduced glutathione, has been demonstrated. In addition, enhanced 
activit ies of GPX and GSH reductase are noted, representing an important protective 
mechanism against oxidant injury [219]. An improvement in the oxygenation of 
premature infants with idiopathic respiratory distress syndrome (IRDS) is accompanied 
by an improvement of the ratio of reduced to oxidized glutathione (GSH redox-ratio), 
indicating an enhanced ROS inactivating capacity [220] The transition of rats from 
fetal to neonatal life is associated with a decrease of the GSH redox-ratio in the liver, 
which can partially be prevented by N-acetylcysteine administration to the mother 
(221) By contrast, no difference has been demonstrated between erythrocyte GPX 
activi ty of babies who suffer from IRDS and matched controls [222] Clinical 
pharmacological strategies, specifically designed to augment the pulmonary antioxidant 
defence capacity may become available in the near future [216]. 
Plasma cysteine levels are much lower in premature infants as compared to plasma 
cysteine levels in mature infants [223]. In addition, erythrocytes of premature infants 
show a much lower rate of GSH synthesis from L-methionine (a process dependent on 
the cystathionase pathway) [223]. In premature infants, the metabolic flow through the 
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transsulfuration pathway may be insufficient to meet their GSH and cysteine 
requirements [223]. Higher GSH concentrations are present in neonatal erythrocytes as 
compared to those in adults. For unknown reasons, higher GSH concentrations are an 
epiphenomenon in inherited pyrimidine 5'-nucleotidase deficiency 1224] GSH levels in 
umbilical cord blood increase with advancing gestational age [225] 
Significantly lower erythrocyte GPX activity and serum selenium concentrations are 
demonstrated in neonates as compared to adult controls [226] . Yet, Rotilio et al found 
approximately similar GPX activities in neonates and controls [227]. They associate a 
high superoxide dismutase / GSH peroxidase ratio with haematological symptoms 
[227] . Erythrocyte GPX activity is found to be lower in prematurely born infants as 
compared to full-term neonates [228] There is no difference between neonatal venous 
and arterial umbilical cord whole blood GPX activities and GPX activity was found to be 
increasing with gestational age and birth weight [229]. In another study, however, 
whole blood GPX activity is not found to be related to birth weight or gestational age 
[230]. 
A deficiency of GSH synthetase is responsible for the disease 5-oxoprolinuna, 
characterized by haemolysis, metabolic acidosis, defective function of the central 
nervous system and 5-oxoprohnuria. Biochemical studies confirm that an enzymatic 
block of the gamma glutamyl cycle leads to a generalized GSH deficiency [ 2 3 1 , 232] In 
a case report on neonatal 5-oxoprolinuna, GSH and GSH synthetase activity are found 
to be 2 5 % and 5% of control values respectively [233]. 
Jaundiced newborns with normal glucose-6-phosphatase (G6PD) activity have 
significantly lower levels of GSH reductase (GSSGR) than non-jaundiced newborns with 
normal G6PD activity [234]. Erythrocyte GPX deficiency, as demonstrated in a 
Japanese family is associated with neonatal hyperbilirubinaemia [235] Erythrocyte GPX 
or GSH deficiency in neonates shows to be more frequently associated with pathologic 
jaundice than in the absence of such deficiency (12.8% vs. 5 4 % , respectively) [236] 
GSH levels in umbilical cord blood are lower after asphyxia [225] . The hepatic 
funct ion of neonates suffering from asphyxia at birth is usually assessed by measuring 
neonatal venous blood aspartate aminotransferase (AST, EC 2.6.1.1) or alanine 
aminotransferase (ALT; EC 2.6.1.2) activities. These activities, however, do not rise 
significantly during the first hours after birth complicated by asphyxia and therefore 
lack sensitivity in the early postpartum period [237] . The Alpha class GSTs are rapidly 
released in relatively large amounts into the bloodstream after hepatocellular damage 
[61. In asphyxiated newborns, venous plasma GSTB1 levels (GSTB1 being the former 
name for GSTA1-1) are shown to be a more sensitive indicator for hepatocellular 
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impairment than serum ALT activities [238]. In addition, arterial umbilical cord plasma 
GSTA1-1 levels demonstrate an association between hepatocellular and metabolic or 
hypoxic impairment [239, Paragraph 6 2], and prove to be a superior marker for 
neonatal hepatocellular impairment as compared to the corresponding AST and ALT 
activities [Paragraph 6.1]. Previously, the in utero fetal venous umbilical cord GSTB1 
concentrations have been shown to be elevated in frankly acidotic human fetus as 
compared to the concentrations in non-acidotic fetus [240]. 
As for GSTP1-1, it has been demonstrated that high GSTP1-1 concentrations in 
cerebrospinal fluid during pediatric meningitis may indicate the severity of inflammation 
and may thus be of prognostic significance [241]. An aberrant expression of GSTP1-1 
is identified in hepatocytes of 14 out of 15 neonates with neonatal biliary atresia and in 
only two out of 12 cases of neonatal hepatitis, whereas no abnormalities are found for 
GST Alpha [242] . 
In summary, a deficiency of GSH in lungs of premature infants may contribute to 
oxygen-induced pulmonary damage A deficiency of glutathione synthetase is 
responsible for the disease 5-oxoprohnuria. Neonatal venous GSTA1-1 plasma 
concentrations is a more valuable marker for asphyxia at birth as compared to AST or 
ALT concentrations, while umbilical cord GSTA1-1 concentrations may be a valuable 
marker for early hepatocellular impairment due to the process of birth 
9. HORMONAL INFLUENCES ON GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES. 
Numerous studies have shown that hormonal status, sex and menstrual phase 
significantly influence the expression of GSH and GSH-related enzymes. Mouse [243], 
rat [ 244 ] , and human class Alpha, Mu, and Pi GSTs are subject to sex-specific 
variations [91. 
The menstrual phase seems to have a significant influence on tissue GSH levels, 
such as those in breast and fat tissue, with the largest effect in the mid-luteal phase 
[245] GPX activity in human endometrium has also been shown to vary with the 
menstrual phase, being highest in the late proliferative and early secretory phase [246]. 
Amenorrhoic women demonstrate significantly lower erythrocyte GPX activities as 
compared to GPX activities in eumenorrhoic women, and when oestradiol 
concentrations are normalized by means of transdermal oestradiol supplementation 
therapy, erythrocyte GPX activity is also restored. Medroxyprogesterone, by contrast, 
does not influence erythrocyte GPX activity [247] 
Men have demonstrated significantly higher plasma GSTA1-1 concentrations than 
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women [248, 249] . In women, but not in men, a significant increase of plasma GSTA1-
1 levels is noted with age [248, 249] It has recently been demonstrated that the 
administration of progesterone, but not oestradiol, to healthy postmenopausal women 
leads to a significant decrease in plasma GSTA1-1 levels yielding premenopausal levels 
[250, Chapter 7]. Interestingly, ovariectomy in mice has resulted in the enhancement of 
liver GST activities, which can be normalised by oestrogen or progesterone 
administration [243]. The high plasma GSTA1-1 levels in postmenopausal women may 
point to an increased hepatocellular leakage of GSTA1-1 from liver tissue of these 
women or point to a progesterone dependent downregulation of GST expression in the 
liver. 
Men show significantly higher GSTP1-1 plasma levels than women, and a significant 
increase w i th age is noted for both sexes [86]. There is no clear explanation for this 
phenomenon GPX activity is significantly lower in blood of postmenopausal women as 
compared to GPX activity in premenopausal women [251], and GPX activity in rat 
endometrial tissue is enhanced by progesterone administration, but decreased by means 
of oestradiol treatment [246]. 
Other studies on hormonal dependence of GSH and GSH-related enzymes show that 
dietary dihydroepiandosterone administration to rats and mice enhances GST activity in 
the liver [252]. Limited studies have indicated a role for growth hormone and thyroxine 
in sex-dependent expression of GST Alpha and Mu mRNAs in rat liver [253] The NO 
donors S-Nitroso-L-acetyl penicillamine (S-NAP) and S-nitrosoglutathione cause a dose-
dependent decrease in both oestradiol and progesterone secretion in granulosa-luteal 
cell cultures [254] . 
In summary, GPX and GST isoenzymes are under hormonal control. GPX activity 
seems to be influenced by oestradiol levels, whereas GST isoenzymes are most 
probably influenced by progesterone levels 
10. GLUTATHIONE AND GLUTATHIONE-RELATED ENZYMES AND GYNAECOLOGICAL CANCER. 
Humans vary in their ability to metabolize carcinogens and individuals with reduced 
ability to detoxify endogenous and exogenous carcinogens may be at increased risk for 
the development of cancer. Conjugation with GSH of electrophihc compounds, 
catalyzed by GSTs, is an important metabolic pathway for detoxification of mutagens 
and carcinogens [255] . Numerous studies on the role of GSH and GSH-related enzymes 
in gynaecological tumours, such as cervical, endometrial, ovarian, uterine and breast 
cancer, have been published. 
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Most studies are dedicated to ovarian tumours, probably because ovarian cancer is 
the most lethal gynaecological malignancy. An enhanced expression of GSTs may be a 
marker of malignant transformation of ovarian, and cervical cells [166, 256, 257]. 
Malignant ovarian tumours express higher GST levels as compared to benign tumours 
[258] . In another study, however, mean GST activity is found to be lower in ovarian 
cancerous tissue as compared to GST activity in normal and benign tissue, while GST 
activity is similar in serous, as compared to GST activity in other malignant ovarian 
tumours [259] . Some studies report high expression of GSTP1-1 to be a predictor for 
resistance to chemotherapy and a useful marker for poor prognosis in ovarian 
carcinoma [84, 85] . However, in other studies GST activity [260, 261] , GSTP1-1 [ 261 , 
262] , GST Alpha [ 261 , 262] and GST Mu [261] expression in particular, show no 
significant correlation with prognosis or survival of patients with ovarian tumours In 
addition, no association is found between the expression of GSTs and the response to 
chemotherapy [263]. Furthermore, no association is found between tumour GSH levels 
and GST Alpha or GST Mu expression, and the response to single agent carboplatin 
treatment in primary ovarian cancer [264]. Other studies report that high GST activity 
in ovarian tumours is associated with a better response to chemotherapy, and survival 
[265J, and that patients with ovarian carcinoma expressing GST, exhibit better survival 
rates [266] . Administration of cisplatin, adriamycin and cyclophosphamide seem to 
induce expression of GST [266]. Lower tumour GSH content is associated with lower 
FIGO stages, and prolonged survival [2621. The ratios of GSH content as well as 
GSTP1-1 activity in ovarian carcinoma before chemotherapy to corresponding levels 
after chemotherapy are higher in non-responders as compared to responders, which 
indicates that GSH and GSTP1-1 are associated with drug resistance in these patients 
I2671 
Conflicting results are reported on the expression of GST in metastatic disease. An 
independent positive correlation between GSTP1-1 expression in ovarian tumours and 
subsequent para-aortal lymph node metastasis [257] was noticed, whereas no 
significant relationship between the expression of GSTP1-1 and the incidence of 
metastasis is found by Volm et al. [268]. Recently, clinical trials were initiated with 
BSO, which in vitro decreases the ability of resistant ovarian carcinoma cells to 
inactivate platinum compounds and alkylating agents [269]. In a phase I trial of ovarian 
cancer it is demonstrated that both in normal and tumorous tissue GSH can be depleted 
after supplementation with BSO [270]. Systemic co-administration of the 
chemoprotectant GSH in combination with cisplatin to patients with ovarian cancer 
results in higher attainable cisplatin dosages [271]. 
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Only a few studies on endometrial cancer have been published. Enhanced GPX 
activit ies are associated with well differentiated rather than poorly and moderately 
differentiated endometrial adenocarcinomas [246]. GST activity is reported to be 
significantly lower in endometrial cancer as compared to normal endometrium in both a 
Japanese and a Finnish population [272]. In another study an over-expression of GST in 
endometrial carcinoma is suggested to account partly for the resistance to 
chemotherapy of this tumour [273] The risk for endometrium cancer is not associated 
with polymorphisms for GSTM1-1 or GSTT1-1 [274] 
An enhanced expression of GST is demonstrated in cervical carcinoma [166], which 
suggests it to be a marker of malignant transformation of cervical cells. Nevertheless, 
GST is present in adult cervical squamous epitheha under normal as well as pathological 
conditions and it is therefore not necessarily linked to carcinogenesis. GSTs are 
therefore not likely to be of any use as markers for cervical epithelial neoplasia [275] 
The GSH content of cervical squamous cell carcinoma is twofold higher than that of 
normal cervical tissue [276] . The tumour margin shows a higher GSH content than the 
centre of the tumour [276] . Enhanced erythrocyte GSH and GSH reductase activities 
are associated wi th the severity of cervical dysplasia [277] . Changes in erythrocyte 
GSH-related indices, together with the histopathological diagnosis may have the 
potential to distinguish low- and high grade cervical dysplastic lesions from one another 
[277] The presence of GSTM1-1 or the GSTT1-1 null genotype does not appear to 
influence the susceptibility to cervical mtra-epithelial neoplasia or squamous cell 
carcinoma [278, 279] . 
Several studies have been published concerning breast carcinoma and GSH and GSH-
related enzymes. It is reported that gamma glutamyl transpeptidase (vGT) expression is 
lost, depending on the degree of malignancy in breast cancer [280]. Interestingly, GSH 
content in breast and adipose tissue is dependent on the menstrual cycle: increasing in 
the luteal phase and being highest in the mid-luteal phase [245] . Breast tumours do not 
express higher levels of GSTs as compared to adjacent normal breast tissue [7, 10], 
although a more recent study has demonstrated enhanced GST levels in tumorous 
breast tissue as compared to adjacent normal tissue [281], GST Mu [282] and GSTP1-1 
[282] in particular. An enhanced GST expression may be involved in chemotherapy 
resistance of breast tumours [283], but many other studies do not find a correlation 
between GST Alpha, Mu or Pi content of the primary tumour and the response or 
duration of the response to chemotherapy [284, 285] . Additionally, GST Mu deficiency 
does not seem to be involved in the etiology of breast cancer [284] Recent studies, 
however, have demonstrated high levels of GSH, GST and GPX to be associated with 
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favourable clinical characteristics and prognosis, whereas low levels of GSH and GST 
activity are associated with more aggressive or more advanced disease in breast cancer 
patients [286] 
The presence of the GSTPIb allele seems strongly associated with testicular cancer, 
whereas in prostate cancer a significantly lower frequency of the GSTPIa allele has 
been observed [287] Testicular germ cell tumours show an altered isoenzyme pattern 
and the decreased GST activity may play a role in the high inherent drug sensitivity of 
human testicular germ cell tumours [288] 
Cytotoxic chemotherapy in gynaecological cancer do not change the activity of 
serum GPX [289] and patients with gynaecological cancer (uterine, ovarian or vulvar) 
have lower serum GPX activities as compared to healthy control women [290] 
In summary, in early studies, GSTP1-1 plasma levels seem to be a reliable marker for 
gynaecological cancer and high GST expression, especially in ovarian tumours seems to 
be indicative of poor prognosis, probably due to chemotherapy resistance In many 
other studies however, these results have not been confirmed. 
11 MISCELLANEOUS. 
In areas with heavy radioactive exposure, such as the Ukrain areas, placental samples 
have been shown to contain significantly lower GST and GSH-reductase activities, and 
lower levels of thiols as compared to samples m non polluted areas [291] Maternal 
cigarette smoking has been found not to affect placental GST activity, but a positive 
correlation between placental GST and aromatase activity has been demonstrated 
[292] 
Erythrocyte GPX activities are shown to be increased in adult Down syndrome [293] 
A high incidence of the GSTM1-1 null genotype has been found in several multifactorial 
diseases, such as endometriosis, favouring the contribution of environmental toxins in 
the pathogenesis of this disease [294, 295] 
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Objective: To study the levels of glutathione S-transferase Alpha 1-1 (GSTA1 
1) and glutathione S-transferase Pi 1-1 (GSTP1-1) in human preovulatory 
ovarian follicular fluid (FF) and pooled granulosa and cumulus cells 
Design: The relation of GSTA1-1 and GSTP1-1 with progesterone (P) and 1 7ß 
oestradiol (17ß-E2) concentrations were studied. 
Setting: The Department of Obstetrics and Gynaecology, the Department of 
Gastroenterology and the Laboratory of Endocrinology and Reproduction of the 
University Hospital St Radboud in Nijmegen, The Netherlands 
Patient(s): Infertile women participating in an m-vitro fertilization programme 
Resuit(s): Detectable amounts of GSTA1-1 and GSTP1-1 were found in ovarian 
follicular fluid and pooled cumulus and granulosa cells. Concentrations of 
GSTA1-1 were always much higher than those of GSTP1-1. Both ovarian FF 
concentrations of GSTA1-1 and GSTP1-1 did not correlate with ovarian FF 
concentrations of 17ß-E2 and Ρ 
Conclusion(s): The high FF concentrations of GSTP1-1 and especially of 
GSTA1-1 suggest that these enzymes may play an important role in the 
detoxif ication processes in the follicles The lack of correlation between 
follicular Ρ and 17β-Ε2 and GSTA1-1 and GSTP1-1 indicates that both enzymes 
presumably are not present as a result of the high steroid levels 
INTRODUCTION. 
Follicular fluid (FF) is formed by a gradual influx of fluid derived from the blood and by 
compounds synthesized and secreted by theca and granulosa cells. Therefore, its 
composition reflects both the plasma composition and the secretory activity of theca 
and granulosa cells 11]. Follicular fluid in humans and animals contains much higher 
concentrations of both progesterone (P) and 17ß-oestradiol (17ß-E2) than does blood 
[2] 
The glutathione S-transferases (GST, EC 2.5.1.18) are a multigene family of 
enzymes that catalyze the nucleophihc addition of glutathione to the electrophilic 
centres of a wide variety of xenobiotics They also serve as transport proteins for a 
broad range of lipophilic compounds, such as bilirubin, bile acids, and steroid hormones 
Glutathione S-transferase Alpha seems to be associated closely with the glutathione-
dependent Δδ-3-ketosteroid isomerase which catalyzes the conversion of pregnenolone 
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to Ρ and of dehydroepiandrosterone to androstenedione, together with 3β hydroxy 
steroid dehydrogenase [3] On the basis of their structural, physico-chemical, 
enzymatic, and immunological properties, the family of enzymes is divided into four 
classes Alpha, Mu, Pi and Theta, each of which consists of one or more isoforms [4 
5] 
Glutathione S transferases have been shown to be present in ovarian luteal tissue in 
pig [6] and rat ovaries [3] as well as in normal human ovarian tissue [7 8] 
Immunohistochemical staining for GST Alpha and GST Pi in human ovaries revealed 
that granulosa cells in graafian follicles as well as in corpora lutea, but not in primordial, 
primary and atretic follicles stained for GST Alpha and to a lesser extent for GST Pi 
Glutathione S-transferase Alpha strikingly parallels sites of steroid production 
To our knowledge the presence of GSTs in human FF has never been reported 
Therefore, we initiated this study to determine the presence and concentrations of 
glutathione S-transferase Alpha 1 1 (GSTA1-1) and glutathione S transferase Pi 1 1 
(GSTP1-1), isoforms of the class Alpha and class Pi GSTs, respectively, in human 
preovulatory FF 
Further, we determined the correlation of both GSTA1 1 and GSTP1 1 with ovarian 
FF concentrations of 17ß-oestradiol (17ßE2) and progesterone (P) to investigate the 
putative role of these enzymes in the detoxification or transport of the very high steroid 
levels We also determined GST concentrations in pooled granulosa and cumulus cells 
in order to find a possible origin for GSTA1-1 and GSTP1 1 in the FF 
MATERIALS AND METHODS. 
Study population 
After informed consent was given, ovarian FF samples were obtained from 10 women 
participating in an in vitro fertilization (IVF) programme The experimental protocol was 
approved by the Medical Ethical Review Committee of the University Hospital Nijmegen 
Multiple follicular development was induced by human menopausal gonadotropins 
(hMG, Humegon, Organon Oss, the Netherlands) as described previously [9] A 
gonadotropm-releasing hormone agonist (GnRH, 1 mg, Lucrin, Abbott, Amstelveen, the 
Netherlands) was administered subcutaneously from day 21 of the preceding cycle until 
the evening of human chorionic gonadotropin (hCG, Pregnyl, Organon, Oss, The 
Netherlands) injection The dosage of hMG was based on the serum E2 concentration 
and varied between 150 and 300 lU/d 
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As soon as the serum E2 concentration reached about 900 pmol/L per follicle, and 
the diameter of the follicle reached > 1 5 mm, 10,000 IU of hCG was injected 
intramuscularly Follicular fluid was aspirated by transvaginal puncture using ultrasound 
guidance and fluid from three follicles was obtained from each patient. The FF was 
centrifuged separately for 10 minutes at 3,000 χ g to remove red blood cells The 
supernatant was frozen and stored at - 20°C until analysis. The FF was examined 
separately for GSTA1-1 and GSTP1-1 and for their corresponding 17β-Ε2 and Ρ 
concentrations. From each patient, the follicle with the highest 17β-Ε2 concentration 
was used for statistical evaluation. 
Forty oocyte-corona-cumulus cell complexes were isolated from follicular aspirates. 
They were visualized under Leitz (Dialux EB 20, Wetzlar, Germany) optics to establish 
the morphology Only mature cumulus cell complexes were used (10). Cumulus cells 
from all complexes were placed separately in 2 mL of human tubal fluid (HTF) medium 
and were washed three times in the same volume of HTF [9] Thereafter the cumulus 
cells were pooled, placed in 10 mL of HTF and centrifuged at 300 χ g for 10 minutes 
The granulosa cells were isolated from clear FF aspirates that were visually free from 
blood Naturally, the aspirated cells contained red blood cells. These were removed 
almost completely by allowing them to settle in 100-mm Petri dishes (Falcon 1001) 
containing 5 mL of HTF for 10 minutes, whereafter the granulosa cells were transferred 
using a Pasteur pipette to a new Petri dish with fresh HTF 
This procedure was performed three times and then the cells were pooled, placed in 
10 mL of HTF and centrifuged at 300 χ g for 10 minutes The cells were homogenized 
in 10 volumes of buffer (250 mM of sucrose, 20 mM of Tris-HCI, and 1 mM of 
dithiothreitol, pH 7,4) with 10 strokes in small glass-glass tissue grinders on ice The 
homogenates were centrifuged at 150,000 χ g at 4° С for 1 hour The supernatants 
were frozen at - 70°C until analysis. 
Blood plasma concentrations of GSTA1-1 and GSTP1-1 were also determined in the 
blood plasma samples of 20 patients taken during follicle puncture. Antecubital venous 
blood samples were taken in the sitting position after 5 minutes of rest in 4-mL 
ethylenediaminetetraacetic acid tubes (no 6 0 6 6 0 1 , Becton and Dickinson, Grenoble, 
France) Blood was centrifuged at 3,000 χ g for 10 minutes at 20°C Plasma was 
removed and stored at -20°C until analysis. 
Assays. 
Glutathione S transferase Alpha 1-1 and GSTP1-1 levels were determined using 
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recently developed ELISAs [ 1 1 , 12]. Briefly, microtiter plates were coated overnight 
w i th purified monoclonal antibody. One hundred microliters of standard (0.08-20 ¿/g/L 
for GSTA1-1; 0.4-100 μgll for GSTP1-1) or 1:1 diluted plasma samples or 1:1 and 
1:100 diluted FF samples were added to the wells and incubated overnight. The next 
day, the plates were washed and incubated with rabbit anti-GSTA1-1 or anti-GSTP1-1 
antiserum. They were washed again and were incubated with horseradish peroxidase-
labelled swine anti-rabbit antigen. After a final wash, the plates were stained wi th o-
phenylenediamine-H202. 
The GSTA1-1 assay has a minimum detectable concentration of 0.04 μglL and mtra-
and interassay coefficients of variation of 2.5% and 7.3%, respectively. In the case of 
GSTP1-1 these values are 0.4 ^g/L, 5.8%, and 10.9% respectively. Dilutions of these 
FF samples were parallel to the standard curves and addition of 3,700 nmol/L 17ß-E2 or 
1600 nmol/L of Ρ had no effect on the standard curves of the GSTA1-1 or GSTP1-1 
assay. Determinations of Ρ and 17β-Ε2 concentrations were performed after diethyl 
ether extraction and Sephadex LH-20 chromatography (Pharmacia, Woerden, the 
Netherlands) in slightly modified RIAs as described previously [13]. The minimum 
detectable concentrations of the assays were 10 pmol/L for 17β-Ε2 and 1.3 nmol/L for 
P. Intra-assay and interassay coefficients of variation were 5.4% and 8.4%, 
respectively, for 17β-Ε2 and 5.2% and 7.3%, respectively, for P. Protein concentrations 
in cumulus and granulosa cells were assayed in duplicate by the method of Lowry et al. 
[14] using bovine serum albumin as a standard. 
Statistics. 
Correlations between FF 17β-Ε2, Ρ, and GSTA1-1 and GSTP1-1 were computed using 
Spearman's rank correlation test. 
RESULTS. 
Follicular GSTA1-1 and GSTP1-1 were detectable in FF of all patients studied. Their 
concentrations as well as those of Ρ and 17β-Ε2 are presented in Table 1. The 
concentrations of GSTA1-1 were approximately 30 times higher than those of GSTP1-
1. Glutathione S-transferase Alpha 1-1 and GSTP1-1 also were detected in pooled 
cumulus and granulosa cells (Table 2). Again, the concentrations of GSTA1-1 were 
much higher than those of GSTP1-1 (17 and 36 times, respectively). In addition, the 
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were 1 71 //g/L (range 0 95 3 57 μglL) and 6 30 /yg/L (range 5 4 - 104 //g/L), 
respectively These plasma concentrations fell within the normal reference ranges for 
healthy women of comparable age [11 12] 
DISCUSSION. 
This study shows that GSTA1 1 and GSTP1-1 are present in considerable amounts in 
human ovarian FF Glutathione S-transferase Alpha 1 1 is present in far higher 
concentrations than GSTP1-1 in both FF and pooled cumulus and granulosa cells 
Median concentrations of both enzymes are higher in follicles of patients undergoing 
IVF than in their blood plasma The level of GSTA1 1 especially is far above the blood 
plasma level, indicating a less important role for the influx of this enzyme from blood 
Remarkably, the concentration of GSTA1 1 in FF as compared to that in blood plasma 
(FF/plasma ratio ± 280) is much more pronounced than that of GSTP1-1 (ratio ± 
2 7) This finding is in concordance with the much higher concentrations of GSTA1 1 in 
both granulosa and cumulus cells as compared to the concentrations of GSTP1-1 
Using immunohistochemical techniques, Rahilly et al [8] have demonstrated that 
GST Alpha is localized to the steroid-producing cells We found that GST 
concentrations are higher in granulosa cells than in cumulus cells (Table 2) Therefore, 
it is conceivable that the granulosa сеііь are the main source of the follicular enzyme 
concentrations 
The functions of GSTA1 1 and GSTP1 1 in ovarian physiology remains unclear 
Glutathione S-transferase Alpha is associated closely with the glutathione dependent 
Δ5-3 ketosteroid isomerase which catalyzes the conversion of pregnenolone to Ρ and 
dehydroepiandrosteron to androstenedione, together with 3β hydroxysteroid 
dehydrogenase [3] Glutathione S transferase Alpha expression was found 
immunohistochemically in human granulosa cells during the second half of the 
preovulatory phase and in corpus luteum tissue, correlating well with sites of Δ5 3 
ketosteroid isomerase activity [8] 
Glutathione S transferase Alpha also was found in cultured pig granulosa cells In 
these cells GST Alpha concentrations increased after stimulation by gonadotropins, in 
association with the production of Ρ [6] However, two studies indicated the 
independence of GST activity from hormonal variations, whereas cytochrome Ρ 450 
dependent hydroxylases seemed to fluctuate with hormonal variations [15, 16] 
The lack of any correlation between follicular GSTs and steroid hormones in the 
same preovulatory phase in women participating in an IVF programme as found in our 
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s t u d y , cou ld po in t to a role for GSTs as de tox i f y i ng enzymes tha t p ro tec t the o v u m 
f r o m reac t i ve o x y g e n species and xenob io t i cs React ive o x y g e n species may be 
re leased in c o n n e c t i o n w i t h fo l l ic le rup tu re , because inh ib i t i on o f o x y g e n f ree radicals 
leads to inh ib i t i on of ovu la t i on [17 ] React ive o x y g e n species are t h o u g h t to play a role 
in o o c y t e m a t u r a t i o n [18 ] Po lych lonna ted b ipheny ls [ 1 9 , 20 ] and hexach lo robenzene 
(HCB) [ 2 1 ] , b o t h no to r ious xenob io t i cs , have been d e m o n s t r a t e d in FF of pa t ien ts 
u n d e r g o i n g IVF and are k n o w n to induce GST in t issues o ther t h a n the ovar ies | 2 2 , 2 3 ] 
In c o n c l u s i o n , h igh concen t ra t i ons of G S T A 1 - 1 and of GSTP1-1 were found in the FF 
as we l l as the c u m u l u s and especia l ly the granu losa cells sugges t ing tha t these 
e n z y m e s m a y p lay a role in de tox i f i ca t i on processes in the fo l l icu lar m i c r o - e n v i r o n m e n t . 
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Glutathione S-transferases (GST) are a family of enzymes involved in the 
detoxification of xenobiotics In humans, GST are divided into four different 
classes, Alpha, Mu, Pi and Theta, with partly overlapping substrate specificity 
and a tissue-specific expression pattern. We studied the cellular distribution of 
GST Alpha and Pi in a variety of human embryonic organs, obtained from an 
extra-uterine monozygotic twin pregnancy at 8 weeks' gestational age. Tissues 
were fixed in 4 % paraformaldehyde and embedded in paraffin. Three 4 μτη 
thick sections were used, one for routine haematein and eosin staining, the 
others for immunohistochemical determination using monoclonal and polyclonal 
antibodies against GST Alpha and Pi, respectively. Both GST Alpha and Pi were 
present in hepatocytes, gastrointestinal epithelium, adrenal gland medulla, and 
tela chonoidea in the telencephalon. GST Pi, but not Alpha was found in the 
epithelium of pancreatic and pulmonary glands, trachea, nephrons and urinary 
collecting ducts, as well as in the pia mater of the telencephalon and in 
developing nerve tissue in the gastrointestinal musculans mucosae In 
summary, we have demonstrated that immunoreactive protein for both GST 
Alpha and Pi is expressed in the human embryo at 8 weeks' gestational age 
The early expression of GST Alpha and Pi in the epithelia of the urinary and 
digestive tracts and respiratory system supports the importance of GST in the 
detoxif ication of potentially toxic or carcinogenic compounds Our results 
suggest that the embryo itself is capable of detoxifying noxious compounds 
that are generated intracellular^ or that cross the trophoblastic tissue 
INTRODUCTION. 
Glutathione S-transferases (GST: EC 2.5.1.18) are a supergene family of dirmene enzymes 
that catalyze the nucleophihc attack of the sulphur atom of the tripeptide glutathione on 
the electrophilic centres of a seemingly endless variety of chemical compounds. Since most 
reactive ultimate carcinogenic forms of chemical carcinogens are electrophiles, GST play 
a critical role in the detoxification of xenobiotics anc carcinogens [ 1 , 2, 3, 4). Mammalian 
GST isoenzymes, which are mainly present in the cytosol, have been grouped into four 
classes based upon primary structure, catalytical properties, immunochemical cross-
reactivity and N-terminal amino acid sequences, namely Alpha, Mu, Pi and Theta [2, 4] 
The isoenzymes of these classes have a partly overlapping substrate specificity and a 
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tissue specific expression; GST Alpha and Mu predominate in the adult liver and small 
intestine, whereas GST Pi is mainly found in erythrocytes, kidney, placenta and fetal liver 
[2, 5] High GST enzyme activity may result in an efficient elimination of carcinogens and 
ultimately lead to cancer prevention. We recently demonstrated an inverse relation 
between GST enzyme activity and the incidence of gastrointestinal malignancies, high GST 
activity in organs with low tumour incidence (liver) and low activity at sites with high 
tumour incidence (colon) [6]. The presence and distribution of GST isoenzymes in human 
adult tissues and numerous tumour cell lines have been actively studied [71, for review see 
Beckett and Hayes [1] and Hayes and Pulford [2]. 
The analysis of GST isoenzyme distribution in human embryonic tissues may provide 
insight into the expression of these important detoxification isoenzymes and ultimately 
may lead to a better understanding of their role in protecting cells from cytotoxic agents 
Since some drugs and chemicals may cross the placenta and accumulate in fetal tissues 
[81, a wide distribution of GST may be important in detoxification Only a few reports have 
been published on the tissue distribution of GST isoenzymes in fetal liver, kidney and lung 
[9, 10] at 12 weeks' gestational age, but no data have been published concerning 
expression earlier in development as well as in other tissues, such as the gastrointestinal 
tract. We now studied the expression of GST Alpha and GST Pi in a variety of embryonic 
organs, obtained from an ectopic monozygotic twin pregnancy at 8 weeks' gestational 
age. 
MATERIALS AND METHODS. 
Tissue samples. 
Specimens of male embryonic monozygotic twins were obtained from the Department of 
Obstetrics and Gynaecology of the University Hospital St Radboud, Nijmegen, the 
Netherlands, after informed consent from the parents. Pregnancy was induced by an in-
vitto fertilization procedure in which two zygotes were replaced in the uterine cavity The 
woman was admitted for abdominal pain at 8 weeks' gestational age and ultrasound 
examination showed a vital singleton intra-utenne pregnancy as well as a vital ectopic twin 
pregnancy. Gestational age was confirmed by ultrasound examination. The ectopic 
pregnancy was localized at the left ovary and was subsequently removed in total at 
abdominal surgery. Macroscopic examination showed an intact, mono-chononic, mono-
ammotic embryonic sac, containing two male embryos at Carnegie stage 23 [111 both with 
a crown-rump length (CRL) of 31 mm Embryonic stomach, small intestine, liver, pancreas, 
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Table I Immunoreactivity of GST Alpha and Pi in human embryonic tissues and in trophoblastic 
tissue 









(Fig l e / l f ) 
1° Urinary duct 
(Fig 2a/2b) 
















































Tissues from an extra uterine 
Pi as described in Materials 
Results section negative, 
monozygotic twin pregnancy were immunostamed for GST Alpha and 
and Methods For a detailed description of staining patterns, see the 
t weakly stained, + moderately stained, + + strongly stained 
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kidney, adrenal gland, trachea, lung, and brain were excized and immediately fixed in 4 % 
paraformaldehyde. In addition a piece of trophoblastic tissue was fixed. After dehydration 
in graded ethanol the tissues were embedded in paraffin. 
Immunohistochemical staining. 
From each specimen three 4/ym thick slices were used' one for standard haematein and 
eosm staining and two for immunohistochemical determination of GST Alpha and GST Pi 
as described previously (12] In short, sections were de waxed in xylol, rehydrated in 
graded ethanol and immersed in methanol (Merck, Darmstadt, Germany) with 2% hydrogen 
peroxide (Merck) for 10 minutes to block endogenous peroxidase activity Subsequently, 
the sections were preincubated with phosphate-buffered saline (PBS) containing 4 % bovine 
serum albumin (BSA, Boehrmger, Mannheim, Germany) and 0 1 % Triton X-100 (BDH 
Chemicals Ltd., Poole, England) (buffer A) to block nonspecific binding The slides were 
incubated overnight in a humid environment at 4°C with either primary mouse monoclonal 
antibody against GST class Alpha (1A11) [13], diluted 1-5,000 in buffer A or rabbit 
polyclonal antibody against GST class Pi (Biotrin International, Dublin, Ireland) diluted 
1 1750 in Buffer A Class Alpha antibody reacts with GSTA1-1, GSTA1-2 and GSTA2-2 
After washing three times 5 mm in PBS the slides were subsequently incubated wi th either 
peroxidase-conjugated rabbit anti-mouse immunoglobulin (Dakopatts, Glostrup, Denmark) 
diluted 1.100 in buffer A or peroxidase-conjugated swine anti-rabbit immunoglobulin 
(Dakopatts) diluted 1.40 in buffer A for 45 minutes at room temperature After three 5 
minute washings in PBS staining was performed using 0 1 % 3,3'-diammobenzidine (Sigma 
Chemical Company, St. Louis, MO, USA) in PBS containing 0 . 0 1 % hydrogen peroxide as 
peroxidase substrate (3 mm) To enhance this staining, slides were incubated in 0 .5% 
CuS04 for 5 minutes. This step was preceded and followed by a washing step of 10 
minutes under running tap water. The sections were counterstamed with haematein and 
examined by light microscopy. Human liver and colon tissues were used as positive 
controls for GST Alpha and Pi, respectively. Omission of primary antibodies and the use 
of pre-immune serum served as negative controls. 
RESULTS. 




Stomach and small intestine. 
In the stomach and small intestine the epithelial cells were stained for GST Alpha and Pi 
(Fig. 1a and 1b, respectively). The staining was mainly cytoplasmic It was not possible 
to discriminate between the different cell types in the gastric or the small intestinal 
epithelium at this stage of embryonic development. Developing nerve tissue in the 
musculans mucosae was weakly stained for GST Pi, but not for GST Alpha. Nuclei in the 
epithelium as well as the connective tissue and musculans mucosae were unstained with 
both antibodies 
Liver. 
Liver tissue consisted of hepatocytes arranged in double cords together with a large 
number of haematopoietic cells in and around the sinusoids. Developing ducts were not 
visible GST Alpha and Pi immunoreactivity was present in most hepatocytes (Fig. 1c and 
1d, respectively) Staining was heterogeneous, with some cells staining strongly and 
others moderately or weakly Generally speaking, hepatocytes around the developing 
central veins were strongly stained. Staining was mainly cytoplasmic, although in some 
cells nuclei (but not nucleoli) stained as well. 
Pancreas. 
Pancreatic tissue did not stain for GST Alpha. Cytoplasmic staining for GST Pi was seen 
in tubular epithelium of glandular pancreatic tissue, whereas connective tissue was 
negative. 
Kidney and urinary tract. 
Sections of embryonic renal tissues showed a primitive renal architecture wi th nephrons 
at various stages of development In early metanephric kidney, distal ends of newly formed 
collecting tubules were surrounded by condensations of cells. These form spheres that will 
fold into S-shaped bodies, one end forming the primitive Bowman's capsule and 
glomerulus, the other fusing with the elongating collecting tubule. S-shaped bodies will 
lengthen and later on in gestation differentiate into the distal and proximal tubule and loop 
of Henle Immunostaimng for GST Pi (Fig 1f) resulted in moderate staining of the nephnc 
tissue; approximately 50% of the epithelial cells in the collecting tube were stained. In the 
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1 . 
Fig. 1 . Localization of GST Alpha (a,c,el and GST Pi (b,d,fi in small intestine la.b), liver ¡c,dl and 
nephric tissue (e,f). B, Bowman's capsule; ct, connective tissue; cv, central vein; e, 
epithelium; h, hepatocyte; hp, haematopoietic cell; I, lumen; t, tubule. Bars indicate 4 цт. 
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connective tissue some cells showed a very weak cytoplasmic staining No GST Alpha 
immunoreactivity was found in both mesonephros and metanephros (Fig 1e) In the latter 
tissue immunostaming for GST Pi resulted in weak immunostaining of the Bowman's 
capsule and tubules, whereas glomeruli remained negative The primary urinary duct did 
not contain GST Alpha immunoreactivity (Fig 2a), whereas wi th the GST Pi antibody the 
cytoplasm of many epithelial cells stained strongly (Fig. 2b) The secondary urinary duct 
showed a very weak cytoplasmic staining in the epithelial cells with the GST Alpha 
antibody With the GST Pi antibody, on the other hand, approximately 50% of the cells 
were stained strongly This staining was only cytoplasmic 
Adrenal gland. 
The cortex did not show immunoreactivity for GST Alpha, whereas in the medulla 
approximately 5% of the cells showed weak cytoplasmic staining Staining for GST Pi 
resulted in a weak staining in the cortex, as well as in the medulla. In the medulla roughly 
the same cells were stained as with the GST Alpha antibody, but the signal was stronger 
Trachea. 
In the trachea, no immunoreactivity for GST Alpha was demonstrated (Fig 2c) 
Immunostaining for GST Pi resulted in a very strong staining of the epithelium, whereas 
only a few chondrocytes were positive (Fig 2d) 
Lung in the glandular phase 
The pulmonary tissue studied did not contain GST Alpha immunoreactivity (Fig 2e) The 
GST Pi antibody (Fig 2f) showed a moderate staining in the cytoplasm of cuboidal 
epithelial cells In addition the mesothelium and most of the cells in the connective tissue 
were weakly stained This staining was only cytoplasmic Smooth muscle cells surrounding 
the large ducts were negative, although developing nerve tissue showed moderate 
immunoreactivity Arteries and arterioles were not stained 
Telencephalon. 
GST Alpha immunoreactivity was confined to a weak staining of epithelial cells in the tela 
chonoidea With the GST Pi antibody, these cells were stained strongly, as were epithelial 
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Fig. 2. Localization of GST Alpha (a,c,e) and GST Pi (b.d.fl in primary urinary duct la,b), trachea 
ledi and lung in glandular/ phase fe,f). ch, chondrocyte; ct connective tissue; e, epithelium. 
Bars indicate 4 μm. 
73 
Chapter 4 
cells in the pia mater. Ependyma cells and brain tissue showed no immunoreactivity. 
Trophoblastic tissue. 
In early trophoblastic tissue decidua basahs cells as well as cytotrophoblast cells stained 
strongly wi th the GST Pi antibody, whereas no immunoreactivity was seen in 
syncytiotrophoblast cells. Some macrophages (Hoffbauer's cells) were weakly stained for 
GST Pi. Staining observed in trophoblastic tissue was only cytoplasmic. Trophoblastic 
tissue did not contain GST Alpha immunoreactivity. 
DISCUSSION. 
Since GST classes Alpha, Mu, Pi and Theta, are active towards different substrates, 
differential expression of these classes may be important in detoxification. The distribution 
of GST isoenzymes in human newborn or adult tissues has been actively studied ( 1 , 2 , 7], 
but little is known about fetal and embryonic tissues. This is particularly important since 
some drugs and chemicals may cross the placenta and accumulate in the fetus [8]. We 
have now shown the cellular localization of GST Alpha and Pi in embryonic tissues at 8 
weeks' gestational age. 
No reports on immunohistochemical staining for GST Alpha and Pi in the embryonic 
gastrointestinal tract have been published previously, although much is known about the 
localization in adults. In the adult oesophagus GST Pi expression was demonstrated in 
submucosal glands and in the basal layers of the squamous stratified epithelium [14] . In 
the adult gastric epithelium GST Alpha was expressed in oxyntic cells, whereas GST Pi 
staining tended to concentrate in mucous secretory cells [12, 14, 15]. In gastric glands, 
parietal, oxyntic and mucous neck cells weakly stained for GST Pi, whereas chief cells 
were negative [12, 14, 15]. In small intestinal epithelium GST Pi was seen in absorptive 
cells and mucous-secretory cells of both villi and crypts of Lieberkühn, whereas GST Alpha 
was only found in the tips of the villi [14, 15, 16]. No GST Pi was found in the duodenal 
submucosal glands of Brúnner [14]. In colon GST Pi is the major isoenzyme, being mainly 
expressed in crypt cells [16 - 211. The localization of GST Alpha and Pi in the embryonic 
gastrointestinal tract is different from adults, since we demonstrated GST Alpha and Pi 
throughout the epithelium of the embryonic gastrointestinal tract. The isoenzymes probably 
are down-regulated in some types of cells later on in gestation or after birth. At 8 weeks' 
gestational age it is not yet possible to discriminate between different cell types in the 
gastrointestinal epithelium. Expression of GST Alpha and Pi along the digestive tract of 
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embryo, fetus and adult may reflect the role of these proteins in the elimination of toxic 
and carcinogenic compounds 
The heterogenous staining of GST Alpha and Pi in embryonic hepatocytes may reflect 
differences in developmental stage Hiley et al [9] found GST Alpha in some hepatocytes 
and GST Pi in most hepatocytes and in biliary duct epithelium at 12 weeks' gestational 
age The haematopoietic cells were not stained They suggested that during gestation the 
GST Pi locus will be down-regulated in hepatocytes but not in epithelium [9] At 8 ratios 
gestational age no biliary ducts are present in the liver In adult liver localization patterns 
are different, hepatocytes only express GST Alpha, whereas biliary duct epithelium only 
contains GST Pi [14 - 16] The function of nuclear staining of GST, as found by us and 
others [14, 16] remains to be clarified Nuclear staining with GST Pi has previously been 
reported in healthy and diseased uterine cervix cells [22] In rats it has been postulated 
that class Mu GST subunits are involved in nuclear RNA processing [23] Any relationship 
between nuclear staining and its function remains to be clarified 
No reports on the expression of GST Alpha or Pi in embryonic pancreatic tissue have 
previously been published The staining pattern of GST Pi antibodies correlates with 
staining found in adult pancreas, sharply outlining the centroacinar and ductular structures, 
and leaving the acini and islets unstained Later on in gestation GST Alpha may be up-
regulated, since Campbell et al [15] have shown that in adult pancreas GST Alpha 
antibodies stained the cells lining ducts and acini, particularly the nuclei of the acinar cells 
The absence of GST Alpha in embryonic renal tissue has previously been shown by 
Faulder et al [24], who demonstrated that GST Alpha was not detectable in cytosol from 
kidney until 10 weeks' post natal age On the other hand. Strange et al [10] found that 
before 20 weeks' gestational age the collecting tubes and primitive Bowman's capsules 
express GST Alpha, whereas primitive glomeruli and mesenchymal tissue do not Between 
20 and 35 ratios gestational age, as the primitive nephron elongates and fuses with the 
collecting tube, its entire length showed GST Alpha and Pi immunoreactivity [10] 
Generally speaking, the expression of GST Alpha and Pi was similar in fetuses before 35 
weeks of gestation [10] Both GST Alpha and Pi were expressed along the entire 
developing nephron until about 35 weeks, after which period expression of GST Alpha was 
restricted to the proximal tubule, and of GST Pi to the collection tubules and distal part of 
the loop of Henle [10] Neither locus was expressed in the glomerulus This expression 
pattern is found in adults as well [14, 15] The physiological significance of changes in 
expression of GST Alpha and Pi in the developing nephron is unclear The proximal tubule 
is the site of considerable metabolic activity and oxygen consumption and presumably the 
production of potentially harmful oxygen-derived free radicals and hydroperoxides GST 
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Alpha, but not Pi isoenzymes, catalyze the detoxification of organic peroxides and may be 
important in the protection of cell structures The presence of GST Pi in nephric structures 
such as loop of Henle, distal convoluted tubule, collecting duct, and further along the 
urinary tract in the ureter and urinary bladder [10], suggests a possible role for GST Pi, and 
to a lesser extent for GST Alpha in the transport or elimination of toxic substances in the 
urine This may give significant protection against toxic compounds after birth, but may 
also be involved in the detoxification of compounds in urine excreted by the embryo and 
fetus from as early as 11 weeks [25] 
In contrast to our results, GST Alpha has previously been shown m cytosol from 
embryonic adrenal gland at 10 weeks' gestational age [24] In adult adrenal gland Campbell 
et al [15] have demonstrated high GST Alpha immunoreactivity in deep reticular layers, 
whereas GST Pi showed weaker and more diffuse staining in parenchyma throughout all 
the layers of the gland The difference in presence of GST Alpha and Pi in adult as 
compared to fetal adrenal glands suggests that GST Alpha will be up-regulated in the 
parenchyma during gestation, whereas GST Pi will be down-regulated 
We found no GST Alpha immunoreactivity in embryonic trachea, but GST Pi was 
present in epithelium and some chondrocytes Terrier et al [14] demonstrated GST Pi in 
adult tracheal chondrocytes, but in contrast to our results not in the cartilaginous matrix 
This may suggest that GST Pi will be down-regulated during gestation or after birth 
We were not able to demonstrate GST Alpha immunoreactivity in embryonic lung, 
although GST Alpha expression in first half of gestation has been shown by others [10, 
26] Strange et al [10] found GST Alpha in both major and distal airway cells throughout 
development Biochemical studies showed apparent down-regulation of GST Pi during the 
first half of gestation, in contrast to a continuous but weak expression of GST Alpha [26] 
The period of weeks 16 24 of gestation is crucial for development of the lung, since it 
changes from a glandular-like secretory organ to an organ capable of gaseous exchange 
Early in gestation GST Pi is present in epithelial cells but as development proceeds 
expression is maintained in proximal but not in more distal airway cells [10] This down 
regulation of GST Pi during the first half of gestation was also demonstrated by 
biochemical studies [26] and appears to precede phenotypic differentiation of the distal 
airways [10] The expression of GST Pi in an early stage of development suggests an 
additional role of this isoenzyme other than the protection of the respiratory tract against 
air pollutants 
Carder ef al [27] studied 21 fetal brains of 12 to 22 weeks' gestational age but in 
contrast to our results did not detect GST Alpha This discrepancy may be due to the 
different antibodies used Our antibody cross-reacts with all known GST Alpha hetero- and 
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homodimers; GST A1-1, GST A1 2 and GST A2-2 [13] Carder et al [27] showed that GST 
Pi was expressed from as early as 12 weeks' gestational age In the adult brain GST Pi was 
shown in choroid plexus, vascular endothelium, ventricular lining cells, pia-arachnoid and 
astrocytes, whereas neurons were consistently negative In general, GST Pi is localized at 
the site of the blood-cerebrospmal fluid (CSF), blood brain, CSF-bram and pia-arachnoid 
barriers, where it may regulate neuronal exposure to potentially toxic substances derived 
from blood or CSF Expression of GST Alpha and Pi this early in gestation may be 
significant in the protection of the developing human brain 
No immunohistochemical data on the expression of GST Alpha or GST Pi in embryonic 
trophoblastic tissue were available until now Pacifici et al [8] were able to measure GST 
activity in placental tissue homogenates from as early as 11 weeks' gestational age No 
relationship between GST activity and gestational age (11-25 weeks) was found, 
demonstrating that placental GST develops before the 11th week of gestation and does 
not undergo rapid changes during the second trimester [8] 
In summary, our results demonstrate that both both GST Alpha and Pi immunoreactive 
protein are present early in human embryonic life at 8 weeks' gestational age Since we 
only stained for immunoreactive protein and did not measure enzyme activity we cannot 
exclude that premature forms of GST are present at this stage of human embryonic life 
Since some drugs and chemicals may cross the placenta and accumulate in fetal tissues, 
a wide distribution of GST early in development may be important The differences 
between our results in embryonic tissues and those obtained by other investigators may 
be due to differences in gestational age, the specific characteristics of the antibodies used, 
whereas intermdividual differences also cannot be ruled out The early expression of GST 
Alpha and GST Pi in the epitheha of the urinary and digestive tracts and the respiratory 
system, which are three major systems involved in elimination and transport of toxic 
substances in the adult human body, supports the importance of these GST in 
detoxification mechanisms in human life 
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ABSTRACT. 
Objective: To investigate a possible pathophysiological involvement of 
glutathione and glutathione-related enzymes, being major detoxicatmg and 
oxygen free radical scavenging systems, in placental and decidual tissue in 
preeclampsia 
Design: A prospective study 
Participants: Seventeen normotensive pregnant women and 24 preeclamptic 
women of whom 10 showed the HELLP syndrome 
Methods: Glutathione (GSH) levels, glutathione S-transferase activity (GST), 
total (TGPX, being non-selenium dependent) and selenium dependent 
glutathione peroxidase activity (SeGPX) were assessed in placental and 
decidual tissues, collected at caesarean section. 
Main outcome measures: Decidual levels were compared to placental levels 
and levels in preeclampsia were compared to those in normotensive 
pregnancy by the Mann-Whitney U test Clinical data were correlated with 
GSH, GST, TGPX and SeGPX levels by Spearman's correlation test. 
Results: GSH levels, TGPX and SeGPX activities were significantly higher in 
decidual tissue as compared to placental tissue (P < 0 0001). GSH levels 
were elevated in preeclampsia as compared to normotensive pregnancy for 
both decidual (P < 0 01) and placental {P < 0 05) tissues GST activity was 
not significantly different between the two groups In preeclampsia TGPX 
activity was elevated in placental tissue (P < 0 05) and SeGPX was higher 
in decidual tissue {P < 0.001) GSH levels correlated significantly with 
diastolic blood pressure and serum urate levels in both decidual and 
placental tissue and wi th platelet count, the degree of proteinuria, serum 
creatinine, AST, ALT and LDH levels in decidual tissue only 
Conclusions: Enhanced glutathione concentrations and glutathione 
peroxidase activities in placental and decidual tissues in preeclampsia were 
found, probably acting as a compensatory mechanism to prevent further 
generation of lipid peroxides and oxygen radicals in the placenta or the feto-
maternal interface. 
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INTRODUCTION. 
Hypertension complicates 6 20 % of all pregnancies and ranks amongst the four most 
common causes of maternal and perinatal mortality in the world [1] The etiology of 
this gestational disorder is still largely unknown Increasing evidence suggests an 
impairment of endothelial cell function, possibly mediated by oxygen free radicals, lipid 
peroxides or other toxins, as crucial determinants in the development of this gestational 
disorder [2, 3] An impaired placental perfusion or an increased activity of the decidual 
lymphoid tissue due to immunologic maladaptation, could lead to an excessive 
production of oxygen free radicals and/or lipid peroxides acting locally or being spilled 
in the maternal circulation Lipid peroxides activate cyclo oxygenase and impair 
endothelial prostacyclin synthetase, thus leading to decreased prostacyclin levels [4] In 
normal conditions a variety of antioxidant mechanisms serve to control peroxidative 
processes [5] , but in preeclampsia, an imbalance between lipid peroxidation and 
antioxidant mechanisms could impair normal endothelial function [6] 
Glutathione and glutathione-related enzymes are involved in the metabolism and 
detoxif ication of cytotoxic and carcinogenic compounds and reactive oxygen species 
Glutathione can act either as a substrate in the cytosolic GSH-redox cycle or directly 
inactivate reactive oxygen species, such as the oxygen radicals 0 2 and OH Glutathione 
is present in all cells at high concentrations (0 5 - 1 0 mM), most of which is in the 
reduced form [7] 
Glutathione S-transferases (GSTs) are enzymes catalyzing the nucleophilic addition 
of glutathione to electrophilic centres of a wide variety of compounds They can also 
serve as transport proteins for a broad range of lipophilic compounds, such as bilirubin, 
bile acids, steroid hormones and various xenobiotics 18, 9] 
Glutathione peroxidases (GPX) are enzymes that catalyze the reduction of organic 
hydroperoxides (lipid hydroperoxides, DNA hydroperoxides) and hydrogen peroxide 
Two major types of GPX have been found of which one type contains selenium 
(SeGPX), being active with both organic hydroperoxides and hydrogen peroxide The 
second type of GPX (TGPX) consists of proteins that do not depend on selenium and 
have negligible activity with hydrogen peroxide This class comprises mainly glutathione 
S transferases [10] 
In this study glutathione levels, glutathione S-transferase and glutathione peroxidase 
activities were studied in placental and decidual tissues of preeclamptic and 
normotensive pregnancies 
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Table 1. Study group characteristics. 
Normotensive pregnancy Preeclamptic pregnancy 
in = 17) in = 24) 
Maternal age (yr) 33 (22-42) 29.5 (22-39) 
Gestational age (wk) 38*5 (37*a - 41 *3) 3 3 * " <26*3- 39) 
Parity 1 (0-3) 0* (0-2) 
Diastolic blood pressure 75 (58-86) 110*195-120) 
(K4; mm Hg) 
Hb (g/dU 11.8 (10.7-13.4) 12.0 (10.4-14.4) 
Ht (L/L) 0.36 (0.32-0.41) 0.36 (0.3-0.4) 
Platelet count (*109/L) 217 (150-301) 93* (31-305) 
Serum creatinine (^mol/L) 60 (54-83) 77* (52-108) 
Serum uric acid (mmol/L) 0.28 (0.17-0.36) 0.39*10.22-0.55) 
Serum AST (U/L) 10 (5-14) 67* (7-510) 
Serum ALT (U/L) 7 (4-11) 56* (5-333) 
Serum LDH (U/L) 208 (182-302) 534* (206-1607) 
Proteinuria (g/L) - 3.81 * (0.3 - 27.6) 
Values are given as median (range). 
* Ρ < 0.01 normo tensive pregnancy vs preeclampsia. 
MATERIALS AND METHODS. 
Study populations. 
Two groups of women were studied: 17 normotensive pregnant and 24 preeclamptic 
w o m e n , 10 of whom developed preeclampsia complicated by the HELLP (Haemolysis 
Elevated Liver enzymes Low Platelets) syndrome The experimental protocol was 
approved by the institutional review board of the University Hospital Nijmegen. Except 
for t w o women in the preeclamptic group, all women were delivered by caesarean 
section (SC; elective SC due to cephalo-pelvic disproportion in the control group and 
emergency SC in the preeclamptic group either for deteriorating maternal or fetal 
condition). Preeclampsia was defined as pregnancy induced hypertension (diastolic 
blood-pressure 90 mm Hg on t w o or more consecutive occasions, each more than 4 
hours apart) and concordant proteinuria (urinary protein > 300 mg/L) [111. The HELLP 
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syndrome was defined as Haemolysis, defined as increased lactate dehydrogenase 
activity (LDH > 600 U/l), Elevated Liver Enzymes, defined as increased AST ( > 70 U/l) 
and ALT ( > 70 U/l) activity and Low Platelets, defined as a platelet count < 100 χ 
10 3 /mm 3 [12]. Blood pressure was taken in sitting position with a sphygmomanometer 
Diastole was recorded at phase IV Korotkoff sound. Urinary protein was determined in 
24 hours urine samples. The characteristics of the women involved in this study are 
depicted in Table 1. 
Tissue preparation and biochemical analysis. 
Fragments of placental and decidual tissue were excised during caesarean section and 
frozen within 20 minutes after excision Tissue fragments (20 - 100 mg) were thawed 
and homogenized in 10 volumes ice-cold homogenizing buffer (250 mM sucrose, 20 
mM Tris-HCI, 1 mM dithnothreitol, pH 7.4) with 10 strokes in small glass-glass 
homogenizers. The homogenates were centrifuged at 150,000 χ g at 4°C for 1 h. 
Supernatants were frozen in liquid nitrogen and stored at -20°C in small portions 
Protein contents were determined using the method of Lowry et al. wi th bovine 
serum albumin as a standard [13]. 
Total GSH was determined by HPLC after labelling with monobromobimane as 
described previously [14]. 
Glutathione S-transferase activity was determined as described earlier by the method 
of Habig et al. using 1-chloro-2,4-dinitrobenzene (CDNB) as a substrate [15] 
Glutathione peroxidase enzyme activity was measured with hydrogen peroxide 
(selenium dependent activity, SeGPX) and t-butylhydroperoxide (total activity, being 
non-selenium dependent, TGPX) (Sigma Chemical Company, St Louis, MO, USA) as 
substrates, essentially as described by Howie ef al. [16]. GSH levels and activities of 
GST, TGPX and SeGPX activities were calculated per mg total cytosohc protein 
Statistical evaluations. 
Comparisons of differences between placental and decidual tissues on the one hand 
and preeclamptic women and normotensive controls on the other were performed by 
the Mann-Whitney U test. Correlations between the parameters were tested wi th the 
Spearman's rank correlation test Differences were considered significant if the Ρ value 
was below 0 05. 
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Table 2 Glutathione levels glutathione S transferase, total and selenium dependent glutathione 













In = 17) 
115 5 * 
(13 3 - 2 4 0 0) 
217 
(111 - 518) 
55 5s 
(24 5 - 101) 
119 
( 1 0 6 - 169) 
Preeclamptic 
pregnancy 
In = 22) 
185 6 * * 




(35 - 167) 
139 3 s ' 
(107 5- 173 5) 
Normotensive 
pregnancy 
In = 17) 
25 6 
(12 9 - 4 9 7) 
202 
( 8 0 - 3 1 8 5) 
46 
(30 5 - 7 5 5) 
106 5 
(78 5 171) 
Preeclamp tic 
pregnancy 
In = 24) 
38 41 
(9 6 1 1 1 3 ) 
191 
(107 5 -458 ) 
60 1 
(29 5 - 116 5) 
119 5 
(85 5 170 5) 
Results are presented as median (range) 
1 Ρ < 0 05, * Ρ < 0 0001, decidual vs placental tissue 
1 Ρ < 0 05, ' Ρ < О Ol, ' Ρ < О 001, preeclamptic vs normotensive pregnancy 
RESULTS. 
Decidual GSH levels were significantly higher as compared to placental levels in both 
normotensive controls and preeclamptic pregnancies GSH levels were significantly 
higher in both decidual tissue and placental tissue in preeclampsia as compared to 
normotensive pregnancy (Table 2, Fig 1) Decidual and placental GSH levels correlated 
significantly wi th several haematological and biochemical parameters reflecting the 
severity of the disease (Table 3) 
GST activities in decidual and placental tissues were not significantly different 
Decidual GST levels correlated significantly with several parameters reflecting the 
seventy of the disease (Table 3) 
Decidual TGPX activity was significantly higher than the corresponding placental 
act iv i ty in the control group Placental TGPX activity, in contrast with that of decidua, 
was significantly higher in the preeclamptic group as compared to the normotensive 
group 
Decidual SeGPX activity in the preeclamptic group was significantly higher than the 
corresponding placental activity (Table 2, Figs 1) and decidual SeGPX activity was 
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Table 3. Correlations between glutathione, glutathione S-transferase, glutathione peroxidases and 
several parameters reflecting the seventy of the disease in preeclamptic pregnancy 
Decidua Placenta 
GLUTATHIONE (GSH) 
GSH vs K4 
GSH vs proteinuria 
GSH vs platelet count 
GSH vs creatinine 
GSH vs urate 
GSH vs AST 
GSH vs ALT 
GSH vs LDH 
GLUTATHIONE S-TRANSFEBASE 
IGST) 
G S T v s R R /- = 0.41 Ρ = 0 0097 
GSTvs Hb г = 0.33 Ρ = 0 . 0 4 
GST vs creatinine r = 0.36 Ρ = 0 03 
GLUTATHIONE PEROXIDASE 
(TGPX) 
T G P X v s L D H N.S. /- = 0 34 Ρ = 0 0 4 
s i g n i f i c a n t l y h igher in p r e e c l a m p t i c p r e g n a n c y as c o m p a r e d t o n o r m o t e n s i v e p r e g n a n c y 
(Table 2 ) . 
T G P X a c t i v i t y c o r r e l a t e d s i g n i f i c a n t l y w i t h SeGPX a c t i v i t y in b o t h d e c i d u a l and 
p l a c e n t a l t issue (r = 0 . 6 7 , Ρ < 0 0 0 0 1 ; г = 0 . 6 0 , Ρ < 0 . 0 0 0 1 , r e s p e c t i v e l y ) . 
D I S C U S S I O N . 
A n i m b a l a n c e b e t w e e n l ip id p e r o x i d e s and o x y g e n free radicals o n the one h a n d and 
d e t o x i c a t i n g and s c a v e n g i n g s u b s t a n c e s o n t h e o t h e r m a y c o n t r i b u t e to t h e e t i o l o g y or 
p a t h o p h y s i o l o g y of p r e e c l a m p s i a [ 3 , 1 7 ] . M o s t o r g a n i s m s are e q u i p p e d w i t h e n z y m a t i c 
and n o n - e n z y m a t i c d e f e n c e m e c h a n i s m s against o x i d a n t s and o t h e r t o x i c c o m p o u n d s . 
I m p o r t a n t a n t i o x i d a n t a n d d e t o x i c a t i n g e n z y m e s are s u p e r o x i d e d i s m u t a s e (SOD), 
cata lase, g l u t a t h i o n e p e r o x i d a s e and g l u t a t h i o n e S-transferase. N o n - e n z y m a t i c 
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/• = 0.57 Ρ = 0 0 0 0 1 /- = 0 39 Ρ = О 01 
r = 0.43 Ρ = 0 047 N.S. 
г = - 0 36 Ρ = 0.03 N.S 
г = 0.40 Ρ = 0 01 NS. 
r = О 42 Ρ = 0 0078 r = 0 34 Ρ = 0.03 
r = 0 46 Ρ = 0 005 N.S 
r = 0.43 Ρ = 0.0064 N.S 





















































Fig 1 Decidual and placental glutathione IGSHI concentrations in normotensive pregnancy (A), 
and preeclampsia with ¡ШІ or without the HELLP syndrome (Ol Bars indicate median 
levels 
detoxification is achieved by many different agents such as transferrin ceruloplasmin 
lactoferrin vitamin E, vitamin C, uric acid and thiols such as glutathione, cysteamme 
and cysteine For example, activities of CuZn SOD and tissue levels of vitamin E were 
shown to be significantly lower in placentas of preeclamptic as compared to those of 
normotensive pregnant women [18] Since the glutathione system in a quantitative 
sense is one of the most important protective systems in humans we focussed our 
attention on glutathione and glutathione related enzymes in both placental and decidual 
tissue the latter being studied for the first time in this respect 
Decidual glutathione levels were much higher as compared to placental glutathione 
levels in both preeclampsia and normotensive pregnancy In fact, the decidual GSH 
levels appeared to be much higher than that in any other human tissue examined 
previously 114, 19, 20] This high decidual level may point to a pronounced protective 
role of this tissue, either protecting the mother against peroxides or oxygen free 
radicals produced by the feto-maternal interface or the placenta [21], or protecting the 
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fetus against such harmful compounds [22]. 
We found considerably higher levels of glutathione in placental and especially 
decidual tissue in preeclampsia as compared to those in normotensive pregnancy. 
Enhanced lipid peroxidation may be involved in the foam-cell formation of decidua and 
in the pathogenesis of preeclampsia [23]. GSH can inhibit lipid peroxidation via 
membrane bound GPX [24]. GSH levels may point to a compensating mechanism in 
order to prevent excessive lipid peroxidation. Human decidua mainly produces 
thromboxane B2 (TxB2), however, after addition of reduced glutathione prostaglandin 
E2 became the main product [25]. Cytosols from decidua vera and placenta were most 
effective in stimulating synthesis of prostaglandin E2. Reduced GSH is able to increase 
the biosynthesis of PGE2 at the expense of other prostaglandins, both in the presence 
or absence of these cytosols [26]. Preeclampsia is associated with a change of the 
prostaglandin/thromboxane balance in favour of thromboxane formation. An increase in 
decidual and placental tissue glutathione concentration may, besides prevention of 
excessive lipid peroxidation point to a compensatory mechanism in order to enhance 
prostaglandin production. Enhanced placental GSH levels in preeclamptic women are in 
accordance with a previous report [27]. 
The decidual glutathione S-transferase (GST) activity was slightly enhanced in 
preeclampsia as compared to normotensive pregnancy, but the difference was not 
statistically significant. There is a possibility of a yet unknown toxin produced by the 
feto-maternal interface. This factor may be detoxified in a reaction with glutathione 
catalyzed by GST. Until now there's only one report investigating placental GST activity 
in preeclampsia and no difference between preeclamptic and normotensive pregnancy 
was found [ 2 8 ] , which is in agreement wi th our results. 
We found a significantly higher SeGPX activity in decidual tissue and significantly 
higher TGPX activities in placental tissue of preeclamptic pregnancy as compared to 
normotensive pregnancy. Interestingly, in normotensive pregnancy, TGPX activity in 
decidual tissue was significantly higher than in placental tissue, whereas in 
preeclamptic pregnancy, SeGPX activity was significantly higher in decidual tissue as 
compared to placental tissue. This may point to a differential upgrading of peroxidases 
in these tissues. In preeclampsia the relative upgrading of SeGPX is in favour of 
decidual tissue and the upgrading of TGPX is in favour of placental tissue. TGPX 
activity correlated significantly with SeGPX activity in decidual and placental tissue 
indicating that GPX activity in placental and decidual tissue is mainly involved in 
detoxifying organic hydroperoxides, and not H 2 0 2 . Conflicting results have been 
published on placental glutathione peroxidase activity in preeclampsia, varying from 
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decreased activities to unchanged activities [28, 29] . Glutathione peroxidase activity 
[30 ] , and messenger RNA levels of glutathione peroxidase [18] were reported to be 
lower in placental tissue of preeclamptic pregnancies as compared to those in 
normotensive pregnancies whereas levels of lipid peroxides were higher [21] The 
discrepancy between our results and those reported in literature could be due to the 
fact that our patients did have a rather severe preeclampsia, leading to an even more 
enhanced compensatory mechanism. There seems to be an interaction between lipid 
peroxides, the prostaglandin/thromboxane system and glutathione peroxidases Lipid 
peroxides, levels of which are elevated in the maternal circulation of hypertensive 
pregnant women [31], may stimulate prostaglandin H2 synthase and increase 
thromboxane and oxygen radical production, which subsequently increases the 
formation of lipid peroxides [30] Cyclooxygenase activity not only generates 
thromboxane but also oxygen radicals 132) Glutathione peroxidases inactivate 
peroxides, thereby diminishing peroxide mediated stimulation of prostaglandin 
synthase Inhibition of glutathione peroxidase activity in normal placentas resulted in a 
dose dependent increase in placental production of both lipid peroxides and 
thromboxane, without affecting prostacyclin, so the ratio of thromboxane to 
prostacyclin progressively increased [30] The thromboxane/prostacyclin and lipid 
peroxide/prostacychn ratios were shown to be threefold higher in preeclamptic placenta 
as compared to normal placenta [21] In this respect, the increased peroxidase activities 
we observed may act as a compensatory mechanism, both in placental and decidual 
tissues. 
In conclusion, we found enhanced glutathione concentrations and glutathione 
peroxidase activities in placental and decidual tissues in preeclampsia, which 
significantly correlated with the seventy of the disease This most probably represents 
a compensatory mechanism to (further) prevent generation of lipid peroxides and 
oxygen radicals in the feto-maternal interface, in order to prevent damage to the fetus 
or the mother 
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ABSTRACT. 
Objective: To investigate the pathophysiologic involvement of glutathione in 
pregnancies complicated by preeclampsia or the Haemolysis Elevated Liver 
enzymes Low Platelets syndrome (HELLP) 
Methods: Total whole blood glutathione levels were measured by high 
performance liquid chromatography in 23 women with pregnancies 
complicated by preeclampsia or the HELLP syndrome, and 22 normotensive 
gravidas Total glutathione levels and the total glutathione / haemoglobin 
ratios of patients were compared to those of controls by the Mann Whitney 
U-test 
Results: Median total glutathione levels were lower in hypertensive 
pregnancies than in normotensive pregnancies (647 [range 268 986] and 
750 [range 495 - 1572] /jmol/L, Ρ = 0 05) The median total glutathione / 
haemoglobin ratios were significantly lower in hypertensive pregnancies 
than in normotensive pregnancies (0 079 [range 0 033 0 122] and 0.101 
[range 0 073 - 0 210] , Ρ = 0 02) 
Conclusion: Decreased total glutathione levels in maternal whole blood may 
indicate decreased detoxificating or free radical scavenging capacity in 
pregnancies complicated by preeclampsia or the HELLP syndrome 
INTRODUCTION. 
Hypertension complicates 6 - 2 0 % of all pregnancies and ranks amongst the four most 
common causes of maternal as well as perinatal mortality in the world [1] The etiology 
of this gestational disorder is largely unknown Increasing evidence suggests an 
endothelial cell dysfunction, possibly mediated by oxygen free radicals, lipid peroxides 
and other toxins, as a crucial determinant in the development of this gestational 
disorder [2] Impaired placental perfusion or increased activity of the decidual lymphoid 
tissue due to immunologic maladaptation could lead to an excessive production of 
oxygen free radicals and/or lipid peroxides, either acting locally or being spilled in the 
maternal circulation Lipid peroxides may activate cyclo-oxygenase and impair 
endothelial prostacyclin synthetase, thus leading to decreased prostacyclin levels [3] 
Under normal conditions a variety of antioxidant mechanisms serve to control 
peroxidative processes [4] , but in preeclampsia an imbalance between lipid peroxidation 
and antioxidant mechanisms could impair normal endothelial function [2, 5] 
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Glutathione and glutathione-related enzymes are involved in the metabolism and 
detoxif ication of carcinogenic and cytotoxic compounds, including reactive oxygen 
species Glutathione can either act as a substrate in the cytosolic glutathione-redox 
cycle or directly inactivate reactive oxygen species, such as 0 2 and OH . Glutathione is 
present in cells in high concentrations (0 5 - 1 0 mM), most of which (more than 99%) 
exists in the reduced form Oxidized glutathione is either converted into the reduced 
form by glutathione reductase or transported out of the cell. Also chemical stress 
leading to extra conjugation with glutathione may result in loss of glutathione [6] 
Erythrocytes and liver contain the highest GSH redox activity [71 The amounts in 
plasma only represent less than 1 % of the total whole blood glutathione pool, which is 
primarily localized in erythrocytes [8, 9] . 
In the present study maternal whole blood total glutathione levels were measured in 
pregnancies complicated by preeclampsia or the Haemolysis Elevated Liver enzymes 
Low Platelets syndrome (HELLP) and compared to levels in normotensive pregnancy 
We also calculated the total glutathione / haemoglobin ratio to account for possible 
variations in haemoconcentration. 
MATERIALS AND METHODS. 
Two groups of pregnant women were studied 22 had normotensive, uncomplicated 
pregnancies, and 23 had pregnancies complicated by preeclampsia (n = 8), the HELLP 
syndrome {n = 6), or both (n = 9) Preeclampsia was defined as pregnancy-induced 
hypertension (diastolic blood pressure (BP) ¿ 90 mm Hg on two or more consecutive 
occasions, each more than 4 hours apart) and concordant proteinuria (urinary protein 
exceeding 0 30 g/L) [10] BP was taken in sitting position with a sphygmomanometer 
Diastole was recorded at phase IV Korotkoff sound The HELLP syndrome was defined 
as Haemolysis, defined as increased lactate dehydrogenase activity (LDH above 600 
U/L), Elevated Liver enzymes, defined as increased aspartate aminotransferase (above 
70 U/L) and alanine aminotransferase (above 70 U/L) activity and Low Platelets, defined 
as a platelet count under 100 χ 103/mm3 [11) 
Antecubital maternal venous blood samples were taken in sitting position after 5 
minutes of rest in 4 mL ethylenediaminetetra-acetic acid tubes (Becton and Dickinson, 
Grenoble, France). Immediately after sampling, 1 mL of whole blood was diluted wi th 1 
mL of a 2 0 % (w/v) aqueous solution of trichloroacetic acid The mixture was shaken 
vigorously and frozen at -20° С until use After thawing, the mixture was centrifuged 
for 10 minutes at 13,000 χ g, and 10 - 20 //L of the clear supernatant was used for 
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e s t i m a t i o n of t h e g l u t a t h i o n e c o n t e n t T o t a l g l u t a t h i o n e levels w e r e d e t e r m i n e d b y h i g h 
p e r f o r m a n c e l iquid c h r o m a t o g r a p h y a f t e r label l ing w i t h m o n o b r o m o b i m a n e , e s s e n t i a l l y 
as d e s c r i b e d p r e v i o u s l y [ 1 2 ] . 
H a e m o g l o b i n , h a e m a t o c r i t , p l a t e l e t c o u n t , c r e a t i n i n e , u r a t e , a s p a r t a t e 
a m i n o t r a n s f e r a s e , alanine a m i n o t r a n s f e r a s e , LDH and p r o t e i n u r i a w e r e analyzed 
r o u t i n e l y at t h e d e p a r t m e n t of Cl inical C h e m i s t r y of t h e U n i v e r s i t y H o s p i t a l S t . 
R a d b o u d Data are e x p r e s s e d as m e d i a n s (range) G r o u p s w e r e c o m p a r e d by the M a n n -
W h i t n e y U-test, and c o n s i d e r e d s i g n i f i c a n t at Ρ < 0 0 5 
Table 1 Population characteristics 
Hypertensive pregnancy Normotensive pregnancy 
(n = 231 (n = 221 
Maternal age (yrs) 28 ( 2 2 - 3 6 ) 33 5 ( 2 6 - 4 0 ) * 
Gestational age (wks) 32 2 ( 1 8 * э - 3 9 * 6 ) 3 6 ' 5 ( 3 5 ' " - 3 7 5 ) ' 
Parity 0 ( 0 - 2 ) 1 ( 0 - 2 ) ' 
Diastolic BP (K 4, mm Hg) 105 ( 3 9 - 1 2 0 ) 73 5 (65 - 85) s 
Hb (mmol/L) 7 9 ( 5 5 - 9 5 ) 7 45 (6 - 8 1 ) 
Ht (L/L) 0 37 (0 26 - 0 45) 0 36 (0 30 - 0 40) 
Platelet count (*103/L) 88 ( 2 6 - 3 0 3 ) 
Serum creatinine (/jmol/L) 82 (52 166) 
Serum uric acid (mmol/L) 0 42 (0 26 0 59) 
Serum aspartate 125 ( 1 1 - 1 3 5 0 ) 
aminotransferase (U/L) 
Serum alanine 105 ( 6 - 1 1 4 0 ) 
aminotransferase (U/L) 
Serum LDH (U/L) 807 (207 - 3210) 
Proteinuria (g/L) 1 0 (0 03 - 27 6) 
Results are presented as median {range) 
* Ρ = 0 000J, ' Ρ = 0 0007, ' Ρ = 0 006, ! Ρ < 0 0001 hypertensive pregnancy vs 
normotensive pregnancy. Mann Whitney U-test, BP = blood pressure, LDH = lactate 
dehydrogenase 
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Fig. 1. Maternal whole blood total glutathione /haemoglobin ratios in normotensive pregnancy 
(A.I, and pregnancies complicated by preeclampia or the HELLP syndrome (9). Horizontal 
lines indicate mean levels. 
RESULTS. 
Maternal age, parity and gestational age were significantly lower and diastolic BP was 
significantly higher in pregnancies complicated by preeclampsia or the HELLP syndrome 
as compared to normotensive, uncomplicated pregnancies (Table 1) 
Median whole blood glutathione levels were lower in women with hypertension than 
in normotensive gravidas, reaching borderline statistical significance (647 [range: 268 -
986] and 750 [range· 495 - 1572] ¿/mol/L, Ρ = 0.05) The median glutathione / 
haemoglobin ratio was significantly lower in hypertensive as compared to normotensive 
pregnancies (median 0.079 [range: 0.033 - 0.121] and 0.101 [range. 0 073 - 0.210], Ρ 
= 0 02, Fig. 1). 
DISCUSSION. 
Median whole blood total glutathione ratios were decreased in pregnancies complicated 
by preeclampsia or the HELLP syndrome. Since whole blood glutathione levels mainly 
originate from erythrocytes [8, 9] , we also calculated the total glutathione / 
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haemoglobin ratio to account for possible variations in haemoconcentration Whole 
blood total glutathione / haemoglobin ratios were significantly lower in hypertensive 
pregnancies as compared to those in normotensive pregnancy, suggesting a decreased 
detoxificating or free radical scavenging capacity 
Several studies show evidence of the involvement of oxygen free radicals and lipid 
peroxidation products in preeclampsia and pregnancy induced hypertension [13 14] 
and numerous studies have been published on the antioxidant and detoxification 
capacity of maternal blood in hypertensive disorders of pregnancy as reviewed by 
Roberts et al [2], and Hubel et al [5] In this respect, several studies have been 
published on glutathione and glutathione-related enzymes Erythrocyte thiols, mainly 
consisting of glutathione [15], and glutathione levels were found to be lower in 
preeclampsia [16] and pregnancy-induced hypertension [17] as compared to 
normotensive pregnancy In addition plasma thiols, and glutathione were significantly 
decreased in pregnancy-induced hypertension [16, 18] In agreement with these results, 
significantly higher levels of non selenium dependent glutathione peroxidase activity 
one of the enzymes that consumes glutathione as a co factor, were found in 
erythrocytes and plasma in severe preeclampsia as compared to normotensive 
pregnancy [14] The results of our study, and those reported in the literature, suggest a 
compensatory increase in the glutathione peroxidase activity in maternal blood resulting 
in a loss of glutathione from whole blood 
In our study a significantly lower gestational age was found in patients as compared 
to controls Non-selenium dependent peroxidase activity and lipid peroxidation products 
increase with advancing gestation in normotensive uncomplicated pregnancy [19], 
suggesting an increased peroxide or oxygen free radical load, and as a consequence, 
glutathione levels may decrease with advancing gestation However, no data in this 
respect are available. 
Whole blood total glutathione / haemoglobin ratios decreased in women with 
advancing age [8] Since in our study maternal age was higher in controls as compared 
to patients, the difference in total glutathione / haemoglobin ratios would even be 
higher if maternal ages of both groups were completely matched 
Kidney and especially liver play a pivotal role in the homeostasis of whole blood 
glutathione, especially in providing precursors such as cysteine to erythrocytes [9] 
Erythrocytes most likely play a significant role in the interorgan transport of glutathione 
[9] Dependence of erythrocytic glutathione concentrations on the hepatic, and to a 
lesser extent renal output of amino acid precursors may explain why red blood cell 
glutathione concentrations are often decreased in hepatic [20] or renal failure [21] 
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Since hepatocellular and renal impairment are hallmarks of the HELLP syndrome and 
preeclampsia respectively, an inadequate provision of glutathione precursors to 
erythrocytes, apart from a possible overconsumption due to oxidative or chemical 
stress may be inferred 
Normalization of glutathione levels in patients with preeclampsia or the HELLP 
syndrome may be a promising therapy for the future In endothelial cell culture systems 
it was demonstrated that an enhancement of intracellular glutathione [22, 23] provided 
a better protection against damage by hydrogen peroxide This may be relevant for 
hypertensive disorders of pregnancy, which are considered endothelial disorders [2] 
Infusion of S-nitrosoglutathione in patients with severe preeclampsia, lowered maternal 
mean arterial pressure, platelet activation, and uterine artery resistance without further 
compromising fetal Doppler indices [24] In addition it is suggested to exert beneficial 
effects in the treatment of the HELLP syndrome [25] Administration of N 
acetylcysteine, a precursor of glutathione, may also be beneficial in the treatment of 
preeclampsia, because it reduces in vitro feto-placental resistance [26], and although it 
is proved to cross the feto-placental barrier [27], it does not seem to induce adverse 
effects in the fetus 128]. N acetylcysteine is easily transported into the cell where it is 
deacetylated, and partly used for the synthesis of reduced glutathione It is noteworthy 
also to be beneficial in preventing free radical oxidative damage in an animal model of 
myocardial damage [29] 
In conclusion, low total glutathione levels have been demonstrated in maternal whole 
blood of patients with preeclampsia or the HELLP syndrome as compared to 
normotensive pregnancy This may result in decreased detoxificating or free radical 
scavenging capacity Administration of glutathione-enhancing agents, such as N-
acetylcysteine may be beneficial in the treatment of these gestational disorders 
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ABSTRACT. 
Objective: Our purpose was to investigate the value of plasma glutathione 
S-transferase Alpha 1-1 (GSTA1-1) measurements in the assessment of 
hepatocellular damage in hypertensive disorders of pregnancy. 
Study design: Patients were recruited at the Department of Obstetrics and 
Gynaecology of the University Hospital St. Radboud, Nijmegen, The 
Netherlands. Five groups of patients were studied, normotensive pregnancy 
{n = 87), pregnancy-induced hypertension (n = 48), preeclampsia (n = 
79), the Haemolysis Elevated Liver enzymes Low Platelets syndrome (HELLP) 
(η = 39), and longitudinally studied normotensive pregnancy (л = 21). 
Blood was collected for the assessment of plasma GSTA1-1 levels and 
serum alanine aminotransferase (ALT) activity. Levels in hypertensive 
pregnancies were compared wi th levels in normotensive pregnancy by the 
Mann-Whitney U test. Patients were categorized according as to whether 
their levels are below (normal) or above (elevated) the upper normal 
reference level. The difference in relative magnitude of elevation between 
the t w o factors was determined by the Wilcoxon matched-pairs signed-rank 
test 
Results: Plasma levels in the longitudinally studied normotensive pregnancy 
group did not differ between gestational ages, and were not significantly 
dif ferent from those of the normotensive control group. Median levels of 
GSTA1-1 and ALT were significantly increased (P < 0 . 0 1 , Ρ < 0.0001 
respectively) in all subgroups of hypertensive pregnancies compared with 
those in normotensive pregnancy. When both levels were elevated, the 
relative magnitude of the increase of GSTA1-1 levels was significantly 
higher than that of ALT activity in both preeclampsia (P < Q.01) and the 
HELLP syndrome (P < 0 0001). Almost half of the patients with 
preeclampsia showed elevated levels of plasma ALT and/or GSTA1-1 levels. 
Conclusion: Plasma GSTA1-1 measurements may provide a more sensitive 
indicator of acute hepatocellular damage in preeclampsia and the HELLP 
syndrome, compared with the assessment of aminotransferase activity, and 
therefore may allow earlier recognition of these syndromes. The clinical 
benefits of plasma GSTA1-1 measurements for monitoring the hepatocellular 
condit ion in the management of these patients need to be elucidated in 
further studies. 
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INTRODUCTION. 
Pregnancy-induced hypertension, preeclampsia and the syndrome of haemolysis, 
elevated liver enzymes, and low platelets (HELLP) are major causes of maternal and 
perinatal morbidity and mortality Remarkably few authors have stressed the 
importance of the hepatic involvement in these multi-system disorders, although liver 
dysfunction is a frequent and important complication of hypertensive disorders in 
pregnancy, associated with the severity of the hypertension and the involvement of 
other organ systems 11] Deterioration of hepatic function is a crucial determinant in the 
clinical management of these pregnancies. Therefore a correct assessment of possible 
hepatocellular damage is essential However, serum aspartate aminotransferase (AST, 
EC 2 6 1 1) and alanine aminotransferase (ALT, EC 2 6 1 2) activities, the standard 
liver function tests, do not accurately reflect the severity of the underlying 
histopathologic condition in these syndromes [2, 3] . AST is found in high 
concentrations in heart and skeletal muscle, kidney, pancreas, and erythrocytes as well 
Haemolysis may contribute significantly to a rise in AST levels in addition to 
hepatocellular damage [4] Elevated serum ALT levels are considered to be more 
specific for hepatocellular damage than serum AST levels are because the concentration 
of ALT in liver is relatively high A sustained elevation of serum ALT levels in patients 
wi th the HELLP syndrome has been found, indicating persistent hepatocellular damage 
[5]. 
The glutathione S-transferases (GST, EC 2 5 1.18) are a multigene family of 
enzymes that possess many biologic functions. They catalyze the addition of 
glutathione to a wide variety of compounds such as xenobiotics and serve as transport 
proteins for lipophilic compounds [6, 7] Cytosolic GSTs are dimeric proteins, divided 
into four classes- Alpha, Mu, Pi, and Theta [8] Two class Alpha subunits have been 
identified, and two homodimeric (GSTA1-1 and GSTA2-2) and a heterodimeric enzyme 
(GSTA1-2) have been purified from human liver [9] 
More than 2 % of the soluble protein in liver consists of GST Alpha 1101. The enzyme 
is released in considerable quantity into the bloodstream during hepatocellular damage 
[7] The half life in plasma is approximately 1 hour and plasma levels will follow 
changes in hepatocellular damage more rapidly than will AST (half-life 17 hours) or ALT 
(half-life 47 hours) |11) In the current study we investigated the possible advantage of 
plasma GSTA1-1 levels measurements compared with that of serum ALT activity in the 
assessment of hepatocellular damage in pregnancy induced hypertension, preeclampsia 
and the HELLP syndrome 
105 
Chapter 5, paragraph 5.3 
MATERIALS AND METHODS. 
Study populations. 
The population characteristics of the subgroups of patients studied are presented in 
Table 1. Some data of 21 preeclamptic patients have contributed to a preliminary study 
[12]. Women entered the study after informed consent was obtained. The experimental 
protocol was approved by the Medical Ethical Review Committee of the University 
Hospital St. Radboud. Pregnancy-induced hypertension (n = 48) was defined as a 
diastolic blood pressure ï 90 mm Hg on two or more consecutive occasions, each more 
than 4 hours apart. Preeclampsia (/? = 79) was defined as pregnancy-induced 
hypertension and concordant proteinuria (urinary protein/creatinine ratio iO.30 g/10 
mmol). The HELLP syndrome (n = 39; 8 were postpartum) was defined as Haemolysis, 
defined as increased lactate dehydrogenase (LDH) activity ( > 6 0 0 U/l), Elevated Liver 
enzymes, defined as increased AST ( > 7 0 U/l) and ALT ( > 7 0 U/l) activity and Low 
Platelets, defined as a platelet count < 1 0 0 χ 10 3 /mm 3 [13, 14). Blood pressure was 
taken w i t h a sphygmomanometer with the patient in the sitting position. Diastole was 
recorded at the phase IV Korotkoff sound. Eighty-seven women were studied during 
uncomplicated, normotensive pregnancies. In addition, plasma levels of GSTA1-1 were 
measured in 21 normotensive nulliparous pregnant women studied longitudinally for 
other purposes [15], who were delivered of term, healthy, appropriate-for-gestational-
age infants at gestational weeks 12, 16, 20, 24, 28, 32, 36 and 38. 
































Results are presented as median; range is given in parentheses. 
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Analytical procedures. 
Antecubital venous blood samples were taken with the patient in the sitting position 
after 5 minutes of rest. Blood for measurement of GSTA1-1 was drawn in 4 mL tubes, 
containing ethylenediaminetetraacetic acid (No. 606601 Becton-Dickmson, Grenoble, 
France). For the measurement of AST, ALT and LDH activity, blood was collected in 4 
mL Corvac Vacutainer glass tubes (Monoject, No. 37, Sherwood Medical, Ballymoney, 
United Kingdom). Blood was centrifuged within 1 5 minutes at 3,000 χ g for 10 minutes 
and plasma or serum collected. Measurements of serum AST, ALT and LDH activities 
were performed at the local department of clinical chemistry on a Hitachi 747 analyser 
(Osaka, Japan). Plasma was stored at -20°C until assessment of glutathione S-
transferase Alpha 1-1 levels. 
Plasma GSTA1-1 concentrations were measured with use of a recently developed 
enzyme linked immunosorbent assay [16]. Microtiter plates were coated overnight wi th 
purified anti-GSTA1-1 monoclonal antibody (5B11). 
One hundred microliters of standard (0.04 to 20 /yg/L GSTA1-1), or 1:1, 1:100 and 
1-1000 diluted plasma samples were added to the wells and incubated overnight. The 
next day the plates were washed and incubated with rabbit anti-GST-Alpha antiserum, 
washed again, incubated with horseradish peroxidase-labelled swine anti-rabbit 
antiserum. After a final wash, plates were stained with o-phenylenediamme-hydrogen 
peroxide Standards and samples were measured in duplicate. A four-parameter 
weighted logistic regression model was used to calculate standard curves and 
unknowns. The assay has a detection limit of 0.04 /vg/L GSTA1-1, and the mtra-assay 
and inter-assay coefficients of variation are 2.5% and 7.3%, respectively. 
Statistical analysis. 
Samples were categorized according to their GSTA1-1 and ALT levels, below (normal) 
or above (elevated) the upper normal reference level (2 SDs above the mean). An upper 
normal reference level of 5.9 /yg/L GSTA1-1 was calculated from plasma samples of 
350 healthy non-pregnant controls [16]. Upper normal reference levels of 25 U/L and 
30 U/L for AST and ALT, respectively, were used as specified by the local department 
of clinical chemistry. 
The statistical significance of differences between median levels of GSTA1-1 and 
ALT between patients and healthy pregnant controls was evaluated with use of the 
Mann-Whitney U test. To avoid spurious differences, data were initially subjected to a 
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K r u s k a l - W a l h s ana lys is . T h e c o r r e l a t i o n s b e t w e e n G S T A 1 - 1 and A L T levels w e r e 
e v a l u a t e d w i t h use of S p e a r m a n ' s rank c o r r e l a t i o n p r o c e d u r e . D i f f e r e n c e s b e t w e e n t h e 
r e l a t i v e m a g n i t u d e s o f e l e v a t i o n s o f p lasma G S T A 1 - 1 and s e r u m A L T levels in a 
s u b g r o u p o f p a t i e n t s w i t h p r e e c l a m p s i a or the HELLP s y n d r o m e w h o had e l e v a t e d 
leve ls o f G S T A 1 - 1 and A L T w e r e e v a l u a t e d w i t h use of t h e W i l c o x o n M a t c h e d - p a i r s 
s i g n e d - r a n k t e s t . D i f f e r e n c e s b e t w e e n g e s t a t i o n a l ages in t h e l o n g i t u d i n a l l y s t u d i e d 
g r o u p and t h e n o r m o t e n s i v e p r e g n a n c i e s w e r e e v a l u a t e d by Kruskal-Walhs ana lys is . Al l 
s t a t i s t i c a l analyses w e r e p e r f o r m e d w i t h use of S P S S / P C + V 5 0 (SPSS, C h i c a g o ) 
s t a t i s t i c a l c o m p u t e r s o f t w a r e . 
Table 2. Longitudinal plasma GSTA1-1 concentrations in uncomplicated nulliparous 

















GSTA1 1 1.1 1.0 1.1 1.4 1.0 1.1 1.2 1.2 
(/yg/L) (0 1 4 5) (0 3 2 5) (0 3 2 6) (0 3-6 0) (0 4-5 5) (0 4 3 6) (0 3-7 1) (0 3-6 0) 
Results are presented as median; range is given in parentheses. 











(50 - 89) 
1 0 
( 0 . 2 - 10.9) 
4 





( 9 0 - 130) 
1 5" 
( 0 . 5 - 285.5) 
7 s 
(2 - 230) 
Preeclampsia 
100 
( 9 0 - 130) 
4 1 s 
(0 9 - 688.0) 
15 s 
(1 - 537) 
HELLP 
100 
(75 - 140) 
131.7 s 
(9 4 - 2399.0) 
1 9 1 s 
( 7 4 - 1140) 
Results are presented as median; range is given in parentheses. 
' Ρ < 0 01, 5 Ρ < 0.0001, significantly different from values during normotensive pregnancy. 
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Table 4 Number of women w i t h normal or elevated GSTA1-1 concentration and/or ALT activ ity 
Normotensive Pregnancy- Preeclampsia HELLP 
Pregnancy induced 
hypertension 
GSTA1-1 and ALT normal 
GSTA1-1 elevated , ALT normal 
ALT elevated, GSTA1-1 normal 

















Percentage is given in parentheses 




6 4'(1 3 - 1 1 6 8) 
2 4 (1 1 - 1 7 9) 
22 4 s (1 6 - 4 0 5 7 3) 
6 4 (2 5 - 38 0) 
Results are presented as median, range is presented in parentheses. 
' Ρ < 0.01, statistical significance of the difference between the ratio's 
of GSTA 1-1 and AL Τ to the appropriate UNRL. 
! Ρ < 0 0001, statistical significance of the difference between the ratio's 
of GSTA 1-1 and ALT to the appropriate UNRL 
R E S U L T S . 
There w a s no s t a t i s t i c a l d i f f e r e n c e b e t w e e n p lasma G S T A 1 - 1 levels at d i f f e r e n t 
g e s t a t i o n a l ages in t h e l o n g i t u d i n a l l y s t u d i e d g r o u p (Table 2 ) , nor d id t h e s e va lues d i f f e r 
f r o m t h o s e in t h e n o r m o t e n s i v e p r e g n a n c y g r o u p (P = 0 . 9 9 5 ) . In t h e g r o u p o f 2 7 5 
w o m e n s t u d i e d c r o s s - s e c t i o n a l l y , p l a s m a G S T A 1 - 1 c o n c e n t r a t i o n s w e r e s i g n i f i c a n t l y 
c o r r e l a t e d w i t h s e r u m A L T a c t i v i t i e s [r = 0 . 7 5 , Ρ < 0 0 0 0 0 1 ) M e d i a n G S T A 1 - 1 and 
A L T levels w e r e s i g n i f i c a n t l y increased in p r e g n a n c y - i n d u c e d h y p e r t e n s i o n (P < 0 . 0 1 , Ρ 
< 0 0 0 0 1 r e s p e c t i v e l y ) , p r e e c l a m p s i a (P < 0 . 0 0 0 1 ) , and t h e HELLP s y n d r o m e (P < 
0 0 0 0 1 ) c o m p a r e d w i t h n o r m o t e n s i v e p r e g n a n c y (Table 3) In p a t i e n t s w i t h p r e g n a n c y -
i n d u c e d h y p e r t e n s i o n and p r e e c l a m p s i a , 1 4 % and 4 6 % , r e s p e c t i v e l y , of t h e s e g r o u p s 
of p a t i e n t s s t u d i e d s h o w e d e l e v a t e d G S T A 1 - 1 and/or A L T levels (Table 4 , F ig. 1) 
Re lat ive m a g n i t u d e s of e l e v a t i o n of p l a s m a G S T A 1 - 1 c o n c e n t r a t i o n s w e r e s i g n i f i c a n t l y 
m o r e p r o m i n e n t t h a n t h o s e of s e r u m A L T a c t i v i t i e s in p a t i e n t s w i t h p r e e c l a m p s i a 
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Fig. 1. GSTA 1-1 and alanine aminotransferase (ALT) as multiple of the upper normal reference 
level for pregnancy-induced hypertension (*), preeclampsia lo) and the HELLP syndrome 
IA). 
(Я < 0.01) or the HELLP syndrome (P < 0.0001) who showed both elevated ALT and 
elevated GSTA1-1 levels (Table 5). GSTA1-1 and ALT levels are presented in Fig. 1 as 
multiple of the upper normal reference level. 
DISCUSSION. 
This study shows significant increases of median GSTA1-1 concentrations and ALT 
activity in hypertensive pregnancies compared with normotensive pregnancies. About 
half of the patients with preeclampsia had elevated plasma GSTA1-1 and/or ALT levels, 
as defined by levels above the upper normal reference level. By measuring plasma 
GSTA1-1 levels the incidence of some degree of hepatocellular damage seems to be 
higher than the previously reported 2 4 % [17, 18]. Gestation by itself does not seem to 
influence hepatocellular integrity because plasma levels of GSTA1-1 studied 
longitudinally in pregnancy did not differ among different gestational ages. The cause 
of impaired hepatocellular integrity in hypertensive disorders of pregnancy and 
especially the HELLP syndrome remains unknown. Enhanced hepatic artery resistance 
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may point to vasoconstriction and hypoperfusion of the hepatic vascular bed, resulting 
in hypoxic damage [19]. Microvascular thrombosis in small hepatic vessels could further 
contribute to hepatic tissue necrosis and thereby to elevated concentrations of liver 
enzymes in blood [14]. Plasma or serum concentrations of biochemical markers of 
hepatocellular damage such as AST and ALT, commonly used in the assessment of 
hepatocellular integrity in preeclampsia and the HELLP syndrome may be misleading if 
used alone. Haemolysis, a prominent feature of the HELLP syndrome, probably 
contributes substantially to the elevated levels of AST and LDH whereas enhanced ALT 
levels may in part reflect accompanying muscle injury [4, 5]. 
There are several reasons why measurement of GSTA1-1 could offer potential 
advantages over the transaminases in the investigation of hepatocellular damage in 
preeclampsia and the HELLP syndrome. GSTA1-1 has a molecular mass of 52 kD and is 
readily and rapidly released into the blood after hepatocellular damage [7]. In addition, 
relatively large amounts of GSTA1-1 enter the circulation because the enzyme 
constitutes as much as 2% of the cytosohc protein in the hepatocyte [10, 20] . In 
contrast to the periportal location of aminotransferases, GSTA1-1 is primarily located in 
centnlobular hepatocytes [21]. This location may be more relevant to the study of a 
syndrome characterized by enhanced hepatic artery resistance [19] 
Plasma concentrations of GSTA1-1 appear to be a more sensitive indicator of acute 
hepatocellular damage than ALT in patients with the HELLP syndrome. Our study 
shows that the relative magnitude of the abnormality of plasma GSTA1-1 levels in 
preeclampsia and the HELLP syndrome was up to 100 times greater than that of serum 
ALT activity Furthermore, the elevation in GSTA1-1 levels has been previously shown 
to precede that of ALT by several hours in two patients with a severe HELLP syndrome 
[12] 
Our results may point to hepatic hypoxia causing centnlobular necrosis and 
subsequent release of relatively large amounts of GSTA1-1 into the blood. In patients 
wi th paracetamol poisoning, halothane hepatitis, or rejection following liver 
transplantation, plasma GST Alpha concentrations are known to provide a more 
sensitive marker for acute hepatocellular damage than aminotransferase activity [22 -
24] Furthermore, when the active phase of hepatocellular damage in these conditions 
is over, plasma concentrations of GST Alpha rapidly revert to normal, a feature of the 
short plasma half-life ( < 9 0 minutes [22]), whereas aminotransferase activity may be 
abnormal for much longer Patients with the HELLP syndrome showed a similar quick 
decline of GSTA1-1 concentrations when their first attack of epigastric pain subsided 
and again when their pregnancies were terminated by caesarean section after their 
111 
Chapter 5, paragraph 5 3 
s e c o n d e p i s o d e of u p p e r a b d o m i n a l pain [ 1 2 ] The s h o r t p l a s m a half- l i fe m a y also 
e x p l a i n w h y in s o m e o f t h e p a t i e n t s t h e e l e v a t i o n of A L T w a s m o r e p r o n o u n c e d t h a n 
t h a t o f G S T A 1 - 1 . Because of the s l o w p lasma c l e a r a n c e , e l e v a t e d levels of A L T m a y 
st i l l be d e t e c t e d several d a y s af ter an a c u t e a t t a c k of l iver d a m a g e , w h e r e a s G S T A 1 - 1 
v a l u e s have a l ready n o r m a l i z e d [ 1 2 ] 
In c o n c l u s i o n , p l a s m a G S T A 1 - 1 m e a s u r e m e n t m a y p r o v i d e a s e n s i t i v e i n d i c a t o r o f 
a c u t e h e p a t o c e l l u l a r d a m a g e in p r e e c l a m p s i a and the HELLP s y n d r o m e and c o u l d have 
s o m e a d v a n t a g e over c o n v e n t i o n a l p a r a m e t e r s of h e p a t o c e l l u l a r d a m a g e , especia l ly in 
ear ly r e c o g n i t i o n o f d isease The cl in ical b e n e f i t s o f p l a s m a G S T A 1 - 1 m e a s u r e m e n t s f o r 
m o n i t o r i n g t h e h e p a t i c c o n d i t i o n in the m a n a g e m e n t of t h e s e p a t i e n t s need t o be 
e l u c i d a t e d in f u r t h e r s t u d i e s 
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The syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP) is a major 
cause of maternal and perinatal morbidity and mortality [1] . The etiology and the 
characteristic pattern of maternal hepatic damage in this condition are not known. 
Deterioration of the mother's condition is a major determinant of the management of 
these pregnancies, and often results in assisted delivery of a premature infant. Little is 
known about the consequences of this disorder in the neonate. Thrombocytopenia has 
not been shown in neonates born from hypertensive pregnancies with associated 
maternal thrombocytopenia [2| 
Plasma glutathione S-transferase Alpha 1-1 (GSTA1-1) is a sensitive indicator of 
hepatocellular damage m various hepatic disorders [3) and the HELLP syndrome [4] To 
assess possible fetal hepatic damage we measured GSTA1-1 concentrations in maternal 
blood plasma and corresponding neonatal arterial umbilical plasma samples in nine 
pregnancies complicated by the HELLP syndrome [1] and in eleven uncomplicated 
normotensive pregnancies. All pregnancies resulted in caesarean section 
Plasma GSTA1-1 levels were measured by an enzyme-linked immunosorbent assay, 
w i t h an anti-human GSTA mouse monoclonal as catching antibody and rabbit anti-human 
GSTA antiserum as the source of detecting antibodies [4] The assay has no cross-
reactivity with other class GSTs and the variations within and between assays were 
2 5% and 7 3 % , respectively. Groups of individuals were compared using the Wilcoxon-
Mann-Whitney-U test. 
Maternal plasma GSTA1-1 levels were much higher in patients than in controls 
(median 37.7 and 1 3 /yg/L, respectively, Ρ < 0 . 0 0 0 1 ; Fig 1.). By contrast, babies born 
to mothers with HELLP syndrome showed similar plasma GSTA1-1 concentrations to 
those born to controls (4.2 and 5 9 μglL·, respectively). These results suggest that in 
HELLP syndrome, hepatocellular damage occurs only in the mother, and there is no 
evidence for neonatal hepatic damage. Toxic substances, oxygen radicals or humoral 
factors may cause the maternal disease and endothelial damage [5]. Since we found no 
evidence of hepatocellular damage in neonates born from pregnancies complicated by the 
HELLP syndrome, those substances either do not seem to cross the fetoplacental barrier, 
or the fetus may not be susceptible to their effects. 
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Fig 1 Maternal and neonatal median plasma GSTA1-I concentrations in HELLP syndrome (Ш) 
and normotensive pregnancy lo) 
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ABSTRACT. 
Haemolysis is a major complication of hypertensive disorders of pregnancy, 
warranting a correct assessment. Lactate dehydrogenase (LDH) and 
haptoglobin measurements, however, may not accurately reflect its seventy. 
Glutathione S-transferase Pi 1-1 (GSTP1-1) is abundantly present in 
erythrocytes and its plasma level may theoretically be a marker for 
haemolysis. Median GSTP1-1 and LDH levels showed to be significantly 
increased (P < 0.01) and haptoglobin significantly decreased IP < 0.01) in 
preeclampsia {n = 67) and the HELLP syndrome (n = 34) as compared to 
normotensive pregnancy {n = 41). Both GSTP1-1 and LDH levels were 
significantly higher in normotensive pregnant women as compared to non­
pregnant women (n = 8 1 ; Ρ < 0.0001). The percentage of preeclamptic 
patients or patients wi th the HELLP syndrome with elevated GSTP1-1 levels 
was lower than those with elevated LDH or decreased haptoglobin levels. 
We conclude that plasma GSTP1-1 levels may provide useful information 
regarding haemolysis in hypertensive disorders of pregnancy in addition to 
serum LDH activity and plasma haptoglobin levels, and that the degree of 
haemolysis in hypertensive disorders of pregnancy, especially in the HELLP 
syndrome, is probably less prominent than generally assumed. 
INTRODUCTION. 
Pregnancy-induced hypertension, preeclampsia and the syndrome of haemolysis, 
elevated liver enzymes and low platelets (HELLP) are major causes of maternal and 
perinatal morbidity and mortality [1] Haemolysis in these multi-system disorders is well 
recognized as a major complication, especially in the HELLP syndrome [2] and is a 
predictor for maternal and perinatal outcome in these disorders [3] Because haemolysis 
is associated with endothelial damage [41, the degree of haemolysis may give an 
indication of the degree of micro-angiopathy involved. Therefore, a reliable assessment 
of the level of haemolysis is mandatory. Measurements of serum lactate dehydrogenase 
(LDH, EC 1.1.1.27) activity may not accurately reflect haemolysis, because, except 
from erythrocytes, serum LDH may also originate from cardiac and skeletal muscle, 
kidney, pancreas or the liver. Therefore, a increase in serum LDH activity in 
hypertensive pregnancies complicated by both hepatocellular damage and haemolysis, 
such as the HELLP syndrome, could partly be due to hepatocellular damage instead of 
120 
Haemolysis and hypertensive disorders of pregnancy 
haemolysis Until now measurements of serum haptoglobin, the transport protein for 
haemoglobin, is regarded to be the most reliable indicator of haemolytic disease in non-
pregnant patients (diagnostic sensitivity and specificity being 83% and 9 6 % , 
respectively) [5] and haemolysis in hypertensive disorders of pregnancy [6, 7] 
However, hepatocellular damage such as in acute hepatitis results in decreased serum 
haptoglobin levels, probably due to an impaired synthesis [8] Therefore, the coincident 
hepatocellular damage in hypertensive disorders of pregnancy may give a falsely high 
impression of haemolysis. Furthermore, haptoglobin levels are undetectably low when a 
certain level of haemolysis has occurred, which makes the detection of any further 
increase in haemolysis impossible. 
The glutathione S-transferases (GST, EC 2.5.1.18) are a multigene family of 
enzymes that possess many biologic functions They catalyze the addition of 
glutathione to a wide variety of compounds such as xenobiotics and serve as 
intracellular transport proteins for lipophilic compounds [9, 10]. Cytosolic GSTs are 
dirmene proteins, divided into four classes· Alpha, Mu, Pi and Theta [11] The Pi class 
GST (GSTP1-1) is found in large quantities in erythrocytes [12, 13], where it is thought 
to serve as a haemoglobin-binding and transport protein [14] Because of the high 
GSTP1-1 concentration in erythrocytes, serum GSTP1-1 measurements have been 
suggested to be a reliable indicator for increased destruction and overproduction of 
blood cells in certain haematological diseases, such as paroxysmal nocturnal 
haemoglobinuna [15] 
In the present study we investigated plasma GSTP1-1 concentrations in hypertensive 
disorders of pregnancy, especially the HELLP syndrome as a possible marker of 
haemolysis as compared to plasma haptoglobin levels and the routinely used serum 
total LDH activity. 
MATERIALS AND METHODS. 
Study populations. 
Eighty-one healthy non pregnant female blood donors between 20 and 40 years of age, 
41 women during uncomplicated normotensive pregnancy, 35 women with pregnancy-
induced hypertension, 67 women with preeclampsia and 34 women with the HELLP 
(Haemolysis Elevated Liver enzymes Low Platelets) syndrome were studied (for 
population characteristics see Table 1) 
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Table 1 Population characteristics 




Number of patients 
Maternal age (yr) 
Gestational age (wk) 
Diastolic blood pressure 














3 7 * 
(26 40) 









1 0 0 * 
( 9 0 - 130) 
0 * 
( 0 - 3) 
34 
3 0 * 
(19 39) 
3 0 * 
( 1 8 - 39) 
1 0 0 * 
(39 125) 
0 * 
( 0 - 1 ) 
Results are presented as median, range is given in parenthesis 
* Ρ < 0 01, normotensive pregnancy vs hypertensive pregnancy 
Women entered the study after informed consent was obtained The experimental 
protocol was approved by the Institutional Review Board of the University Hospital 
Nijmegen Pregnancy induced hypertension was defined as a diastolic blood pressure ä 
90 mm Hg on two or more consecutive occasions, each more than 4 hours apart 
Preeclampsia was defined as pregnancy-induced hypertension and concordant 
proteinuria (urinary protem/creatmine ratio к 0 30 g/10 mmol) [16] The HELLP 
syndrome was defined as Haemolysis, defined as increased lactate dehydrogenase 
activity ( > 600 OIL), Elevated Liver Enzymes, defined as increased AST ( > 70 U/L) and 
ALT ( > 70 U/L) activities and Low Platelets, defined as a platelet count < 100 χ 
10 3 /mm 3 [1] Blood pressure was taken in sitting position with a sphygmomanometer 
Diastole was recorded at phase IV Korotkoff sound 
Analytical procedures. 
Antecubital venous blood samples were taken in the sitting position after 5 minutes of 
rest Blood for measurement of plasma GSTP1-1 and haptoglobin levels was drawn in 4 
mL EDTA tubes (Becton and Dickinson, Grenoble, France, no 606601) For the 
measurement of LDH activity blood was collected in 4 mL Corvac vacutamer glass 
tubes (Monoject, Sherwood Medical, Ballymoney, Northern Ireland, no 37) Serum LDH 
activ i ty was measured on a Hitachi 747 analyzer (Hitachi, Osaka, Japan), plasma 
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haptoglobin was determined by rate nephelometry using the CobasFara analyzer 
(Hoffmann-Laroche, Basel, Switzerland). Both measurements were performed at the 
local laboratory for clinical chemistry. EDTA blood from 10 healthy staff members was 
haemolysed by a single freeze-thaw procedure for assessment of haemoglobin and 
GSTP1-1 concentrations. 
Plasma GSTP1-1 concentrations were measured using a recently developed enzyme 
linked immunosorbent assay [17]. Microtiter plates were coated overnight with purified 
anti-GSTP1-1 monoclonal antibody. One hundred μ\ of standard (0 4-100 ^g/L GSTP1-
1), or 1:1 or 1.100 diluted plasma samples were added to the wells and incubated 
overnight The next day the plates were washed and incubated with rabbit anti-GSTPi 
antiserum, washed again, and incubated with horseradish peroxidase labeled swine 
anti-rabbit antiserum. After a final wash, plates were stained with o-
phenylenediamine/H202. Standards and samples were measured in duplicate. A four 
parameter weighted logistic regression model was used to calculate standard curves 
and unknowns. The assay has a detection limit of 0.4 ^g/L GSTP1-1 and the intra- and 
inter-assay coefficients of variation are 5.8 % and 10.9 %, respectively. 
Statistical analysis. 
The statistical significance of differences between median levels of GSTP1-1, 
haptoglobin concentrations and LDH activity between hypertensive pregnant patients 
and normotensive pregnant controls and between these normotensive pregnant controls 
and healthy female blood donors between 20 and 40 years of age was evaluated using 
the Mann-Whitney U test A P-value < 0.05 was considered as statistically significant. 
In all pregnant patients the correlations between plasma GSTP1-1 and serum LDH, and 
GSTP1-1 and haptoglobin levels were evaluated using the Spearman's rank coefficient 
of correlation 
Plasma samples were categorized according to their GSTP1-1, LDH and haptoglobin 
levels being above (elevated) the upper normal reference level (UNRL, being two times 
the standard deviation above the mean) for GSTP1-1 and LDH and below (decreased) 
the lower normal reference level (LNRL, being two times the standard deviation below 
the mean) for haptoglobin. An upper normal reference level of 21.8 A*g/L for GSTP1-1 
was calculated from plasma samples of 230 healthy blood donors [17] An upper 
normal reference level of 330 U/L for LDH and a lower normal reference level of 0.40 
g/L for haptoglobin was used as specified by the local department of clinical chemistry. 
All statistical analyses were performed using the Astute* module for Microsoft Excel' 
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GSTP1-1 and haptoglobin concentration and serum 
Blood donors 
20 - 40 years 
147 
( 3 4 - 305) 
0.92 
(0.02 - 2.2) 
7.9 
(3 9 - 57 4) 
Normotensive 
pregnancy 
2 1 5 * 
( 1 2 9 - 368) 
0 94 
( 0 . 1 4 - 1 8) 
12 5 * 





( 1 4 9 - 421) 
0.92 
( 0 . 0 2 - 1.8) 
14.2 
(7 8 - 4 4 . 8 ) 
ι LDH activity 
Preeclampsia 
289* 
(162 - 1166) 
0 . 5 ' 
(0 02 - 1.8) 
1 5 . 7 ' 
( 6 . 4 - 90.3) 
HELLP 
8 2 5 ' 
(602 - 5980) 
< 0 . 0 2 ' 
( < 0.02-1.2) 
34.5* 
( 6 . 7 - 281.7) 
Results are presented as median; range is given in parenthesis. 
' Ρ < 0.01, normotensive pregnancy vs hypertensive pregnancy. 
* Ρ < 0.0001, normotensive pregnancy vs healthy female blood donors 20 - 40 years. 
Table 3. Percentage of women with abnormal LDH, haptoglobin or GSTP1-1 levels 
Blood donors Normotensive Pregnancy- Preeclampsia HELLP 








4 . 9 % 
7.3% 
2.4% 
1 4 . 3 % 
5 7% 
1 4 . 3 % 
3 8 . 8 % 
41 8% 
2 6 . 9 % 
100% 
9 7 % 
7 3 . 5 % 
UNRLare > 330 U/L, < 0.40 g/L, > 21.8 pg/L for LDH, Haptoglobin and GSTP1-1 respectively. 
RESULTS 
Whole blood from 10 healthy volunteers (median haemoglobin concentration 8.7 
mmol/L) contains extensive amounts of GSTP1-1, median GSTP1-1 plasma level being 
4.2 g/L. GSTP1-1 levels and LDH activities were significantly higher in normotensive 
pregnancies (P < 0.0001) as compared to healthy blood donors of the same age (Table 
2). Median GSTP1-1 level and LDH activity were significantly higher and plasma 
haptoglobin levels were significantly lower in preeclampsia and the HELLP syndrome 'P 
< 0.01) as compared to normotensive pregnancy (Figs. 1 - 3, Table 2). In all women 
studied, plasma GSTP1-1 concentrations correlated significantly with serum LDH 
activity (r = 0.70, Ρ < 0.0001) and plasma haptoglobin levels (л = -0.43, Ρ < 
0 0001). 
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Fig. 1. Serum LDH activities in healthy female non-pregnant blood donors ( + ), normotensive 
pregnancy (Al, pregnancy-induced hypertension 101, preeclampsia (Y) and the HELLP 
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2. Plasma haptoglobin levels in healthy female non-pregnant blood donors I +1, 
normotensive pregnancy (Al, pregnancy-induced hypertension (ШІ, preeclampsia (ΎΙ and 
the HELLP syndrome (+). The upper dotted line indicates the LNRL; the lower dotted line 
indicates the detection limit of the assay. 
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N o n Normot Pregnancy Preeclampsia H E L L P 
pregnant p r e g n a n t I n d u c e d 
hypertension 
Fig 3 Plasma GSTP1 1 levels in healthy female поп pregnant blood donors (•¥), normotensive 
pregnancy <A), pregnancy-induced hypertension (%), preeclampsia (W) and the HELLP 
syndrome t+) The dotted line indicates the UNRL 
The percentages of women with elevated levels of GSTP1-1 or LDH, or decreased 
levels of haptoglobin are depicted for each different group in Table 3 
DISCUSSION. 
Haemolysis in hypertensive disorders of pregnancy, especially the HELLP syndrome is 
well recognized as a complication, although part of the characteristic elevation of 
serum LDH activity may as well reflect hepatocellular damage Earlier it has been shown 
that the observed increase in total serum LDH activity in the HELLP syndrome mainly 
consists of LDH isotype 5 which predominantly originates from the liver and skeleton 
muscles, whereas the LDH-1 and LDH-2 isotypes, originating from heart muscle and 
erythrocytes, showed a moderate absolute increase and even a relative decrease as 
compared to the LDH-5 isotype [6, 18 - 20] Acute liver injury was reported to lead to a 
decrease in serum haptoglobin concentrations, probably due to an impaired synthesis of 
haptoglobin [81 Therefore, the decrease in plasma haptoglobin levels observed in 
patients with preeclampsia and the HELLP syndrome could be explained by both 
haemolysis and the acute hepatocellular damage This means that both LDH and 
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haptoglobin may not be accurate parameters for haemolysis in patients with the HELLP 
syndrome A peripheral blood smear for assessment of microangiopathic haemolytic 
disease (ι e schistocytes and fragmentocytes) has also been suggested [1] , but in 
analogy with the Haemolytic Uraemic Syndrome, destructed erythrocytes may not be 
detected when they are already trapped in thrombi and affected arterioles [21] 
Because erythrocytes contain abundant amounts of GSTP1-1, measurement of 
GSTP1-1 plasma levels may more accurately reflect haemolysis, as was earlier 
suggested in a study on haemolysis in various hematological diseases, such as 
paroxysmal nocturnal haemoglobinuna and acute leukaemia [15] Normal plasma 
GSTP1-1 levels, on the other hand, strongly plead against the existence of haemolysis. 
In the present study we showed that a) median values of GSTP1-1 are significantly 
elevated in patients with preeclampsia or the HELLP syndrome as compared to 
normotensive pregnancies, but b) less patients with preeclampsia or the HELLP 
syndrome showed elevated GSTP1-1 levels as compared to elevated LDH or decreased 
haptoglobin levels 
Because platelets contain GSTP1-1 as well, a rise in plasma GSTP1-1 levels could 
theoretically not only be due to haemolysis but also due to platelet destruction 
Because there is actually no evidence in literature that the decrease in platelet count in 
the HELLP syndrome is due to platelet destruction but only to increased consumption 
and activation [22], it seems unlikely that platelets significantly contribute to the 
observed rise in plasma GSTP1-1 levels Although it was suggested that platelet 
activation may cause an elevation in plasma GSTP1-1 levels [23] this could not be 
confirmed in methodological studies [17, 24] 
In pregnancy serum LDH values are elevated as compared to the non-pregnant 
situation due to a relative increase in the LDH-4 and LDH-5 isotypes, probably released 
from the placenta [25] Pregnancy itself showed a significant increase in plasma 
GSTP1-1 levels (Table 2), which may be due to a release from the placenta Pregnancy-
associated rises in serum GSTP1-1 levels were described earlier by Tsuchida ef al [26] 
In conclusion, serum LDH or haptoglobin measurements may overestimate the 
degree of haemolysis in hypertensive disorders of pregnancy, such as preeclampsia and 
the HELLP syndrome Plasma glutathione S-transferase Pi 1-1 measurements as a 
marker for haemolysis during pregnancy deserve further study 
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ABSTRACT 
In this study serum liver enzymes and albumin levels were assessed in 54 
women 31 (range 3 - 101) months after pregnancies complicated by the 
HELLP syndrome Serum levels of aminotransferases, lactate 
dehydrogenase, gamma glutamyl transferase, alkaline phosphatase, albumin 
and conjugated bilirubin were not elevated Total bilirubin levels, however, 
were elevated in 20 % of these women, which is significantly different from 
the prevalence in 151 women with a previous normal pregnancy (χ2 = 
12 23, Ρ < О 001), or in the normal female population (χ2 = 22 34, Ρ < 
0 00001) This may suggest that such a dysfunction of the bilirubin 
conjugating mechanism represents a risk factor for the development of the 
HELLP syndrome 
INTRODUCTION. 
The syndrome of haemolysis, elevated liver enzymes and low platelets (HELLP) is a 
major complication of pregnancy Hepatocellular impairment is one of the hallmarks of 
this pregnancy-induced disease [1] Usually, signs of liver damage resolve within a few 
days after termination of pregnancy, although the HELLP syndrome develops 
postpartum in up to 30 % of cases 
In our long term follow up programme of women with pregnancies complicated by 
the HELLP syndrome we noticed that a significant number of them seems to experience 
persistence of the upper abdominal pain or fatigue To our knowledge, except for a 
small study in three women [2], there are no studies concerning the follow-up of 
hepatocellular integrity at least one month after pregnancies complicated by the HELLP 
syndrome To investigate whether persistent abdominal pain or fatigue could be related 
to hepatic dysfunction, serum levels of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), lactate dehydrogenase (LDH), alkaline phosphatase, total 
bilirubin, conjugated bilirubin, gamma glutamyl transferase (yGT), and albumin were 
assessed in women after pregnancies complicated by the HELLP syndrome 
MATERIALS AND METHODS. 
Women were selected from the department's archival system in the period of 1 - 1 -
1989 until 1 - 1 - 1996 and subsequently invited for participation in this study The 
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study protocol was approved by the institutional review board of the University 
Hospital Nijmegen. The HELLP syndrome was defined as Haemolysis, defined as 
increased LDH activity ( > 600 U/l), Elevated Liver Enzymes, defined as increased AST 
( > 70 U/l) and ALT ( > 70 U/l) activities and Low Platelets, defined as a platelet count 
< 100 χ 10 3 /mm 3 . 
Antecubital venous blood samples were taken in sitting position after 5 minutes of 
rest in 20 ml 'Corvac' vacutainer glass tubes (Monoject; Sherwood Medical, 
Ballymoney, Northern Ireland; no 37). All measurements were performed at the local 
department of clinical chemistry on a Hitachi 747 analyser (Osaka, Japan). 
Serum levels of AST, ALT, LDH, YGT, alkaline phosphatase, total bilirubin, 
conjugated bilirubin and albumin were compared to reference levels used at the local 
department of clinical chemistry. 
RESULTS. 
Fifty-four women were recruited. Patient characteristics during the HELLP syndrome 
were (median, range): gestational age 31 (24 - 40) weeks at delivery, diastolic blood 
pressure 110 (86 - 140) mm Hg (K4), AST 234 (70 - 2640) U/L, ALT 190 (70 - 910) 
U/L, LDH 1177 (600 - 7670) U/L and platelet count 52 (10 - 99) χ 103/rnrn3. Eight of 
these patients developed HELLP syndrome postpartum. At follow up of 31 months 
Table- Liver function parameters at follow-up of women with a previous HELLP syndrome 




Alkaline Phosphatase (U/L) 
Total Bilirubin (¿/mol/L) 





11 (5 - 38) 
6 ( 2 - 6 9 ) 
2 0 9 ( 1 2 0 - 3 2 9 ) 
42 ( 1 9 - 9 6 ) 
6 ( 2 - 4 3 ) 
1 (0 - 3) 
1 0 ( 6 - 4 9 ) 










4 0 - 5 0 
Number of women with 
abnormal values (%) 
2(4) 
1 (2) 
0 (0 ) 
0 (0 ) 
11 (20) 
2 (4 ) 
1 (2) 
I 4 (7 ) , I 1 (2) 
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postpartum (median, range 3 - 101), serum levels of AST, ALT, LDH, vGT, alkaline 
phosphatase, conjugated bilirubin and albumin showed to be normal By contrast, 
eleven out of 54 women (20 %) showed elevated total bilirubin levels (Table). 
DISCUSSION. 
This study was performed to investigate possible hepatic dysfunction in 54 women 
who had suffered from the HELLP syndrome. During long time follow-up of these 
women there were no biochemical signs of impaired hepatocellular integrity, or 
decreased synthesis capacity of albumin. 
Screening for hepatocellular integrity therefore does not seem appropriate. However, 
we found signs of elevated unconjugated bilirubin levels in a subset of women. 
Therefore we compared our data with a control group of women from our department, 
six to eight weeks after an uncomplicated pregnancy, where elevated total bilirubin 
levels in 7 out of 151 women (5%), and elevated conjugated bilirubin levels in 3 out of 
151 women (2%) were found [ 3 ] . Data from a large population study were similar for 
total bilirubin levels which showed to be elevated in 36 out of 745 women (4.8%) [4] . 
The prevalence of elevated total bilirubin levels in our patient group was significantly 
higher as compared to the above mentioned control groups (χ2 = 12.23, Ρ < 0.0001 
and χ2 = 22.34, Ρ < 0 . 0 0 0 0 1 , respectively). These data point to an impairment of the 
bilirubin conjugating mechanism in one out of five women (20%) with a previous HELLP 
syndrome. Since no signs of haemolysis were present, according to normal LDH levels, 
and in the absence of liver disease, unconjugated hyperbilirubmaemia may point to 
Gilbert's syndrome, which is mainly characterized by an impaired hepatic bilirubin UDP-
glucuronyl transferase activity [5). The prevalence of Gilbert's syndrome in the normal 
population is 4 . 8 % for women [4] . In addition to the impairment of conjugation of 
bilirubin, the metabolism of other compounds may also be disturbed in Gilbert's 
syndrome [ 6 ] . The increased prevalence of unconjugated hyperbilirubmaemia, as found 
in our study, may therefore predispose to the development of conditions such as the 
HELLP syndrome. This finding warrants further investigation. 
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The assessment of hepatocellular integrity, by means of liver enzyme measurements in 
umbilical cord blood may contribute to a correct evaluation of the neonatal condition 
immediately after birth Aspartate aminotransferase (AST; EC 2 6.1.1) or alanine 
aminotransferase (ALT; EC 2.6 1.2) levels in blood are the most often assessed clinical 
markers for hepatocellular integrity. However, elevations of these levels may not 
specifically indicate hepatic damage for several reasons There is an apparent lack of AST 
tissue specificity. Apart from liver tissue AST is found in high concentrations in heart and 
skeletal muscle, kidney, pancreas and erythrocytes. Haemolysis, for example, significantly 
contr ibutes to increased serum AST levels. Additionally, AST in liver is present in both 
mitochondria and cytosol, the majority being present in mitochondria (56% for fetal liver, 
and 8 0 % for adult liver) [1), whereas hepatic ALT is limited to the cytosol [2] Acute 
hepatocellular damage, such as viral hepatitis, results in leakage of mainly cytosolic liver 
enzymes in the circulation, and the circulating amount of mitochondrial AST is relatively 
low in these diseases 13] Serum ALT is considered to be more specific for hepatic damage 
than AST, because the concentration of ALT in liver is relatively high as compared to other 
organs Glutathione S-transferase Alpha 1-1 (GSTA1-1) levels in blood are considered as 
the most specific and sensitive marker for acute hepatocellular damage in adults [4] It is 
rapidly released, in relatively large amounts, into the blood after hepatocellular damage. 
Because of the short plasma half-life ( ± 1 hour) its level will follow changes in acute 
hepatocellular damage more accurately than those of the aminotransferases [4]. In the 
study of Beckett et al. [5], peripheral venous GSTA1-1 levels were suggested to be a more 
reliable marker for hepatocellular integrity in asphyxiated neonates as compared to ALT. 
ALT levels did not rise during the first 24 hours after birth complicated by asphyxia, while 
GSTA1-1 levels were elevated to a maximal level at six hours after birth and declined 
before ALT levels even rose. Additionally, the magnitude of elevation of GSTA1-1 was 
higher than that of ALT [5] Glutathione S-transferases (GST, EC 2 5 1 18) are 
detoxif ication enzymes that catalyze the addition of glutathione to a wide variety of 
xenobiotics. Cytosolic GSTs are dimeric proteins and are divided into four main classes: 
Alpha, Mu, Pi and Theta [6] . More than 2% of the soluble protein in the liver consists of 
class Alpha GST. In contrast to the periportal location of aminotransferases, glutathione 
S-transferase Alpha is primarily located in centnlobular hepatocytes [7] Two class Alpha 
subunits have been identified and both homodimers (GSTA1-1 and GSTA2-2) and the 
heterodimer (GSTA1-2) have been purified from human liver [8]. 
In the current study three markers for hepatocellular integrity (AST, ALT and GSTA1-1) 
were studied in arterial and venous umbilical cord plasma, drawn immediately after birth. 
Ninety-three arterial and corresponding venous umbilical cord plasma samples were 
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collected at the Department of Obstetrics and Gynaecology of the 'Nij Smellmghe' 
Hospital, Drachten, the Netherlands With 49 of them maternal venous plasma samples 
were obtained as well Arterial and venous umbilical cord blood samples were routinely 
drawn immediately after birth in prehepannized 2 mL tubes (Kemper Medical BV, Uden, the 
Netherlands, no 260545) A small volume was used for the assessment of blood gas 
values on an ABL-330 analyzer (Radiometer Nederland BV, Zoetermeer, the Netherlands) 
Antecubital maternal venous blood samples were taken in sitting position after 5 minutes 
of rest in 5 mL hepannized tubes (Becton and Dickinson, Leiden, the Netherlands, no 
367684), either less than 4 hours before elective caesarean delivery or less than 15 
minutes after vaginal birth Blood was centrifuged within 10 minutes at 1,200 χ g for 10 
minutes and plasma collected Plasma AST and ALT levels were immediately assessed on 
a Hitachi 704E analyzer (Boehnnger Mannheim BV, Almere, the Netherlands) The 
remainder was stored at -80°C until assessment of GSTA1-1 levels Plasma GSTA1-1 was 
measured using a recently developed enzyme linked immunosorbent assay [9] The assay 
has a detection limit of 0.04/yg/L GSTA1 1 and the intra- and inter-assay coefficients of 
variation are 2 5% and 7 3%, respectively 
Groups were compared by the Mann-Whitney U test Correlations were determined by 
Spearman's rank coefficient of correlation, when appropriate The experimental protocol 
was approved by the local institutional review board 
Both arterial and venous umbilical cord GSTA1-1 and AST levels were significantly 
higher than corresponding maternal venous levels, whereas ALT was not (Table 1 ) Arterial 
umbilical cord plasma AST correlated significantly with corresponding maternal 
Table 1 Maternal and neonatal umbilical cord aminotransferase and GSTA1-1 levels 
(/? = 49) 
Maternal venous Arterial umbilical cord Venous umbilical cord 
plasma plasma plasma 
AST (U/L) 10(1 160) 1 8 ( 2 - 4 5 ) " 1 5 ( 1 - 4 3 ) o c 
ALT (U/L) 3 ( 1 - 1 1 8 ) 3(1 21) 3 5 ( 1 - 1 8 ) 
GSTA1-1 (A/g/L) 1 2 ( 0 2 - 2 3 8 ) 1 1 2 ( 1 6 600)" 8 3 ( 1 6 - 5 5 0 ) " * 
Results are presented as median (ranges) 
" Ρ < 0 0001 arterial umbilical cord vs maternal venous level 
" Ρ = 0 0003 venous umbilical cord vs maternal venous level 
Ρ = 0 002 arterial vs venous umbilical cord level 
" Ρ < 0 0001 venous umbilical cord vs maternal venous level 
" Ρ = 0 028 arterial vs venous umbilical cord level 
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venous levels (r = 0 32, Ρ = 0 02), whereas ALT and GSTA1-1 did not (/· = 0 17, Ρ = 
0 24 and r = 0 19, Ρ = 0 20, respectively) Venous umbilical cord plasma AST correlated 
significantly with corresponding maternal venous levels (r = 0 44, Ρ = 0 0022), whereas 
ALT and GSTA1-1 levels did not (r = 0 14, Ρ = 0 37 and r = 0 15, Ρ = 0 43, 
respectively) 
Arterial umbilical cord GSTA1-1 correlated significantly with the corresponding AST and 
ALT levels (r = 0 46, Ρ < 0 0001 and r = 0 4 1 , Ρ < 0 0 0 0 1 , respectively) Arterial 
umbilical cord AST correlated significantly with corresponding ALT levels (r = 0 58, Ρ < 
0 0001) 
Arterial umbilical cord plasma GSTA1-1 levels were significantly lower in the caesarean 
delivery group as compared to the vaginal birth group, whereas no difference was noted 
for AST or ALT (Table 2) Arterial umbilical cord AST and GSTA1 1 levels correlated 
significantly with base deficit (r = 0 29, Ρ = 0 005, r = 0 29, Ρ = 0 005, respectively), 
whereas ALT did not (r = 0 06, Ρ = 0 54) Arterial umbilical cord AST, ALT, and GSTA1-
1 levels correlated significantly with birthweight (/• = 0 22 Ρ = 0 0 3 6 , r = 0 47 Ρ = 
0 47, and r = 0 26, Ρ = 0 0 1 , respectively) 
In this study significantly higher arterial umbilical cord AST and GSTA1 1 but not ALT 
levels were found as compared to maternal venous plasma levels Earlier, Werner et al [10] 
found significantly higher AST, but similar ALT levels in umbilical vein specimens obtained 
for prenatal diagnostic use, as compared to maternal venous levels Maternal AST 
correlated with umbilical cord AST, whereas maternal ALT and GSTA1-1 did not correlate 
with their corresponding umbilical cord levels The observed correlation between maternal 
and umbilical cord AST suggests a relation between both levels Maternal venous AST 
levels were reported to be higher in pregnancy as compared to the non-pregnant situation, 
which was suggested to be due to release from placental tissue [10] or uterine muscle [ 1 1 , 
12] 
Table 2 Arterial umbilical cord plasma aminotransferase and GSTA1 1 levels in relation to the route 
of delivery 
Entire group Vaginal birth Caesarean delivery 
In = 931 In = 64) In = 291 
AST (U/L) 18(2-126) 18(2 45) 18(9 126) 
ALT (U/L) 4 (1 - 21) 4 (1 21) 5 (1 15) 
GSTA1 1 (¿yg/L) 1 1 5 ( 0 6 1360) 1 3 7 ( 1 1 1125)' 8 2 ( 0 6 1360) 
Results are presented as median (ranges) 
Ρ = 0 002, vaginal birth vs caesarean delivery 
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Placental AST may be released in the fetal circulation as well thus explaining the 
correlation between maternal and umbilical cord AST. However, the fact that venous 
umbilical cord AST is lower than arterial AST pleads against this suggestion There may 
also be a possibility that fetal AST crosses the feto-placental barrier. Two earlier studies 
in which fetal umbilical cord blood was obtained during diagnostic umbilical vein puncture 
in utero, showed that both umbilical cord AST and ALT did not correlate with 
corresponding maternal levels [10, 13]. 
Median arterial umbilical cord AST and GSTA1-1, but not ALT levels were significantly 
higher than corresponding venous levels. The higher arterial AST levels as compared to 
venous umbilical cord levels are in contrast wi th the results of Perkins et al, who did not 
f ind any difference between arterial and venous umbilical cord levels for AST and ALT 
[14] In previous studies significantly elevated GSTA1-1 [5] and AST [1 5], but similar ALT 
levels [5, 15] were observed in peripheral venous blood within 24 hours after 
uncomplicated delivery, as compared to the period thereafter. The high umbilical cord 
GSTA1-1 (our study) and the reported high neonatal peripheral venous GSTA1-1 levels [5] 
were suggested to be due to an increased hepatocellular leakage in fetal and early neonatal 
life. In addition, lactate dehydrogenase (LDH) was found to be approximately twice as high 
in neonatal blood as compared to maternal blood [14, 16] mainly due to the rise in the 
liver-specific LDH5 [16]. This again pleads for high fetal or early neonatal hepatocellular 
leakage. 
The finding of increased arterial umbilical cord GSTA1-1 but not of AST or ALT levels 
after vaginal birth as compared to those after caesarean delivery, may indicate that the 
route of delivery has a significant effect on fetal hepatocellular integrity. This could be due 
to transient periods of hypoxia during uterine contractions which probably more affects 
the centnlobular, and to a lesser extent the periportal hepatocytes The predominant 
centnlobular location of GSTA1-1, where the aminotransferases are mainly located 
penportally, supports this hypothesis. Earlier, Perkins et al. noted that the route of delivery 
did not influence umbilical cord serum AST and ALT levels [14] 
Correlations of arterial umbilical cord AST and GSTA1-1 plasma levels wi th arterial 
umbilical cord base deficit values were significant, indicating an association between 
hypoxia or metabolic impairment and hepatocellular integrity. No correlation was found 
between arterial umbilical cord ALT level and base deficit. Beckett et al. did not find an 
elevation of ALT in neonatal peripheral venous blood in the first few hours following birth 
complicated by asphyxia [5], but ALT levels were maximally elevated 48 hours after birth. 
Lehmann et al reported no difference in AST levels in umbilical cord blood drawn 
immediately postpartum of neonates with or without hypoxic events in utero [17] By 
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c o n t r a s t , A S T levels in peripheral v e n o u s s a m p l e s 2 4 hours p o s t p a r t u m w e r e s i g n i f i c a n t l y 
h igher in n e o n a t e s w i t h h y p o x i c e v e n t s in utero [ 1 7 ] 
W e e s t a b l i s h e d a s i g n i f i c a n t c o r r e l a t i o n o f arterial u m b i l i c a l c o r d A S T , G S T A 1 - 1 and 
e s p e c i a l l y A L T levels w i t h b i r t h w e i g h t . These resul ts are in a g r e e m e n t w i t h t h o s e of 
Werner et al. [ 1 0 ] , Nava et al. [1 3] a n d M o n i z et al [ 1 8 ] , w h o n o t e d a s i g n i f i c a n t increase 
w i t h a d v a n c i n g g e s t a t i o n a l age in u m b i l i c a l cord b l o o d A S T and A L T levels. Th is m a y be 
d u e t o i n c r e a s i n g h e p a t i c p e r f u s i o n d u r i n g g e s t a t i o n as it w a s s h o w n t h a t GST A l p h a 
a c t i v i t y in f e t a l h e p a t o c e l l u l a r t i s s u e does n o t seem t o c h a n g e f r o m t h e t e n t h w e e k o f 
g e s t a t i o n o n w a r d s [ 5 , 1 9 , 2 0 ] . 
In c o n c l u s i o n , w e studied three potent ia l markers for hepatocel lu lar i n t e g r i t y in u m b i l i c a l 
c o r d b l o o d The c o r r e l a t i o n b e t w e e n u m b i l i c a l c o r d and m a t e r n a l per iphera l v e n o u s A S T 
levels m a k e s t h i s p a r a m e t e r u n r e l i a b l e , w h i l e ALT does n o t s e e m to be sens i t i ve e n o u g h 
to d e t e c t early hepatocel lular i m p a i r m e n t . G S T A 1 - 1 as assessed in neonata l u m b i l i c a l c o r d 
b l o o d , be ing s e n s i t i v e and s p e c i f i c , and u n r e l a t e d to t h e m a t e r n a l leve l , s e e m s t o be t h e 
m o s t re l iab le m a r k e r f o r ear ly n e o n a t a l hepatocel lu lar i n t e g r i t y and e v e n m a y d e t e c t 
impaired hepatocel lular in tegr i ty due t o t h e vaginal b i r t h p r o c e s s Umbi l ica l c o r d G S T A 1 - 1 
m a y provide a valuable indicator of n e o n a t a l c o n d i t i o n i m m e d i a t e l y a f t e r b i r t h , t h e c l in ica l 
r e l e v a n c e of w h i c h needs t o be f u r t h e r e s t a b l i s h e d 
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ABSTRACT. 
Objective' To investigate possible delivery-related impaired neonatal 
hepatocellular integrity by assessment of arterial and venous umbilical cord 
plasma levels of glutathione S transferase Alpha 1-1 (GSTA1-1) 
Methods - GSTA1 1 levels were assessed in arterial and venous umbilical 
cord and compared to maternal venous plasma samples The influence of 
maternal, delivery, and neonatal characteristics on arterial umbilical cord 
GSTA1-1 levels was studied, using linear regression analysis after log-
transformation 
Results: Median (range) arterial umbilical cord GSTA1-1 plasma levels were 
higher than venous umbilical cord levels (9 68 [0 64 1125] //g/L and 7 66 
[0 78 - 987 5] //g/L, respectively, Ρ < 0 005) Median (range) arterial and 
venous umbilical cord GSTA1-1 levels were higher than, and did not 
correlate wi th, maternal venous plasma levels (8 79 [1 79 - 183] //g/L and 
6 47 [1 58 164 5] //g/L versus 1 47 (0 46 - 10 4] //g/L, Ρ < 0 001) 
Neonates born vaginally demonstrated higher median (range) levels than 
those delivered by caesarean section (13 41 [1 02 1125] //g/L and 5 73 
[0 64 172 90] //g/L, respectively, Ρ < 0 001) Neonates with unfavourable 
pH (arterial pH under 7 20) demonstrated higher median (range) levels than 
those with normal pH (arterial pH at least 7 20) (15 15 [0 77 - 1125] //g/L 
and 8 82 [0 64 - 120 90] //g/L respectively, Ρ < 0 001) Stepwize multiple 
linear regression analysis showed that birth weight had the largest influence 
on arterial umbilical cord GSTA1-1 levels, followed by arterial base deficit, 
and route of delivery 
Conclusion: Arterial umbilical cord GSTA1 1 plasma levels, being unrelated 
to maternal venous levels, may give a reliable impression of early neonatal 
hepatocellular integrity and may become an additional indicator of neonatal 
condition immediately after birth 
INTRODUCTION. 
The neonatal condition immediately after birth usually is assessed by umbilical cord 
blood gas analysis and Apgar score estimation These tests do not necessarily reflect 
impaired integrity of vital organ systems Early assessment of hepatocellular integrity 
may contribute to a correct evaluation of the neonatal condition immediately after birth 
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Hepatic function in neonates who have suffered asphyxia at birth usually is assessed by 
measuring aminotransferase activities in neonatal venous blood However, these 
activities do not seem to rise during the first hours after birth complicated by asphyxia 
and, therefore, lack sensitivity in the early postpartum period [1] 
The glutathione S-transferases are a multigene family of enzymes that possess many 
biologic functions They catalyze the addition of glutathione to a wide variety of 
xenobiotics and serve as intracellular transport proteins for lipophylic compounds [2, 3] 
Cytosolic glutathione S-transferases (GST) are dimeric proteins, divided into four 
classes Alpha, Mu, Pi and Theta [4] Two class Alpha subunits have been identified 
and a heterodimeric (GSTA1-2) and two homodimeric (GSTA1-1 and GSTA2 2) 
enzymes have been purified from human liver [5J They are released rapidly into the 
blood after hepatocellular damage [3] in relatively large amounts because the enzyme 
constitutes as much as 2% of the cytosolic protein in the hepatocyte [6, 7] In contrast 
to the periportal location of aminotransferases, glutathione S transferase Alpha is 
primarily located in centnlobular hepatocytes [8] Its half-life in the plasma of adults is 
approximately 1 hour, and its plasma levels will follow changes in hepatocellular 
damage more rapidly than aspartate aminotransferase (half life 17 hours) or alanine 
aminotransferase (half-life 47 hours) [9] 
We studied the influence of several neonatal, maternal, and delivery characteristics 
on neonatal hepatocellular integrity by means of assessment of GSTA1-1 levels in 
arterial umbilical cord blood plasma immediately after birth Ratios of venous to arterial 
umbilical cord plasma levels were determined in order to find an indication for a 
possible concentration-dependent clearance mechanism Umbilical cord plasma levels 
were compared to birth characteristics (arterial umbilical cord pH, base deficit, 
bicarbonate [HC0 3 ] , duration of the second stage of labour, and birthweight) and 
maternal characteristics (age, diastolic blood pressure, and smoking behaviour) The 
whole group studied was divided in neonates with unfavourable pH (pH under 7 20) or 
normal neonates (pH at least 7 20) and the vaginal birth group was divided according 
to the duration of the second stage of labour longer than 60 minutes or 60 minutes or 
less 
MATERIALS AND METHODS. 
Arterial umbilical cord plasma samples were collected from 315 neonates, venous 
plasma samples from 405 neonates and both arterial and venous plasma samples from 
300 neonates at the department of Obstetrics and Gynaecology, University Hospital 
149 
Chapter 6, paragraph 6 2 
Nijmegen, the Netherlands. The experimental protocol was approved by the institutional 
review board of the University Hospital Nijmegen. Birth, neonatal, and maternal 
characteristics were collected from maternal patient charts. Except for a subset of 103 
women, suffering from various hypertensive disorders of pregnancy known to be 
associated with impaired hepatocellular integrity, none of the pregnant women had 
evidence of hepatocellular disease Maternal venous plasma GSTA1-1 levels were 
measured in 41 women, of whom 16 were suffering from hypertensive disorders of 
pregnancy with signs of hepatocellular damage and 25 were normotensive without 
signs of hepatocellular damage. 
Arterial and venous umbilical cord blood samples were drawn immediately after birth 
in prehepannized 1 mL tubes (Smith Industries, Keene, NH). A small volume was used 
for the assessment of blood gas values. The remainder was stored at 4°C for a 
maximum of 72 hours Afterward, blood was centrifuged at 11,000 χ g for 3 minutes 
and plasma collected. Delayed centr i fugaron of hepannized blood for a maximum of 72 
hours did not influence plasma GSTA1-1 levels, nor were there any differences 
between hepannized and ethylenediaminetetraacetic acid (EDTA) plasma levels (MFCM-
K, unpublished results). Antecubital maternal venous blood samples were collected in 4 
mL EDTA tubes (Becton and Dickinson, Grenoble, France), with the subject in the 
sitt ing position after 5 minutes of rest, either less than 4 hours before elective 
caesarean delivery or less than 15 minutes after vaginal birth. Blood was centrifuged 
wi th in 15 minutes at 3,000 χ g for 10 minutes and plasma collected. Plasma was 
stored at -20°C until assessment of GSTA1-1 levels. 
Plasma GSTA1-1 levels were measured using a recently developed enzyme linked 
immunosorbent assay 1101 The assay has a detection limit of 0.04 /yg/L and the intra-
assay and inter-assay coefficients of variation are 2 5% and 7.3%, respectively The 
ratio of venous to arterial umbilical cord GSTA1-1 levels in groups of increasing arterial 
levels were tested by one-way analysis of variance with the according Tukey contrast 
test. 
Groups were compared by the Wilcoxon test (pH at least 7.20 versus pH less than 
7.20, and duration of the second stage of labour 60 minutes or less versus longer than 
60 minutes). The Wilcoxon's test for paired samples was used to test differences 
between arterial and venous umbilical cord levels and between maternal and umbilical 
cord levels for statistical significance. Spearman rank correlation coefficients were 
calculated when appropriate. Bonferoni correction for multiple statistical comparisons 
was applied to correct for multiple statistical comparisons Я-values < 0.01 were 
considered significant 
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The effects of the maternal and neonatal characteristics on the natural log-
transformed arterial GSTA1-1 levels were analysed separately using linear regression 
techniques. Smoking (no, yes) and route of delivery (vaginal birth, elective caesarean 
delivery, emergency caesarean delivery) were treated as class variables and all others 
as continuous variables. The differences were expressed as relative change (with 9 5 % 
confidence interval [CI]) per unit increase of the characteristic studied (relative change 
more than 1. increase; relative change less than 1: decrease), calculated from the 
regression coefficient (with standard deviation) from the model. 
Multiple linear regression with stepwize procedures was used to select the maternal 
and neonatal characteristics that contribute independently to the change of arterial 
GSTA1-1 plasma levels. Because stepwize procedures do not identify other important 
characteristics, the Я-values for entry into the model were considered in order to find 
close alternatives to the characteristics selected. Differences are expressed as relative 
changes (95% CI) per unit increase in the characteristic studied, adjusted for the effect 
of other variables in the model. 
RESULTS. 
Median (range) maternal characteristics in this study were age 31 (18 - 43) years, 
parity 1 (0 - 12), and diastolic blood pressure 80 (50 - 149) mm Hg 
The median (range) arterial and venous umbilical cord GSTA1-1 plasma level was 
significantly higher than the median (range) maternal venous plasma level in the 25 
normotensive pregnancies studied (8.79 [1.79 - 183] //g/L, and 6 47 [1.58 - 164 5] 
¿/g/L versus 1 47 [0.46 - 10.4] //g/L, respectively, Ρ < 0.001). No statistically 
significant correlation was found between either arterial or venous umbilical cord 
plasma GSTA1-1 levels and maternal venous plasma levels in the group of 41 pairs 
studied (/- = -0.25, Ρ = 0 . 1 1 ; г = -0.03, Ρ = 0.83 respectively), or in the 25 
normotensive pregnancies (r = 0.12, Ρ = 0.57; r = 0.23, Ρ = 0.20, respectively). 
The median (range) arterial umbilical cord GSTA1-1 plasma level was significantly 
higher than the median (range) venous umbilical cord plasma level (9 68 [0.64 - 11251 
//g/L and 7 66 [0.78 - 987.5] //g/L, respectively; Ρ < 0.005; η = 300) and both levels 
correlated significantly (r = 0 86, Ρ < 0.001) The venous-arterial ratio decreased 
significantly with increasing arterial GSTA1-1 levels (Table 1) 
The median (range) arterial umbilical cord plasma GSTA1-1 level was significantly 
lower after caesarean delivery {n = 98) than after vaginal delivery (n = 217) (5.73 
[0 64 - 172.901 //g/L and 13.41 [1.02 - 1125] ¿/g/L, respectively, Ρ < 0 001). The 
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median (range) arterial umbilical cord level was lower in the elective caesarean delivery 
group (n = 59) than the emergency caesarean delivery group (n = 39), however this 
difference did not reach statistical significance (5 02 [0.64 - 25.90] //g/L and 6.58 
10 77 - 1 72.90] //g/L respectively; Ρ = 0.06). 
The median (range) arterial umbilical cord GSTA1-1 level was significantly higher in 
the group wi th arterial umbilical cord pH less than 7.20 (n = 76) than in those with pH 
at least 7.20 (n = 229) (15 15 [0.77 - 1125] //g/L and 8.82 [0.64 - 120.90] μglL, 
respectively; Ρ < 0.001). The median (range) arterial GSTA1-1 levels were higher in the 
vaginal birth group with prolonged second stage of labour (n = 37) than in those with 
normal second stage (n = 160) (19.72 [3.2 - 460.8] //g/L and 12.33 [1 0 - 1125 0] 
¿/g/L respectively; Ρ = 0.03), but the difference was not significant. For the use of 
further analysis we combined the latter t w o groups into the so-called 'vaginal birth 
group'. 
Table 2 shows the relative change (95% CI) of arterial GSTA1-1 per unit increase of 
the neonatal or maternal characteristics under study, estimated from the univariate 
regression models. Significant relative changes were observed for birthweight, arterial 
pH, base deficit, H C 0 3 , placental weight, gestational age, and route of delivery Table 
3 shows the characteristics that independently influence the arterial umbilical cord 
GSTA1-1 level. For instance, the estimated relative increase in arterial GSTA1-1 levels 
is 9 8% per 1 mmol/L increase in base deficit, adjusted for other variables in the model 
(ie birthweight and route of delivery) Considering the Ρ value for entering in the 
Table 1 Venous-arterial ratios of umbilical cord plasma GSTA1-1 levels by increasing 
arterial levels 
Arterial GSTA1-1 Ratio η 
< 5//g/L 0 98 (0 5 0 - 1 82)* 66 
5-10//g/L 0.97(0 51-1.21)* 86 
10-20//g/L 0 96(0 1 8 - 1 3 4 ) * 69 
20-40//g/L 0 8 1 ( 0 0 8 - 1 4 1 ) ' 43 
¿ 40//g/L 0 54(0 0 3 - 2 75)' 36 
Total 0 95 (0 03 - 2 75) 300 
Data are presented as median Irangel 
", ', ' same symbol indicates no statistical difference (Tukeys-contrast test, α = 0.051. 
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Table 2 Mean relative change of arterial umbilical cord GSTA1 1 levels per unit of the maternal 
and neonatal characteristics, using linear regression analysis of the log-transformed 
GSTA1 1 levels 










Arterial base deficit (mmol/L) 
Arterial H C 0 3 (mmol/L) 
Placental weight (g) 
Gestational age (d) 




1 001 (0 97 1 033) 
1 00 (reference) 
0 836 (0 61, 1 156) 
0 993 (0 98, 1 003) 
1 832 (1 58, 2 121) 
0 030 (0 00, 0 177) 
1 133 (1 09, 1 177) 
0 875 (0 84, 0 912) 
1 002 (1 00, 1 003) 
1 020 (1 01, 1 025) 
1 00 (reference) 
0 489 (0 33, 0 720) 



















CI = confidence interval, HC03 = bicarbonate, GSTA1-I = glutathione S-transferase Alpha I 1 
In column two, I 00 indicates no relative change, the relative change of base deficit of J 133 
indicates an increase in arterial umbilical cord GSTA1-1 of 13 3% per unit of increase in base 
deficit 
m o d e l w e f o u n d t h a t a l ternat ive var iables f o r b i r t h w e i g h t w e r e p l a c e n t a l w e i g h t and 
g e s t a t i o n a l a g e , f o r base d e f i c i t th is w a s p H and f o r r o u t e of d e l i v e r y t h i s w a s H C 0 3 
D I S C U S S I O N . 
W e s t u d i e d the i n f l u e n c e of m a t e r n a l , b i r t h , and n e o n a t a l c h a r a c t e r i s t i c s o n u m b i l i c a l 
c o r d G S T A 1 1 levels The absence of a n y c o r r e l a t i o n b e t w e e n m a t e r n a l v e n o u s and 
a r t e r i a l and v e n o u s u m b i l i c a l cord levels as w e l l as t h e lack of i n f l u e n c e of several 
m a t e r n a l f a c t o r s o n n e o n a t a l levels i n d i c a t e d t h a t m a t e r n a l f a c t o r s do n o t i n f l u e n c e 
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Table 3 Adjusted mean relative change of arterial GSTA1 1 using stepwize selection procedures 
on all maternal and neonatal characteristics, in a multiple linear regression procedure 
Relative change (95% CI) P-value 
Intercept 
Birthweight (kg)" 
Arterial base deficit (mmol/L)1 




2 021 (1 23, 3 33) 
1 626 (1 41, 1 88) 
1 098 (1 06, 1 14) 
1 0 (reference) 
0 681 (0 47, 0 98) 
0 508 (0 37, 0 69) 
0 006 
< 0 001 
< 0 001 
0 042 
< 0 001 
C/= confidence interval, HC03 -bicarbonate, GSTA1 1 = glutathione S-transl'erase Alpha 1-1 
R2 = 0 30 
In column two, 1 00 indicates no relative change, the relative change of base deficit of I 098 
indicates an increase in arterial umbilical cord GSTA J-1 of 9 8 % per unit of increase in base 
deficit, adjusted for the other characteristics in the model 
* alternative placental weight, gestational age 
' alternative pH, (second stage of labour longer than 60 mini 
1 alternative HC03, (second stage of labour 60 mini 
neonatal levels Therefore, umbilical cord plasma GSTA1-1 levels do seem to reflect 
neonatal hepatocellular integrity Recent data on pregnancies complicated by the 
Haemolysis Elevated Liver enzymes Low Platelets syndrome showed that enhanced 
maternal venous GSTA1-1 levels are not accompanied by elevated arterial umbilical 
cord levels [11] We found significantly higher umbilical cord GSTA1-1 levels as 
compared to maternal venous plasma levels These findings are in accordance with 
those of Beckett et al. [1], who found increased levels in peripheral venous blood of 
newborns after uncomplicated delivery As stated by them, the observed high levels 
could be due to a higher hepatocellular leakage in fetal and early neonatal life, as a 
consequence of the premature stage of the hepatocytes [1] 
There seems to be some clearance of arterial GSTA1-1 by the placenta because 
venous umbilical cord levels were significantly lower than arterial levels The clearance 
mechanism seems to depend on arterial umbilical cord levels, because increasing arterial 
levels result in lower venous-arterial ratios 
The intriguing finding of higher arterial umbilical cord GSTA1 1 levels after vaginal 
birth as compared to those after caesarean delivery may indicate that the route of 
delivery has a significant effect on fetal hepatocellular integrity This could be due to 
either transient periods of hypoxia during uterine contractions or mechanical stress by 
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uterine contractions and passage through the birth canal. 
Arterial umbilical cord pH and base deficit significantly influenced arterial umbilical 
cord GSTA1-1 plasma levels, possibly indicating decreased fetal hepatocellular integrity 
due to hypoxia or metabolic impairment. This result is in agreement with the study of 
Holt et al [12] The influence of the pH was slightly lower than that of the base deficit, 
indicating that a model with the pH is almost similar to a model including base deficit 
PH reflects acute birth-related hypoxia, whereas base deficit more adequately indicates 
chronic hypoxia. It seems plausible that chronic hypoxia causes more extensive 
hepatocellular impairment Hepatocellular impairment related to acute hypoxia in the 
last period of the second stage of labour may not be reflected in elevated arterial 
umbilical cord GSTA1-1 levels because some time is required for hypoxia-related 
breakdown of hverparenchym and subsequent leakage of this enzyme The finding that 
fetal plasma GSTA1-1 seems to be cleared by the placenta may point to an even higher 
degree of hepatocellular impairment 
The influence of birthweight on arterial umbilical cord GSTA1-1 levels was 
significant. The increasing level wi th gestational age may be due to increasing hepatic 
perfusion during gestation as it was shown that glutathione S-transferase Alpha activity 
in fetal hepatocellular tissue does not seem to change from the tenth week of gestation 
onwards [ 1 , 13, 14] A significant increase with advancing gestational age is found for 
umbilical cord aminotransferase activities as well 115]. 
In conclusion, we reported detectable GSTA1-1 levels in umbilical cord blood. Levels 
were associated with birthweight, characteristics indicating intrauterine hypoxic stress, 
and route of delivery. Assessment of this enzyme may give a reliable impression of 
early neonatal hepatocellular integrity and may become an additional indicator of 
neonatal condition immediately after birth 
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Chapter 7 
Glutathione S-transferases (GST, EC 2.5.1.18) are detoxification enzymes that catalyze 
the addition of glutathione to a wide variety of xenobiotics. Cytosolic GSTs are dimeric 
proteins and are divided into four classes: Alpha, Mu, Pi and Theta [1] More than 2% 
of the soluble protein in the liver consists of class Alpha GST. These enzymes are 
released in considerable quantity into the bloodstream during hepatocellular damage 
Because class Alpha GSTs have a short plasma half-life ( ± 1 hour), its concentration 
wil l fol low changes in acute hepatocellular damage more accurately than the activities 
of the aminotransferases [2] . Two class Alpha subunits have been identified and both 
homodimers (GSTA1-1 and GSTA2-2) and the heterodimer (GSTA1-2) have been 
purified from human liver [2] 
Tiainen and Karhi [3] were the first to report that men had markedly higher plasma 
GST-Alpha concentrations than women, which was confirmed recently by our group in 
a much larger study population (median plasma GSTA1-1 concentration in 175 men, 
1.92 /yg/L and in 175 women, 1.28 /jg/L; [4]) However, in women but not in men, a 
significant increase with age was noted (the median plasma GSTA1-1 concentration in 
83 women aged 20-40 years was 1.08 /vg/L, in 57 women aged 40-60 years, 1 44 
/yg/L, and in 33 women above the age of 60 years, 1.84 ¿/g/L; P<0 05 vs women 40-
60 and P < 0 01 vs women 20-40; [4]) We suggested that a change in hormone 
concentrations related to menopause may account for the higher concentrations in 
elderly women [4]. 
To test the hypothesis that the relatively high plasma GSTA1-1 concentrations in 
postmenopausal women can be decreased by hormone replacement therapy, these 
concentrations were measured in 64 healthy postmenopausal women who received 
hormone replacement therapy during 1 year in a randomized, double-blind, prospective 
study The study was designed to test reduced frequency of progestogen 
(norethisterone acetate, NETA) use m a three-monthly hormone replacement therapy 
(long cycle) vs the standard monthly replacement therapy (Trisequens*). Long-cycle 
treatment was given during 4 cycles of 84 days, and Trisequens* was given during 12 
cycles of 28 days. 
Selected subjects were healthy, non-hysterectomized women, aged 45 to 60 years 
who were amenorrheic for at least 6 months and who had a serum follicle-stimulating 
hormone concentration higher than 36 U/l and a serum oestradiol below 150 pmol/L 
All women had serum AST and ALT activities below the upper normal reference limit 
The 29 women in the long-cycle group received 2 mg of micronized 1 7ß-oestradiol on 
days 1-78 and 1 mg on days 79-84 and 1 mg of NETA on days 69-78. The 35 women 
in the Trisequens* group received 2 mg of 1 7ß-oestradiol on days 1-22 and 1 mg on 
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days 23-28, and 1 mg of NETA on days 13-22. 
Plasma samples (K3EDTA) were collected on three different occasions: (a) at the 
start of the study (baseline); (b) 1-3 three days before the last NETA administration 
(17ß-oestradiol only; cycle days 66-68 in the long-cycle group and cycle days 10-12 in 
the Trisequens" group); and (c) on days 8-10 of the last NETA administration (17ß-
oestradiol+NETA, cycle days 76-78 in the long-cycle group and cycle days 20-22 in 
the Trisequens' group). 
Plasma GSTA1-1 concentrations were measured by sandwich ELISA as reported 
recently [4] To evaluate the significance of differences between or within two groups, 
the Mann-Whitney U-test and the Wilcoxons matched-pairs signed-rank test were used, 
respectively This study was approved by the Medical Ethical Review Committee 
No significant differences in plasma GSTA1-1 concentrations were detected between 
the long-cycle and the Trisequens* group before, during, or at the end of the trial 
period. When compared to those at baseline, plasma GSTA1-1 concentrations were 
slightly higher (P = 0.20 for the whole group) at the end of the last 1 7ß-oestradiol-only 
phase, after almost one year replacement therapy. By contrast, plasma GSTA1-1 
concentrations were slightly lower than baseline concentrations at the end of the last 
17ß-oestradiol + NETA period (P = 0 12 for the whole group). 
Table Plasma glutathione S-transferase Alpha 1-1 (GSTA1-1) concentrations in 
postmenopausal women receiving 17ß-oestradiol and norethisterone acetate (NETA) in a 
28-day (Trisequens*) or a 84-day (long cycle) treatment cycle 
Median plasma GSTA1-1 concentration (^g/l) 
(range) 
Trisequens* Long cycle All 
(n = 35) (n = 29) (n = 64) 
Baseline 
1 7ß-oestradiol only 
1 7ß-oestradiol + NETA 
1 84 
(0 61-8 27) 
1 99 
(0 46-9 08) 
1 82" 




(0 86-9 35) 
1 58" 
(0 67-4 84) 
1 94 
(0 53-8 27) 
2 25 
(0 46-9 35) 
1 8 1 e 
(0 39-4 84) 
Results are presented as median franges) 
17ß oestradiol only vs baseline and 17$-oestradiol + NETA vs baseline were not significantly 
different 




In both the Trisequens" group and the long-cycle group, 8-10 days of 1 7ß-
oestradiol + NETA resulted in a significantly lower median plasma GSTA1-1 
concentration ( Ж 0 03 and P<0 003, respectively. Table 1) Overall, the last 17ß-
oestradiol+ NETA phase resulted m a 20% decrease of the median plasma GSTA1-1 
concentration (in 48 women the plasma GSTA1 1 concentration decreased, in 16 
women the plasma GSTA1-1 concentration increased, P<0 0002 for the whole group), 
when compared to 17ß oestradiol only Sex-related differences in the expression of 
GST isoenzymes in liver were reported in rats [5] and mice [6] but not in humans In 
female mice, ovariectomy resulted in increased liver GST activities that could be 
normalized by replacement of oestrogen and progesterone [6] In humans, men had 
higher plasma GST Alpha concentrations than women [3, 4] . In women, but not in 
men, an increase with age was noted [4] This study shows that 17ß-oestradiol 
replacement did not decrease the relatively high plasma GSTA1-1 concentrations 
detected in elderly women By contrast, the 8-10 days of replacement with 1 7ß-
oestradiol combined with the progestogen NETA resulted in a 20% decrease of the 
median plasma GSTA1-1 concentration in postmenopausal women, indicating that the 
relatively high plasma GSTA1-1 concentrations observed in elderly women may be 
related to the low progestogen concentrations found in these women 
The effect of hormone replacement therapy on plasma GSTA1-1 concentrations in 
women reported in this study is on the same order of magnitude as the influence of 
gender and age on plasma GSTA1-1 concentrations Although the effects of these 
variables are rather small, they should be kept in mind when plasma GSTA1-1 
concentrations of groups of patients are compared to reference intervals obtained from 
the general population 
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Summary and conclusions 
The glutathione / glutathione-related enzyme system in a quantitative sense is one of 
the most important detoxicating systems in humans. Glutathione and glutathione-
related enzymes (glutathione S-transferases and glutathione peroxidases) are involved in 
the detoxification of endogenous and exogenous toxic compounds, carcinogens, and 
oxygen radicals. Additionally, the glutathione peroxidases are involved in the 
metabolism of leukotnenes and prostaglandins Plasma levels of glutathione S-
transferase subtypes are markers for disease. Recently, several publications have 
suggested that deficiencies in this system may be related to the etiology of 
hypertensive disorders of pregnancy. In 1995, collaborative research on this subject 
was started at the University Hospital St. Radboud, Nijmegen. In this thesis several 
studies on the role of the glutathione / glutathione-related enzyme system in 
hypertensive disorders of pregnancy, and in other gynaecological or obstetrical topics 
are presented. 
In Chapter 7, the aim of this thesis is outlined. 
In Chapter 2, a review of the glutathione / glutathione-related enzyme system, with 
special reference to gynaecological and obstetrical topics is given 
In Chapter 3, the results of a study on the presence of glutathione S-transferase 
Alpha 1-1 (GSTA1-1) and glutathione S-transferase Pi 1-1 (GSTP1-1) in human ovarian 
preovulatory follicular fluid of patients undergoing an m-vitro fertilization program are 
presented. Detectable levels of GSTP1-1 and especially GSTA1-1 are demonstrated in 
follicular fluid, which are not related to concentrations of oestradiol and progesterone. 
In Chapter 4, the expression of GST Alpha and GST Pi is demonstrated in several 
tissues from embryos at 8 weeks' gestational age, obtained at surgery for an ectopic 
twin-pregnancy Both GST Alpha and GST Pi are present in fetal liver tissue, 
gastrointestinal epithelia, the adrenal gland, and the tela chonoidea of brain tissue. GST 
Pi, but not GST Alpha is demonstrated in the epithelial tissue of pancreatic ducts and 
embryonic lung, trachea, nephrons, and urinary collecting ducts, and in the pia mater of 
brain tissue The presence of these two subtypes of GST, this early in embryonic 
development, especially in the epithelium of lungs, intestines, and urinary ducts points 
to the important role of these detoxicating enzymes in protecting the fetus from 
noxious agents early in development This is important, because several exogenous 
toxins are known to cross the trophoblast. 
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In Chapter 5, several studies are presented on the role of the glutathione / 
glutathione-related enzyme system in one of the most important obstetrical disease 
entities i.e gestational hypertension. 
In Paragraph 5 1, the glutathione levels, and activities of glutathione S-transferase, 
selenium-dependent and selenium-independent glutathione peroxidase in placental and 
decidual tissues of patients with preeclampsia or normotensive pregnancy are 
investigated. In decidual tissue the glutathione levels are higher than in any human 
tissue measured previously, both in preeclampsia and in normotensive pregnancy. In 
preeclampsia, placental and decidual total glutathione levels are significantly higher 
than those in normotensive pregnancy. In preeclampsia as compared to normotensive 
pregnancy, the selenium-dependent glutathione peroxidase activity is significantly 
higher in decidual tissue, whereas selenium-independent glutathione peroxidase activity 
is significantly higher in placental tissue Total GST activity in preeclampsia is not 
different from the activity in normotensive pregnancy The observed enhanced 
detoxicating capacity may point to a compensatory mechanism to protect the mother 
or the fetus from the increased load of oxygen free radicals or endogenous toxins. 
In Paragraph 5.2, the maternal whole blood glutathione levels and glutathione / 
haemoglobin ratios in pregnancies complicated by preeclampsia or the Haemolysis 
Elevated Liver enzymes Low Platelets syndrome (HELLP) are studied. Maternal whole 
blood glutathione / haemoglobin ratios are significantly lower in hypertensive 
pregnancies as compared to those in normotensive uncomplicated pregnancies, 
suggesting impaired detoxificating or radical scavenging capacity at the time of the 
disease 
In Paragraph 5.3 results are presented of a study on hepatocellular integrity in 
hypertensive disorders of pregnancy. This is assessed by measurements of serum 
alanine aminotransferase (ALT) activity and concentrations of plasma GSTA1-1, a 
sensitive and specific marker for hepatocellular integrity. GSTA1-1 is shown to be a 
more sensitive marker for hepatocellular integrity in hypertensive disorders of 
pregnancy, especially in preeclampsia and the HELLP syndrome, as compared to serum 
ALT activity Furthermore, when both parameters are evaluated, it is demonstrated that 
approximately 50% of patients with preeclampsia shows signs of impaired 
hepatocellular integrity. 
In Paragraph 5.4, the hepatocellular integrity in neonates born to mothers with the 
HELLP syndrome is assessed by plasma GSTA1-1 measurements Although the mothers 
show markedly elevated GSTA1-1 concentrations, their neonates demonstrate 
physiological concentrations. The HELLP syndrome may be caused by (placenta-derived) 
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endogenous toxins or oxygen free radicals This study indicates that these substances 
either do not cross the placenta or the fetus is not susceptible to their effects 
In Paragraph 5 5, the assessment of haemolysis in hypertensive disorders of 
pregnancy is evaluated Measurements of serum lactate dehydrogenase (LDH) activity 
and haptoglobin levels are not specific for haemolysis in hypertensive disorders of 
pregnancy These multi system disorders are characterized by haemolysis and impaired 
hepatocellular integrity, the latter resulting in leakage of liver specific LDH into the 
bloodstream and an impaired production of haptoglobin Hepatocellular impairment may 
thus lead to a falsely high estimate of the degree of haemolysis Additionally, the 
assessment of haptoglobin levels as an indirect marker for haemolysis, can not 
discriminate in the highest ranges of haemolysis due to a rapid depletion of circulating 
haptoglobin Glutathione S-transferase Pi 1-1 (GSTP1-1) is abundantly present in 
erythrocytes and is absent in hepatocellular tissue It has been demonstrated a good 
marker for haemolysis in haematological disease In our study the comparison of LDH, 
haptoglobin, and GSTP1 1 suggests that the estimation of haemolysis by 
measurements of GSTP1-1 plasma levels points to a lower degree of haemolysis than 
the commonly used parameters in hypertensive disorders of pregnancy 
In Paragraph 5 6, the hepatocellular integrity of non pregnant women who 
experienced a HELLP syndrome in the past is investigated Both hepatocellular integrity 
and albumin synthesis capacity is shown to be normal Interestingly, approximately 
20% of these former HELLP patients show elevated total serum bilirubin levels, an 
incidence which is significantly higher than the incidence in the normal population or in 
a control group of women with uncomplicated obstetrical histories This may point to 
Gilbert's syndrome, characterized by a dysfunction of the UDP-glucuronyltransferase 
system which is one of the most important detoxicating systems in humans 
In Chapter 6, results are presented of two studies on birth related changes in 
hepatocellular integrity of neonates 
In Paragraph 6 1, three parameters of neonatal hepatocellular integrity in umbilical 
cord blood aspartate aminotransferase (AST), ALT, and GSTA1-1 are compared AST is 
not a specific parameter for hepatocellular integrity, as apart from hepatocellular tissue, 
it is also found in high concentrations in heart and skeletal muscle kidney, pancreas 
and erythrocytes Haemolysis, for example, also contributes to increased AST serum 
levels ALT activity may not be sensitive enough GSTA1 1 is a sensitive and specific 
marker for hepatocellular integrity as shown in various acute hepatocellular diseases 
and birth related asphyxia The aminotransferases are penportally distributed in the 
liver whereas GSTA1-1 is distributed uniformly and therefore important for the 
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assessment of hypoxia related hepatocellular impairment Although related to base 
deficit , AST turns out to be of less value because maternal AST correlates with 
umbilical cord AST activity ALT is relatively insensitive as it does not correlate with 
markers for hypoxia GSTA1 1 seems to be a reliable marker for birth-related neonatal 
hepatocellular integrity Interestingly, the route of delivery has a significant influence on 
GSTA1-1, but not on AST and ALT levels Vaginal birth results in GSTA1-1 levels twice 
as high as those in caesarean delivery, suggesting a mild hypoxic stress which may 
affect centnlobular hepatic cells 
In Paragraph 6 2, umbilical cord GSTA1-1 levels are evaluated in a large group of 
neonates Results on GSTA1 1 measurements in umbilical cord blood can be confirmed, 
and multivariate analysis shows significant correlations with markers for hypoxic stress 
and metabolic impairment There are signs of hepatocellular impairment in groups with 
unfavourable pH ( < 7 20) at birth as compared to those with normal pH (г 7 20), 
whereas maternal factors do not influence neonatal umbilical cord GSTA1-1 levels 
GSTA1-1 may be cleared by the placenta 
In Chapter 7, results are presented on plasma GSTA1-1 levels in postmenopausal 
women before, and after hormone replacement therapy Previous studies show that 
GSTA1-1 significantly increases with age in women, but not in men The progesterone 
component in HRT is able to reduce plasma GSTA1-1 levels significantly, warranting a 
cautious interpretation of GSTA1-1 levels in postmenopausal women 
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Samenvatting en conclusies 
Het glutathion / glutathion-gerelateerde enzym systeem is in kwantitatieve zin één van 
de meest belangrijke ontgiftende systemen van de mens. Glutathion en glutathion-
gerelateerde enzymen (glutathion S-transferases en glutathion peroxidases) zijn 
betrokken bij de ontgifting van endo- en exogene toxinen, kankerverwekkende stoffen 
en zuurstofradicalen Daarnaast spelen met name de glutathion peroxidases een rol in 
het metabolisme van leukotnenen en Prostaglandines, stoffen van belang voor o.a. de 
bloedstolling en bloeddruk-regulatie. Bepaalde subtypen van de glutathion S-
transferases zijn signaalstoffen voor ziekten Recent hebben verschillende studies de 
aandacht gericht op mogelijke deficiënties van dit systeem bij verschillende vormen van 
zwangerschapsvergiftiging. Sinds 1995 bestudeert een projectgroep in een 
samenwerkingsverband tussen de afdeling gynaecologie-verloskunde en het 
laboratorium van de afdeling maag, darm- en leverziekten van het academisch 
ziekenhuis Nijmegen de rol van dit systeem bij diverse gynaecologische en 
verloskundige aandoeningen. In dit proefschrift worden diverse studies gepresenteerd 
over de rol van dit systeem bij diverse vormen van zwangerschapsvergiftiging, evenals 
bij andere gynaecologische en verloskundige onderwerpen. 
In hoofdstuk J wordt het doel van dit proefschrift uiteengezet 
In hoofdstuk 2 wordt een overzicht van het glutathion / glutathion-gerelateerde 
enzym systeem gegeven, met name met betrekking tot de rol van dit systeem bij 
gynaecologische en verloskundige aandoeningen, 
In hoofdstuk 3 worden de resultaten van een studie naar de aanwezigheid van 
glutathion S-transferase Alpha 1-1 (GSTA1-1) en glutathion S-transferase Pi 1-1 
(GSTP1-1) in follikelvocht van patientes die deelnamen aan een in vitro fertilizatie (IVF) 
programma gepresenteerd GSTA1-1 en met name GSTP1-1 worden in hoge 
concentraties aangetroffen in folhkelvocht, welke niet gerelateerd zijn aan de 
concentraties van de hormonen progesteron en 1 7ß-oestradiol 
In hoofdstuk 4 worden GST Alpha en GST Pi iso-enzymen aangetoond in zich 
ontwikkelende organen van 8 weken oude menselijke embryo's, verkregen bij een 
operatie voor een buitenbaarmoederlijke zwangerschap. Zowel GST Alpha als Pi zijn 
aanwezig in levercellen, epitheel van weefsel van het spijsverteringskanaal, bijniermerg 
en m de ζ g tela chorioidea van de grote hersenen GST Pi, maar niet Alpha werd 
aangetoond in het epitheel van pancreasklierbuizen en longblaasjes, de luchtpijp, 
nierlichaampjes, urine-verzamelbuizen en in het zachte hersenvhes van de grote 
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hersenen De aanwezigheid van deze twee GST-subtypen in deze vroege embryonale 
ontwikkelingsfase, met name in de bekledende shjmlagen van longen, darmen en 
urinewegen geven een aanwijzing voor het belang van deze ontgiftende enzymen vroeg 
in de ontwikkeling Deze resultaten suggereren dat het embryo al vroeg m staat is 
giftige stoffen onschadelijk te maken. 
In hoofdstuk 5 worden verschillende studies gepresenteerd over de rol van het 
glutathion / glutathion-gerelateerde enzym systeem bij één van de belangrijkste 
verloskundige ziektebeelden: zwangerschapshypertensie Zwangerschapshypertensie is 
een syndromale ziekte, waarbij meerdere orgaansystemen zijn betrokken. De werkelijke 
oorzaak van de diverse vormen van zwangerschapshypertensie is ondanks veel 
onderzoek nog onbekend. Mogelijk is er sprake van het ontstaan van een giftige stof of 
zogenaamde zuurstofradicalen in de placenta (moederkoek), die vrijkomen in de 
moederlijke bloedsomloop, met als gevolg moederlijke ziekte Immunologische 
mechanismen kunnen hieraan ten grondslag liggen, danwei een gedeeltelijk ontbrekend, 
of slecht functionerend ontgiftend systeem. 
In paragraaf 5. 1 worden de activiteiten van de glutathion S-transferases en selenium-
afhankelijke en onafhankelijke glutathion peroxidases, alsmede concentraties van 
glutathion in de placenta en de decidua1 van vrouwen met pre-eclampsie2 bestudeerd 
Zowel bij gezonde zwangeren als zwangeren met pre-eclampsie worden in de decidua 
zeer hoge concentraties glutathion aangetroffen, hoger dan bekend van welk menselijk 
weefsel dan ook De glutathion concentraties zijn in zowel de placenta als de decidua 
hoger bij pre-eclamptische zwangerschappen in vergelijking met gezonde 
zwangerschappen. BIJ zwangeren met pre-eclampsie waren zowel de selenium-
afhankelijke glutathion peroxidase activiteit in de decidua, als de selenium-
onafhankelijke glutathion peroxidase activiteit in de placenta verhoogd, in vergelijking 
met gezonde zwangerschappen Deze toegenomen 'ontgiftende capaciteit' wijst 
mogelijk op een compensatiemechanisme ter bescherming van de moeder en het 
ongeboren kind tegen mogelijke zuurstofradicalen en endogene toxinen, mogelijk 
geproduceerd door de placenta. Dit compensatiemechanisme is bij deze patiënten 
echter niet toereikend. 
In paragraaf 5.2 worden de glutathion concentraties in het bloed van zwangeren met 
' slijmvlies dat de baarmoederholte bekleedt tijdens de zwangerschap 
2 zwangerschapsvergiftiging, gekenmerkt door hoge bloeddruk en eiwitverlies in de urine 
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ernstige pre-eclampsie en/of het HELLP syndroom3 bestudeerd. De moederlijke 
glutathion concentraties in deze groep patiënten zijn lager dan die van gezonde 
zwangeren, wat suggereert dat deze zwangeren minder in staat zijn circulerende 
zuurstofradicalen of giftige stoffen onschadelijk te maken tijdens hun ziekte. 
In paragraaf 5 3 worden de resultaten gepresenteerd van een studie naar 
leverbeschadiging bij diverse vormen van zwangerschapsvergiftiging, te weten 
zwangerschapshypertensie, pre-eclampsie en het HELLP syndroom De leverschade 
werd geëvalueerd middels bepalingen van de alanine aminotransferase (ALAT) en 
GSTA1-1 concentraties in het bloed. De activiteit van het ALAT in het moederlijke 
bloed, een enzym dat zich in de lever bevindt en vrijkomt bij leverbeschadiging, wordt 
beschouwd als de standaard-meting voor leverschade. GSTA1-1 is een ontgiftend 
enzym dat zich in hoge concentraties in de lever bevindt Het blijkt dat GSTA1-1 een 
gevoeligere maat voor leverschade is dan ALAT bij pre-eclampsie en het HELLP 
syndroom Als beide metingen worden geëvalueerd, blijkt dat er bij méér pre-eclampsie 
patiënten sprake is van leverschade dan gerapporteerd in de literatuur. 
In paragraaf 5 4 wordt m.b ν GSTA1-1 metingen in navelstrengbloed mogelijke 
leverschade bij pasgeborenen van moeders met het HELLP syndroom onderzocht 
Hoewel de moeders met het HELLP syndroom duidelijk verhoogde GSTA1-1 waarden 
hadden, waren de GSTA1-1 concentraties van hun kinderen niet verhoogd 
In paragraaf 5 5 worden drie verschillende metingen van de hémolyse4 bij 
zwangerschapshypertensie, pre-eclampsie en het HELLP syndroom vergeleken, te 
weten, lactaat dehydrogenase (LDH), haptoglobine en GSTP1-1 LDH bevindt zich zowel 
in rode bloedcellen als in levercellen, dus als LDH als maat voor hémolyse gebruikt 
wordt bij ziektebeelden die zich tevens kenmerken door levercelverval (zoals b.v 
zwangerschapsvergiftiging), kan de mate van hémolyse te hoog ingeschat worden Ook 
haptoglobine, een indirecte maat voor hémolyse, kan een vals hoge indruk geven van 
bloedcelafbraak, omdat bij leverbeschadiging de aanmaak van dit molekuul gestoord is. 
Tevens kan er geen onderscheid gemaakt worden in de mate van hémolyse als het 
haptoglobine onmeetbaar laag is. GSTP1-1 bevindt zich in hoge concentraties in rode 
bloedcellen en komt vrij bij hémolyse. Het bevindt zich niet tot nauwelijks in 
leverweefsel Uit deze studie blijkt dat als GSTP1-1 gemeten wordt, er minder sprake 
van hémolyse lijkt te zijn dan geschat zou worden op grond van LDH en haptoglobine 
vorm van zwangerschapsvergiftiging, gekenmerkt door afbraak van rode bloedcellen, 
leverbeschadiging en een afname van het aantal bloedplaatjes in de bloedbaan 
' afbraak van rode bloedcellen 
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metingen. 
In paragraaf 5 6 wordt de leverfunctie onderzocht van een groep vrouwen die in het 
verleden een HELLP syndroom hebben doorgemaakt Het blijkt dat de leverfunctie en de 
synthesecapaciteit van albumine zich volledig hersteld hebben. BIJ 20% van deze 
voormalige HELLP patiënten werden te hoge totaal bilirubine concentraties gevonden, 
wat een hogere mcidentie is dan die in de normale bevolking of in een groep vrouwen, 
met een ongecompliceerde verloskundige voorgeschiedenis Dit is een aanwijzing dat 
een deel van deze vrouwen lijdt aan het syndroom van Gilbert, wat zich kenmerkt door 
een stoornis in het z.g UDP-glucuronyltransferase systeem. Mogelijk kan deze stoornis 
de ontwikkeling van het HELLP syndroom in de hand werken 
In hoofdstuk 6 worden de resultaten gepresenteerd van twee studies naar aan de 
geboorte gerelateerde leverbeschadiging bij pasgeborenen. 
In paragraaf 6 7 worden de resultaten gepresenteerd van de vergelijking tussen drie 
verschillende parameters voor levercelbeschadiging in navelstrengbloed, t.w aspartaat 
aminotransferase (ASAT), ALAT en GSTA1-1. De ASAT bepaling lijkt minder geschikt, 
omdat er een relatie bestaat tussen moederlijke en kinderlijke concentraties. De ALAT 
bepaling lijkt eveneens van minder belang, omdat geen enkele geboorteparameter 
invloed heeft op de ALAT concentratie. GSTA1-1 leek de meest geschikte parameter, 
omdat deze duidelijk correleerde met diverse klinische parameters en met met de 
moederlijke concentraties. De GSTA1-1 concentraties blijken hoger te zijn bij vaginale 
bevallingen in vergelijking met die bij keizersneden, terwijl de ASAT en ALAT 
activiteiten dit verschil niet vertonen. Dit wijst op een lichte mate van 
levercelbeschadiging als gevolg van de vaginale geboorte, mogelijk als gevolg van een 
hypoxische beschadiging van het centrale deel van de leverlobjes. 
In paragraaf 6.2 werden de GSTA1-1 concentraties in navelstrengbloed geëvalueerd 
in een grote groep pasgeborenen. De resultaten van paragraaf 6.2 werden bevestigd en 
een multivariate analyse het een significant verband zien met andere parameters voor de 
conditie van het kind, zoals de zuurgraad (pH) en het base-overschot. Er zijn 
aanwijzingen voor levercelverval bij pasgeborenen met een ongunstige pH (< 7,20) bij 
de geboorte, in vergelijking met een groep pasgeborenen met een gunstige pH ( i 7,20). 
Tevens bleek dat moederlijke factoren de navelstrengbloed GSTA1-1 concentraties niet 
beïnvloeden. GSTA1-1 lijkt door de placenta uit het navelstengbloed verwijderd te 
worden. 
Tot slot worden in hoofstuk 7 de resultaten besproken van GSTA1-1 metingen in 
bloed van vrouwen in de postmenopauze vóór en na behandeling met hormonale 
substitutie-therapie. Uit eerdere studies van is gebleken dat de bloedconcentratie van 
GSTA1-1 bij vrouwen stijgt met toename van de leeftijd, terwijl dit bij mannen niet het 
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geval was. Dit zou mogelijk een gevolg kunnen zijn van het wegvallen van de 
beschermende invloed van vrouwelijke geslachtshormonen. Aanvulling van deze 
hormonen bij vrouwen in de overgang bracht inderdaad een daling teweeg van de 
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worden. Succes met je vele werkzaamheden. 
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gezwicht bent voor de industrie. Bedankt voor je 'erfenis'1 
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Prof dr J.B.M.J. Jansen Bedankt voor Uw onvoorwaardelijke steun aan dit 
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dank voor het beschikbaar stellen van je materiaal en expertise als postmenopauze-
goeroe en vele andere hulp. 
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Medewerkers CKCL, hartelijk dank voor het verwerken van de vele monsters. 
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behorende bij het proefschrift 
T H E G L U T A T H I O N E / O L U T A T H I O N E - R E L A T E D E N Z Y M E S Y S T E M IN R E P R O D U C T I O N 
Maarten Knapen, 18 september 1998 
1 Stellingen over eigen onderzoek kunnen het lezen van het bijbehorende proefschrift 
voorkomen 
2 Een goede samenwerking tussen basale onderzoekers en artsen in de kliniek leidt tot 
synergisme 
3 Samenwerking tussen verloskundige en gynaecoloog (in opleiding) is geen zaak van 
' twee geloven op een kussen' maar is gebaseerd op wederzijds respect en 
vertrouwen 
4 Eigenwijsheid is niet altijd wijsheid 
5 De penconceptionele periode is meer bepalend voor de uitkomst van de 
zwangerschap dan alle maanden daaropvolgend 
6 Het uitstellen van de eerste zwangerschap en het gebruik van 
fertiliteitsbevorderende therapieën verhogen de prevalentie van meerlingen in 
Nederland enorm De Nederlandse bevolking zou hierover geïnformeerd dienen te 
worden 
Steegers-Theumssen RPM et al, J Reprod Med 1998,43 173 9 
7 Het zg zoutarme dieet voorkomt en geneest zwangerschapshypertensie niet, het 
voorschrijven hiervan is derhalve zinloos 
- Knuist M et al, Br J Obstet Gynaecol 1998,105 430 4, Van Buut BJA et al. Hypertension m 
Pregnancy 1997,16 335 346 
8 In vivo magnetische resonantie spectroscopie (MRS) is mogelijk een nieuwe non-
i nvas i ve onderzoeksmethode ter differentiatie van maligne en benigne 
ovariumtumoren 
- Massuger LFAG et al. Cancer 1998,82 1726 30 
9 Hyperhomocysteinemie is een onafhankelijke risicofactor voor cardiovasculaire 
aandoeningen atherosclerotische plaques in de carotisartene gaan deels in regressie 
tijdens suppletie van foliumzuur gecombineerd met pyridoxine en vitamine B12 
Graham IM et al, JAMA 1997,277 1775-81, Peterson JC et al, Lancet 1998,351 263-
10 Chance favours the prepared mind 
- Louis Pasteur 
MFCM Knapen 
11 The words used in clinical medicine have a tremendous influence on the subject 
they describe or purport to describe They perpetuate illnesses, syndromes and signs 
whose existence is doubtful, they deny recognition to others whose existence is 
beyond question and, moreover, they distort text-book descriptions to conform to 
the chosen word 
Asher R Richard Asher Talking Sense London Pitman 1972 ρ 25-
12 Een typediploma volgens het tienvingersysteem (blind) is eén van de meest 
waardevolle diploma's voor onderzoekers 
- eigen ervaring -
13 Het verrichten van een promotieonderzoek levert een positieve waarde aan de 
vorming tot medisch specialist, wat niet geëvenaard kan worden door een te 
langdurig AGNIO - arbeidsverleden 
14 Doofheid en slechthorendheid zijn sociaal sterk invaliderende en maatschappelijk 
nauwelijks onderkende ziektebeelden In Nederland lijden een miljoen mensen aan 
een gehoorverhes van meer dan 25 decibel, 350 000 daarvan dragen een 
gehoorapparaat van wie de helft ouder is dan 55 jaar 
De Volkskrant, 24 - 1 19Э8 -
15 Een AIO schap wordt zwaar onderbetaald Co-schappen, ook een postdoctorale 
opleiding, worden gewoon niet betaald 
16 Studeren dient voor iedereen financieel mogelijk te blijven, en er dient niet 
gediscrimineerd te worden op grond van leeftijd 
1 7 All great truths were once blasphemies 
George Bernard Shaw 


